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Aims 
1.  To develop and apply quantitative polymerase chain reaction tools for 
the  detection  of  Coxiella  burnetii  in  waste  from  livestock  production 
industries. 
2.  To develop a quantitative assay to assess the efficacy of disinfectants 
against Coxiella burnetii in liquid waste from livestock production. 
3.  To develop molecular tools to determine the viability of Coxiella burnetii 
recovered from wastes of livestock production. 
4.  To develop an enzyme-linked immunosorbent assay for the detection 
of anti-Coxiella burnetii antibodies in Australian marsupials.  
12/06/2009  School of Veterinary and Biomedical Sciences   
xxiv 
Thesis abstract 
The  aim  of  this  study  was  to  develop  improved  methods  to  detect  viable 
Coxiella burnetii in wastes from livestock production.  The impetus for this work 
arose  because  there  is  a  significant  risk  of  infection  for  humans  attributed  to 
contact with waste products from the livestock production industry.  This situation 
is further compounded by the lack of suitable tools to detect viable C. burnetii in 
these wastes.  In addition, effective disinfection strategies for livestock wastes are 
also  required  to  reduce the risk of infection with  C. burnetii  for  individuals that 
come into contact with these waste products. 
A  quantitative  real-time  PCR  system  (qPCR)  with  high  sensitivity  and 
specificity  was  developed  to  detect  the  C.  burnetii  in  environmental  samples 
associated with domestic ruminants and native Australian marsupials.  Different 
detection chemistries and procedures were evaluated based on their sensitivity, 
specificity and reproducibility.  Overall it was found that the TaqMan PCR targeting 
the  IS1111a  locus  provided  the  most  sensitive  and  reproducible  test.    The 
Geneworks PowerSoil™ DNA isolation kit provided the best compromise between 
reproducibility and recovery of DNA from livestock wastes.  When combined, the 
IS1111a TaqMan qPCR and Geneworks PowerSoil DNA Extraction Kit provided a 
test which was capable of detecting as few as two C. burnetii genome equivalents 
in 0.2g of soil or faeces. 
Coxiella  burnetii  has  been  shown  to  display  extreme  resistance  to 
environmental exposure.  Therefore, assessment of the viability of the organism in 
environmental  matrices  is  more  useful  for  risk  assessment  programs  than 
detection of DNA alone.  A quantitative reverse transcriptase PCR was developed  
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that was able to detect viable C. burnetii cells in soil.  The sensitivity of the assay 
was enhanced by heat-treating the soil samples prior to extraction of RNA. 
The  factor  most  often  associated  with  transfer  of  C.  burnetii  to  humans  is 
exposure to livestock or their waste.  Therefore, decontamination of waste from 
livestock production industries is a key factor in preventing outbreaks of Q fever.  
A  system  was  developed  to  determine  the  efficacy  of  various  disinfectant 
treatments against the environmental pathogen C. burnetii.  Treatments evaluated 
included sodium  hypochlorite, ozone,  ultraviolet  light, peracetic acid (PAA), and 
Virkon  S
®.    Sodium  hypochlorite  at  a  concentration  of  0.1  mM  reduced  the 
infectivity  of  C.  burnetii  by  over  92%  while  treatment  with  the  same  sodium 
hypochlorite  concentration  in  wastewater  showed  significantly  reduced  efficacy.  
Despite this reduced potency, sodium hypochlorite is still useful for control of C. 
burnetii in the liquid waste of animal production. 
Commercially available ELISA and CFT assays exist for ruminants but there 
are no immunological tests available for detecting C. burnetii in marsupials even 
though  Australian  marsupials  are  known  to  be  susceptible  to  C.  burnetii.    An 
indirect ELISA for detecting anti-Coxiella antibodies in kangaroos was developed.  
Paired serum and faecal samples were taken from 379 ruminants from Western 
Australia and the serum was tested with a commercially available ELISA and the 
complement fixation test while the faeces was tested using the qPCR developed 
during  this  study.    Paired  serum  and  faecal  samples  were  taken  from  343 
kangaroos from WA and were tested with the antibody-ELISA developed during 
this study and by qPCR. A very low prevalence of anti-Coxiella antibodies was 
observed  in  the  ruminants  sampled  and  results  from  immunological  tests 
correlated poorly with qPCR data.  The development of an ELISA for use with 
kangaroo  serum  was  problematic  because  of  the  lack  of  reference  sera  from  
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animals known to be infected with C. burnetii.  Despite this results from the ELISA 
developed  suggested  that  the  apparent  seroprevalence  in  the  WA  animals 
surveyed was approximately 34%.  Results from testing kangaroo faeces with the 
qPCR  correlated  poorly  with  the  results  from  the  antibody-ELISA.  These  data 
suggest that kangaroos may be a significant reservoir of C. burnetii in Western 
Australia  and  due  to  cohabitation  of  kangaroos  and  domestic  ruminants,  may 
provide a link between the wildlife and domestic cycles of C. burnetii.  
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1.  Literature review  
 
1.1  Historical aspects 
From  1933  onwards  a  series  of  acute  febrile  illness‟s  were  observed  in 
workers  from  a  slaughterhouse  in  Brisbane,  Queensland,  Australia  who  were 
serologically negative for infection with pathogens that were known, and could be 
tested for, at the time (Babudieri 1959).  A consistent pattern to the infections was 
observed by Ted Derrick who was the chief investigator of the Brisbane outbreak.  
The similarities between individual cases indicated a common cause and in 1937 
Derrick  described  a  fever  of  unknown  origin  in  meat  workers  in  Queensland, 
Australia  that  was  subsequently  named  „Query‟  (Q)  fever  (Babudieri  1959; 
Williams and Sanchez 1994).  The causative agent was initially thought to be a 
virus despite the fact that rickettsia-like organisms were identified in the spleens of 
infected laboratory animals (Reimer 1993). 
Burnet  and  Freeman  initially  described  the  organisms  isolated  from  clinical 
material from Q fever patients as a rickettsia, which led to the name Rickettsia 
burneti (Reimer 1993).  At approximately the same time a group of researchers in 
Montana, USA, led by a rickettsiologist named Herald Cox, were investigating a 
tick-borne agent which resulted in a laboratory-acquired illness.  They isolated a 
small  Gram  negative  rod  which  they  named  Rickettsia  diaporica.  Subsequent 
investigation  showed  that  the  organism  isolated  by  Cox  was  the  same  as  the 
causative agent of the Brisbane outbreaks isolated by Burnet (Babudieri 1959).  
Continuing research by the Australian authors led to a greater understanding of 
the nature of Q fever including the organism‟s ability to infect wild animals which 
they thought might provide a natural reservoir for the disease (Derrick 1939; Smith  
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1940).  Arthropod vectors were shown to be able to carry the Q fever agent (Smith 
1940) and it was speculated that the tick Haemophysalis humerosa was involved in 
the sylvatic cycle of the organism (Derrick 1939) and could transmit infection to 
cattle (Babudieri 1959).  Infection of humans was at that time thought to occur via 
tick bite or, perhaps, inhalation of contaminated dust.  A laboratory epidemic of Q 
fever in 1940 demonstrated that the primary method of transmission was inhalation 
(Dyer, Toppings et al. 1940).  The same study also implied that some instances of 
disease previously categorised as “primary atypical pneumonia” could in fact have 
been caused by Q fever. 
Numerous  epidemics  of  a  febrile  disease,  given  the  name  „Balkangrippe‟, 
plagued  German  occupying  forces  in  Europe  during  World  War  II  (Babudieri 
1959).  After the end of the war these cases were retrospectively classified as Q 
fever (Babudieri 1959).  The end of the war also appeared to coincide with the 
disappearance  of  the  disease  from  the  Balkans  and  Italy,  which  lead  to  the 
hypothesis that the disease had been imported by American and Australian troops 
(Babudieri 1959).  However, new outbreaks occurred in 1947 and 1948 in southern 
Germany and Italy that were later proven to be caused by R. burneti (Babudieri 
1953). 
In 1948 several phenotypic traits of the agent of Q fever led to the organism 
being removed from the genus Rickettsia and a new genus being established.  To 
reflect the contributions made by both Burnet and Cox the genus was renamed 
Coxiella and the agent hence became C. burnetii (Reimer 1993).  Since the late 
1940‟s  interest  in  Q  fever  and  advances  in  immunological  and  molecular 
techniques has stimulated a large amount of research into this disease and the 
aetiological  agent  (Babudieri  1959).    More  recently,  the  threat  of  bioterrorism  
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(Kagawa, Wehner et al. 2003; Welch, Baselski et al. 2003; Hassani, Patel et al. 
2004; Beare, Samuel et al. 2006) has stimulated additional research in this area. 
1.2  Bacteriology 
1.2.1  Classification and related species 
Since Rickettsia burneti was renamed Coxiella burnetii in 1948 (Philip 1948) it 
has  remained  the  only  definitively  characterised  member  of  that  genus.    Gene 
sequence analysis has led to placement of the Coxiella genus within the gamma 
subdivision of the proteobacteria in the order Legionellae, family Coxiellaceae but 
the  genus  is  significantly  removed  from  other  members  of the γ-proteobacteria 
(Seshadri,  Paulsen  et  al.  2003).    While  Coxiella  shares  lifecycle  and  parasitic 
strategies  with  other  members  of  the  Rickettsiae  and  Chlamydiae,  genome 
analysis has revealed that their genetic structures differ considerably in terms of 
metabolic capabilities, transporter profiles, the extent of genome reduction and the 
presence of mobile genetic elements  (Seshadri, Paulsen et al. 2003).  Instead, 
Coxiella is most closely related, in terms of phylogenetic analysis, to the pathogens 
Rickettsiella and Legionella (Weisburg, Dobson et al. 1989; Roux, Bergoin et al. 
1997).  Both L. pneumophila and C. burnetii multiply in host alveolar macrophage 
phagosomes and it has been demonstrated that they also contain similar icm/dot 
pathogenesis  systems  which  assist  intracellular  multiplication  (Zusman, 
Yerushalmi and Segal, 2003). 
Recent  investigations  indicate  that  there  are  more  members  of  the  genus 
Coxiella but they are yet to be cultured or named.  Coxiella-like organisms have 
been described from several species of ticks from varied geographical locations 
(Noda, Munderloh et al. 1997; Bernasconi, Casati et al. 2002; Mediannikov, Ivanov 
et al. 2003; Lee, Park et al. 2004; Reeves, Loftis et al. 2005).  Reeves et al. (2005)  
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used genetic methods to characterise an agent found in bat ticks which showed a 
strong similarity to C. burnetii.  However, results from standard PCR‟s performed 
to detect several C. burnetii genes were negative indicating that these genes are 
either  lacking  or  have  significantly  different  sequences  in  this  novel  bacterium.  
Similarly, a study in Korea identified a Coxiella spp., which possessed the com1 
gene but lacked the icd, cbhE’ and cbbE’ genes found in C. burnetii.  These results 
indicate that com1 is a genus specific gene whereas genes such as icd, cbhE’ and 
cbbE’ are specific for C. burnetii (Lee, Park et al. 2004).  Bernasconi et al. (2002) 
found Coxiella species in eight ticks in Switzerland that were, with the exception of 
one of the isolates, identical to the endosymbiont identified by Noda et al. in 1997.  
This  endosymbiont  was  distinguished  from  Coxiella  burnetii  using  phylogenetic 
analysis of the 16S rDNA sequence (Noda, Munderloh et al. 1997).  Homology of 
the 16S rDNA sequence of an organism isolated from Haemaphysalis concinnae 
ticks in far east Russia indicated that the organism was most closely related to C. 
burnetii and the organism isolated by Noda et al. (2007) (Mediannikov, Ivanov et 
al. 2003).  A proposed novel species of Coxiella (cheraxi) was also isolated from 
the  Australian  redclaw  crayfish  (Cherax  quadricarinatus)  and  showed  95.6% 
homology to C. burnetii based upon 16S rRNA sequences (Tan and Owens 2000).  
The authors proposed that this novel species of Coxiella may have diverged from 
C. burnetii approximately 200 million years ago.  There has been some debate 
about the inter-strain homogeneity of C. burnetii. Using DNA-DNA hybridisation, 
Vodkin  et  al  (1986)  found  little  genetic  variation  between  different  isolates.  
Conversely,  Thiele  et  al.  (1993)  found  considerable  heterogeneity  in  DNA 
restriction patterns of C. burnetii isolates using pulsed field gel electrophoresis.  
12/06/2009  School of Veterinary and Biomedical Sciences   
1-5 
1.2.2  Morphology 
Coxiella  burnetii  is  a  pleomorphic  obligate  intracellular  bacterium  that 
replicates  to  high  number,  albeit  slowly  (Zamboni,  Mortara  et  al.  2001),  in  the 
phagolysosomes  of  eukaryote  phagocytic  cells  (Hackstadt  and  Williams  1981).  
Analysis of the complete genome of Coxiella Nine Mile phase I RSA493 showed 
83 pseudogenes many of which were disrupted by only a single frameshift, which 
suggests  that  they  are  relatively  recent  developments.    Thus  it  seems  that  C. 
burnetii is undergoing reductive evolution and that the obligate intracellular lifestyle 
of the bacterium may only be a recent innovation (Seshadri, Paulsen et al. 2003). 
Coxiella burnetii has a cell wall structure that resembles other Gram negative 
bacteria in that it is tri-laminar with a dense intermediate layer which shares many 
common chemical elements with the peptidoglycan found in other Gram negative 
bacteria  (Amano  and  Williams  1984).    However,  while  Coxiella  possesses 
enzymes required for the early stages of peptidoglycan synthesis it appears to lack 
enzymes  that  are  needed  to produce the final form of the polymer.   This may 
indicate  that  C.  burnetii  obtains  the  necessary  intermediates  for  formation  of 
peptidoglycan  from  its  host  (Gonzales  and  Paretsky  1981).    Furthermore,  C. 
burnetii fails to take Gram stain well and gives a variable result when exposed to 
this stain (Gimenez 1965; McCaul and Williams 1981). 
1.2.3  Phase variation 
Antigenic  variation  similar  to  the  rough/smooth  phenomena  seen  in  many 
Gram negative bacteria has been observed in various strains of C. burnetii.  The 
most studied example is the Nine Mile strain which was isolated from ticks near 
Nine Mile River in Montana.  Serial passage of this isolate through embryonated 
eggs resulted in a variant which was antigenically distinct from the organism that  
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was  originally  isolated  (Stoker  and  Fiset  1956)  and  which  seems  to  be  at  a 
selective advantage under in vitro conditions (Burton, Stueckemann et al. 1978; 
Moos and Hackstadt 1987). 
The transition from “wild-type” phase I to non-pathogenic phase II in the Nine 
Mile strain is characterised by the gradual loss of the methylated sugars virenose 
and dihydrohydroxystreptose (Ftacek, Skultety et al. 2000; Slaba, Hussein et al. 
2003) as well as many other sugar components of the “O” antigen side chains.  
Some components of the outer core of the LPS are also lost (Schramek and Mayer 
1982;  Schramek,  Radziejewska-Lebrecht  et  al.  1985;  Amano,  Williams  et  al. 
1987).  The loss of various antigenic components of C. burnetii LPS appears to 
occur in a set, sequential order  during serial passage of the organism through 
tissue culture with two “intermediate” forms between phase I and phase II (Hotta, 
Kawamura et  al. 2002).   While phase I LPS can be chemically reduced to the 
phase  II  form  Ftacek  et  al  (2000)  observed  that  in  vitro  shortening  of  the  O-
polysaccharide  chains  does  not  occur,  instead  there  is  a  redistribution  of  the 
existing LPS populations due to an increase in the number of cells expressing 
truncated O-chains.  It seems that this redistribution of LPS populations results in 
the  phase  II  form  of  C.  burnetii  binding  much  more  strongly  to  host  cell 
components than phase I (Williams, Peacock et al. 1981).  Slaba and associates 
also found this with a series of experiments which showed that phase II LPS was 
more  exposed  than  phase  I  LPS  to  components  of  the  host‟s  immune  system 
(Slaba, Hussein et al. 2003).  This could explain why phase II Coxiella is more 
easily cleared by the host‟s immune system.  The lippopolysaccharide of Coxiella 
is a very important molecule in the defence of the organism against the host‟s 
immune  system  (Lukacova  and  Kazar  1996).    Phase  II  variants  of  C.  burnetii 
appear  to  have  reduced  virulence  in  comparison  to  phase  I  strains  (Moos  and 
Hackstadt  1987;  Andoh,  Russell-Lodrigue  et  al.  2005).    Ormsbee  et  al  (1978)  
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found that phase I was in fact 3000 times more infective than phase II in a guinea 
pig model.  Conversely, it seems that phase II cells are significantly more infective 
for  tissue  culture  cells  than  phase  I  cells  (Moos  and  Hackstadt  1987;  Baca, 
Klassen et al. 1993).  Moos and Hackstadt (1987) also found that Nine Mile Crazy 
variant,  which  has  intermediate  length  LPS,  displays  an  intermediate  level  of 
infectivity.  However, attachment and internalisation of C. burnetii appears to be a 
passive endocytotic event (Baca, Klassen et al. 1993). 
In the Nine Mile strain the change from phase I to phase II LPS occurs with a 
concomitant  chromosomal  deletion.    This  deletion  has  been  shown  to  span  a 
region characterised by a high number of genes postulated to be associated with 
LPS  and  lipooligosaccahride  (LOS)  synthesis  and  general  carbohydrate 
metabolism  (Vodkin  and  Williams  1986;  Hoover,  Culp  et  al.  2002;  Denison, 
Massung et al. 2007).  It appears that for C. burnetii phase variation may provide a 
means  to  conserve  energy  in  immunocompromised  hosts  by  removing 
metabolically expensive structures on the cell surface that are required for host 
immune system evasion (Ftacek, Skultety and Toman, 2000).  However, phase 
variation is not completely consistent between isolates in regard to the size and 
location  of  the  chromosomal  deletion  and  LPS-synthesis  genes  are  not  always 
involved (Vodkin and Williams 1986).  Thompson et al. (2003) used sequencing 
and  PCR  with  a  comprehensive  set  of  primers  to  search  for  chromosomal 
deletions in three strains, the M-44 Grita strain and the Australian strains QD and 
C5, which have been shown to have truncated LPS.  The primers were designed 
to  cover  the  region  corresponding  to  the characteristic deleted region from  the 
phase II Nine Mile strain.  The authors‟ results indicated that none of the three 
strains  examined  contained  deletions  that  would  affect  function  in  the  same 
regions as the Nine Mile strain.  Phase II isolates that have been shown to have  
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the deletion include NM phase II clone 4, NM phase II clone 1, NM Baca and RSA 
514 (Denison, Massung et al. 2007). 
1.2.4  Lifecycle stages 
McCaul and Williams (1981) proposed the names small cell variant (SCV) and 
large cell variant (LCV) for two morphologically distinct C. burnetii cells seen in 
persistently infected host cells.  A third lifecycle variant called the small dense cell 
(SDC)  has  also  been  proposed  (McCaul  and  Williams  1981),  which  is 
distinguishable  from  the  SCV  by  the  increased  physical  resistance  it  displays 
(McCaul,  Banerjee-Bhatnagar  et  al.  1991).    Both  LCV and SCV have a typical 
Gram negative cell wall containing two distinct layers separated by the periplasmic 
space.  The SCV differs in that the space between layers in its cell wall is filled with 
a material comprised of peptidoglycan and proteins and may explain the increased 
environmental stability of the SCV in comparison to the LCV (McCaul and Williams 
1981).  A later study demonstrated that the LCV had only 2% peptidoglycan by 
weight whereas the SCV contained 32% (Amano, Williams et al. 1984).  It was 
proposed that incomplete cross-linking of peptidoglycan was responsible for the 
increased  susceptibility  of  the  LCV  to  lysis  by  osmotic  shock  and  other 
environmental stressors (Amano, Williams et al. 1984).  Furthermore, where the 
LCV is typically up to 2 µm in length, has dispersed chromatin and possesses a 
more rounded shape, the SCV is rod shaped with a length of about 0.45 µm and 
an  electron-dense  nucleoid  (Nermut,  Schramek  et  al.  1968).    Both  of  these 
variants are metabolically active but the processing of glucose and glutamate is 
considerably lower in the SCV than the LCV (McCaul, Hackstadt et al. 1981).  The 
existence of an in vivo C. burnetii endogenous spore was confirmed in 1994 by 
electron microscopic examination of three cardiac valves from different patients 
with Q fever endocarditis.  Previously this life cycle variant had only been observed  
12/06/2009  School of Veterinary and Biomedical Sciences   
1-9 
in vitro (McCaul, Dare et al. 1994). Both SCV and LCV are capable of dividing by 
binary fission within an appropriate host cell.  
Coleman et al. (2004) performed a temporal analysis of the differentiation of 
C. burnetii and found that Coxiella’s lifecycle followed a typical bacterial growth 
cycle.    A  lag  phase  followed  infection  of  host  cells  during  which  time  SCV‟s 
differentiated into LCV‟s.  The LCV predominates during exponential growth which 
supports earlier work showing that this form is metabolically and replicatively active 
(Zamboni, Mortara et al. 2001).  During the transition from exponential growth to 
stationary phase the population proportions changed such that SCV become more 
prevalent.    This  progression  was  paralleled  by  a decrease in metabolic activity 
(Coleman, Fischer et al. 2004) as was proposed by Zamboni et al (2001).  During 
differentiation  a sporulation-like process occurs where the septum  is positioned 
asymmetrically to form a differentiated daughter cell (SCV) which is released from 
the mother cell following cell lysis (McCaul, Williams et al. 1991). 
1.2.5  Tissue tropism 
Coxiella burnetii has been shown to have a strong affinity for mononuclear 
phagocytes  and  therefore  can  be  found  readily  in  the  spleen,  liver  and  bone 
marrow during the acute stage of Q fever (Baca and Paretsky 1983; Baumgartner 
and Bachmann 1992).  Further evidence for this predilection was provided by a 
vaccination trial in mice, which showed that the spleens of the animals contained 
as  many  as  20-fold  more  Coxiella  than  the  next  most  heavily  infected  tissue 
sampled (liver) (Zhang, Wen et al. 2005). In addition, the number of bacteria in 
spleen tissue remained elevated for 13 days once infection had been established 
but blood and lung tissue samples had relatively low levels of infection (Zhang,  
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Wen et al. 2005).  This indicates that the spleen is the major site of C. burnetii 
replication in non-pregnant mice. 
In  pregnant  animals  it  appears  that  C.  burnetii  displays  a  tropism  for 
reproductive tissues.  The trophoblast cells of chorioallantoic membrane were the 
first cells infected in the placenta of pregnant goats experimentally infected with 
Coxiella  (Sanchez,  Souriau  et  al.  2006).    The  same  study  also  showed  that 
massive bacterial multiplication occurred in the portion of the placenta that was 
associated with the foetus in the last week of pregnancy while the maternal portion 
remained  relatively  lesion  free  and  contained  only  low  levels  of  Coxiella.    This 
great proliferation of bacterial cells in the foetal placentas coincided with abortion 
of the foetuses (Sanchez, Souriau et al. 2006).  Another experimental infection of 
pregnant goats found that almost all aborted kids were PCR positive for Coxiella 
(Arricau Bouvery, Souriau et al. 2003).  It has been hypothesised that there might 
be  a  correlation  between  hormonal  levels  of  pregnant  animals  and  increased 
Coxiella infection (Biberstein, Behymer et al. 1974), perhaps helping to explain the 
altered tissue tropism that occurs in pregnant animals.  This argument is further 
strengthened by the presence of coding regions in the C. burnetii genome that are 
similar to eukaryotic genes for fatty acid desaturases and sterol reductases.  This 
may indicate  that  Coxiella  possesses a tissue or  organ tropism for placenta or 
reproductive tissue (Seshadri, Paulsen et al. 2003). 
1.2.6  Resistance to chemical and physical stress 
The small cell variant of C. burnetii has been shown to be incredibly resistant 
to  physical  and  chemical  insult  including  elevated  temperature  and  pressure, 
desiccation,  osmotic  shock  and  several  chemical  disinfectants  (Ransom  and 
Huebner 1951; Malloch and Stoker 1952; McCaul, Hackstadt et al. 1981; McCaul,  
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Banerjee-Bhatnagar  et  al.  1991;  Cerf  and  Condron  2006).    It  has  also  been 
demonstrated that C. burnetii remains viable for 30 days in dried sputum; 120 days 
in dust; 49 days in dried guinea pig urine; 586 days in tick faeces; 42 months in 
milk stored at 4–6°C and 12-16 months in wool stored at 4-6°C (PHAC 2001).  The 
resistance of the metabolically active LCV is less dramatic and the two variants 
can be distinguished by their respective resistance to osmotic shock, with the LCV 
undergoing plasmolysis (McCaul, Hackstadt et al. 1981; Williams, Peacock et al. 
1981).  The SCV and SDC also share some characteristics with the spore-forming 
bacteria Bacillus subtilis.  These may contribute to the extreme resistance that it 
shows and include a low level of water in the spore core (Cortezzo, Koziol-Dube et 
al. 2004) and protection of DNA by saturation with DNA-binding proteins (Nermut, 
Schramek et al. 1968).  In addition, the C. burnetii genome contains a gene with 
strong homology to the stationary phase regulator sigma factor of Bacillus subtilis 
(Seshadri and Samuel 2001). 
The  association  of  peptidoglycan  and  protease-resistant  covalently  bound 
proteins  may  in  part  explain  the  resistance  to  environmental  stressors  that  C. 
burnetii  exhibits  (Amano  and  Williams  1984).    However,  the  Coxiella  genome 
contains no pathways for synthesis of storage compounds such as glycogen and 
polyhydroxybutyrate,  which  raises  questions  about  how  this  pathogen  remains 
viable in the extracellular environment for so long (Seshadri, Paulsen et al. 2003). 
1.3  Pathogenesis and pathology of Q fever 
1.3.1  Host immune response 
It has been demonstrated that cellular and humoral immune responses are 
involved  in  host  resistance  to  infection  by  C.  burnetii,  both  of  which  can  be 
stimulated  by  challenge  with  viable  cells  or  vaccination  (Waag,  England  et  al.  
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1997;  Zhang  and  Samuel  2003).    However,  an  experimental  infection  in 
immunodeficient mice showed that acquired immunity is essential for the host to 
clear infection by phase II C. burnetii because the innate immune response of the 
SCID mice was only sufficient to stop the replication of Coxiella but not sufficient to 
clear the infection (Andoh, Russell-Lodrigue et al. 2005). 
Phagocytosis of infectious micro-organisms by polymorphonuclear leukocytes, 
monocytes and macrophages is accompanied by a respiratory burst resulting in 
production of reactive oxygen species (Salin and McCord 1975) which are thought 
to have microbicidal properties (McRipley and Sbarra 1967).  It has been shown 
that this respiratory burst does not occur when neutrophils phagocytose C. burnetii 
cells  and  it  appears  likely  that  an  absence  of  superoxide  anions  allows  the 
pathogen to establish a persistent infection (Akporiaye, Stefanovich et al. 1990).  
Brennan et al. (2004) found that two major factors involved in the host‟s control of 
C. burnetii infection are reactive oxygen intermediates (ROI) and reactive nitrogen 
intermediates (RNI).  IFN-γ stimulation results in activation of NADPH oxidase, a 
ROI,  which  reduces  oxygen  to  a  superoxide  anion  which  can  then  enter  the 
phagosome and subsequently be converted to hydrogen peroxide by a dismutase.  
The hydrogen peroxide can then break down the membrane of the Coxiella cells 
by disrupting protein channels in the outer membrane (Clark 1990).  Both factors 
were found to inhibit replication in murine cell lines and mice (Brennan, Russell et 
al. 2004).   Production of ROI and RNI is linked to the host‟s T cells activating 
enhanced  biocidal  mechanisms  in  macrophages  (Asher  et  al,  1980,  Izzo  and 
Marmion,  1993).    The  cytokine  response  initiated  by  invading  C.  burnetii  cells 
appears to be dependent upon the strain of Coxiella present.  The Nine Mile strain 
induces less TNFα, IL-6 and IL-8 production compared to the Priscilla strain, which 
in turn induces less IL-1β and IFN-γ than the Nine Mile strain.  It seems that C. 
burnetii,  partially  through  the  LPS  content  of  the  cells,  is  able  to  selectively  
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stimulate  or  suppress  groups  of  pro-inflammatory  cytokines  (Kuznetsova, 
Tokarevich  et  al.  2003).    A  factor  specific  to  phase  I  C.  burnetii  cells  but 
independent  from  LPS  has  also  been  found  to  have  immunosuppressive 
characteristics (Waag and Williams 1988).  Conversely, the chloroform-methanol 
residue (CMR) of Coxiella appears to stimulate non-specific humoral and cellular 
antiviral  immunity,  possibly  via  activation  of  antigen  processing  cells  (Zvilich, 
Williams et al. 1995).  It has also been shown that factors of C. burnetii promote a 
potent protective antibody response to lethal viral infections (Waag, Kende et al. 
1990),  protozoal agents  (Clark 1979)  and bacteria  (Mika,  Goodlow et  al. 1954; 
Kelly  1977;  Damrow,  Cantrell  et  al.  1981).    While  the  cellular  component 
responsible for this phenomena has not been fully characterised it is believed to be 
associated with the lippopolysaccharide (LPS) of the pathogenic phase I form of 
the organism (Waag and Williams 1988).  The non-specific immunity induced by 
C.  burnetii  is  believed  to  be  caused  by  sensitisation of the immune system, in 
particular  the  interferon  response,  leading  to  an  enhanced  response  when 
challenged  by  an  invading  micro  organism  (Clark  1979;  Hoebe,  Janssen  et  al. 
2003).  
Helbig et al. (2005) suggested that the hosts‟ idiosyncratic immune response 
to C. burnetii determines progression to the acute form of Q fever.  Helbig et al. 
(2005) performed a study to quantify the genetic relationship between HLA allele 
frequency and progression to chronic Q fever.  They showed that Q fever fatigue 
syndrome (QFS) patients were more likely to carry HLA-DRB1*11 compared to Q 
fever-negative  controls,  patients  who  made  a  complete  and  uncomplicated 
recovery from acute Q fever or sufferers of Q fever endocarditis (QFE) (Helbig et 
al. 2005).  Only weak associations were observed between the QFE group and 
immune  response  genes  (Helbig,  Harris  et  al.  2005).    Possession  of  HLA-
DRB1*11  and  HLA-DRB1*12  (DR5)  molecules  has  been  associated  with  lower  
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interferon  gamma  production  and  increased  humoral  T  helper  2  responses 
(Petrovsky  and  Harrison  1997)  and,  as  mentioned  previously,  production  of 
interferon gamma is important for clearing Coxiella infections (Brennan, Russell et 
al. 2004). 
In humans, antibodies to phase II C. burnetii antigen remain elevated for at 
least one year whereas anti-phase I antibodies are barely detectable using the 
complement fixation test (Enright, Longhurst et al. 1971).  In addition, phase II 
antigen generally fixes complement more strongly compared to phase I antigen 
(Enright, Longhurst et al. 1971).  These results were supported by similar data 
obtained with the immunofluorescence test.  The study focused on 191 human 
patients who had presented with symptomatic Q fever following an outbreak of the 
disease in Switzerland (Dupuis, Peter et al. 1985).  Conversely, a study on 30 Q 
fever-positive abattoir workers found that IgM to phase I antigen persisted for 27 
weeks in one patient while IgM to phase II antigen was not detected beyond 17 
weeks using an IgM immunofluorescence technique (Hunt, Field et al. 1983).  In 
addition, phase II-specific IgM was only detectable for 10 weeks (Hunt, Field et al. 
1983).  In general Hunt et al. (1983) observed that phase I-specific IgM occurs with 
higher titres and persists for longer periods than phase II-specific IgM. Host levels 
of  anti-phase  II  IgG  have  been  shown  to  be  elevated  earlier  than  anti-phase  I 
antibodies in infections in humans, guinea pigs and mice (Hunt, Field et al. 1983; 
Peacock, Philip et al. 1983; Peter, Dupuis et al. 1985; Moos and Hackstadt 1987; 
Li, Niu et al. 2005). 
1.3.2  Pathogenesis 
Infection in animals and humans most often occurs via inhalation (De Lay, 
Lennette et al. 1950; Abinanti, Welsh et al. 1955; Tigertt, Benenson et al. 1961;  
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Riemann, Brant et al. 1975; Yanase, Muramatsu et al. 1998; Gardon, Heraud et al. 
2001)  and,  after  primary  multiplication  in  the regional lymph nodes, a transient 
bacteraemia  persists  for  five  to  seven  days  (Woldehiwet  2004).    Subsequent 
progression of the infection may take one of several courses although the exact 
factors  that  contribute  to  disease  differentiation  remain  speculative.    The 
pathogenesis  of  C.  burnetii  has  been  associated  with  genetic  characteristics 
identified by RFLP patterns, plasmid groups and strain type (Samuel, Frazier et al. 
1985; Hendrix, Samuel et al. 1991; Russell-Lodrigue, Poels et al. 2005).  Acute Q 
fever has been linked to genomic groups I, II and III whereas groups IV and V 
have been associated with the chronic form of the disease  (Hendrix, Samuel et al. 
1991).    However,  other  studies  refute  that  genetic  characteristics  of  Coxiella 
determine the form of Q fever caused (Yu and Raoult 1994; Toman, Hussein et al. 
2003)  and  suggest  that  disease  outcome  is  more  closely  associated  with  host 
immune factors (Koster, Goodwin et al. 1985; Honstettre, Imbert et al. 2003).  The 
interaction between host factors and disease outcome was highlighted in a study 
conducted by Raoult et al. (Raoult, Tissot-Dupont et al. 2000), which showed that 
progression from acute to chronic Q fever was strongly associated with aspects of 
physiology including pregnancy, vascular or valvular lesions, cirrhosis and cancer.  
However, the immunogenic characteristics of the invading coxiellae may also play 
a  role  in  the  development  of  the  chronic  form  of  Q  fever.    For  example, 
considerable  amounts  of  two  branched  sugars  of  the  LPS  (virenose  and 
dihydrohydroxystreptose) of C. burnetii react strongly with phase I antibody and 
thus may be preferentially displayed during chronic infection (Slaba, Hussein et al. 
2003). 
Chronic C. burnetii infections may persist for months and perhaps even years 
(Marmion 1997) in both humans and animals (Baca, Scott et al. 1985; Marmion, 
Storm et al. 2005) and prior to onset patients may have undetectable levels of  
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antibody (Raoult, Tissot-Dupont et al. 2000).  It has been suggested that long term 
persistence of C. burnetii in bone marrow may be universal following primary acute 
Q fever (Helbig, Harris et al. 2005).  Given the predilection of C. burnetii for tissues 
that contain high numbers of mononuclear phagocytes (Baca and Paretsky 1983) 
it is reasonable to suggest that bone marrow would be one of the first sites to be 
colonised in a host.  The viability and numbers of the pathogen may be regulated 
by the hosts‟ immune system except in a small percentage of infections, which 
may  subsequently  develop  into  Q  fever  fatigue  syndrome  (QFS),  Q  fever 
endocarditis (QFE), a reoccurrence of the original disease or osteoarthritis (Raoult, 
Bollini et al. 1989; Helbig, Harris et al. 2005).  Of these Q fever endocarditis has 
the highest rate of mortality but QFS can also have a huge impact on the sufferer 
and their family due to the length of illness (possibly more than 10 years) and the 
lack of effective treatment and diagnostic tools (Marmion 1997).  Chronic Q fever 
may take up to 20 years to develop and if misdiagnosed can do significant damage 
to  heart  valves  and  may  lead  to  more  significant  health  problems  (Kimbrough, 
Ormsbee et al. 1981). 
Coxiella. burnetii can be maintained in vitro for months or even years without 
addition  of  fresh  uninfected  tissue  culture  cells  with  little  change  in  the  growth 
characteristics of the host cells (Khavkin and Amosenkova 1981; Baca, Scott et al. 
1985; Roman, Coriz et al. 1986).  When an infected cell divides only one daughter 
cell receives the parasitised vacuole leaving the other daughter cell uninfected and 
susceptible to infection by C. burnetii (Roman, Coriz et al. 1986; Hechemy, McKee 
et al. 1993).  The transfer of C. burnetii to only one daughter per mitotic division 
may play some part in chronic long-term Q fever infections. 
In gram negative bacteria LPS is the most important virulence factor and the 
same  appears  to  be  true  of  C.  burnetii  (Baca  and  Paretsky  1983;  Schramek,  
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Radziejewska-Lebrecht  et  al.  1985;  Amano,  Williams  et  al.  1987;  Moos  and 
Hackstadt 1987).  The full length LPS of phase I C. burnetii isolates may provide 
protection  from  the  hosts‟  immune  system  and  prevent  clearance  during  the 
bacteraemic stage of infection (Lukacova and Kazar 1996; Slaba, Hussein et al. 
2003).    Coxiella  burnetii  cells  then  gain  access  to  human  macrophages  and 
monocytes by binding to the complex of leukocyte response integrin and integrin-
associated protein on the cell surface and subsequently being internalised (Mege, 
Maurin et al. 1997; Seshadri, Paulsen et al. 2003).  Internalisation is a passive 
phagocytic  process  although,  for  phase  I  cells,  active  subversion  of  the 
phagosome  then  occurs  where  phagolysosomal  fusion  is  delayed,  perhaps 
providing  enough  time  for  the  pathogen  to  revert  from  the  dormant  small  cell 
variant  to  the  metabolically  active  large  cell  variant  (Howe  and  Mallavia  2000).  
Following  this  delay  the  phagosome  fuses  with  a  lysosome  to  form  a 
phagolysosome (Howe and Mallavia 2000).  Coxiellae are acidophiles and thus the 
harsh acidic (pH 4.7-5.2) environment of the phagolysosome actually enhances C. 
burnetii’s metabolism (Hackstadt and Williams 1981; Hackstadt 1983; Zuerner and 
Thompson  1983;  Baca, Roman et  al. 1993).    Survival of  Coxiella  in this harsh 
environment is thought to be aided by genes associated with stress-response and 
vacuole  detoxification  (Seshadri,  Paulsen  et  al.  2003)  and  a  high  proportion  of 
basic proteins that serve as a proton “sink” to buffer against the acidic environment 
in the phagolysosome (Seshadri and Samuel 2001).  However, it seems that C. 
burnetii does not have an intrinsic resistance to other bactericidal conditions found 
in  the  host  cells  phagolysosome.    Instead,  coxiellae  expend  considerable 
metabolic effort to inhibit the respiratory burst (Clark 1990) through production of 
acid  phosphatase  (Baca,  Roman  et  al.  1993).    Fusion  of  the  infected 
parasitophorous  vacuole  (PV)  with  other  vacuoles  may  provide  C.  burnetii  with 
fresh nutrients for growth and division (Howe, Melnicakova et al. 2003).  Over a  
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period  of  approximately  six  days  the  population  dynamics  of  the  invading  C. 
burnetii  cells  changes  such  that  the  metabolically  dormant  SCV‟s  predominate 
(Coleman, Fischer et al. 2004).  The SCV‟s are eventually released from host cells 
by active flow of fluid into the vacuole combined with periodical contractions of the 
host cell which result in cell rupture (Khavkin and Amosenkova 1981). 
1.3.3  Clinical manifestation in humans 
Chronic  and  acute  forms  of  Q  fever  are  probably  misdiagnosed  and 
underreported because of the non-specific nature of Q fever symptoms (Williams 
and Sanchez 1994).  It generally takes 7-40 days for acute Q fever to become 
apparent but this is dependent upon the dose, age of the individual and the route 
of infection (Williams and Sanchez 1994).  However, due to the cryptic nature of 
infections  with  C.  burnetii  approximately  60%  of  cases  result  in  asymptomatic 
seroconversion  (Arricau-Bouvery  and  Rodolakis  2005).    The  most  common 
symptoms associated with acute Q fever are fever, headaches, myalgia, arthralgia 
and rashes (Williams and Sanchez 1994).  Infection with C. burnetii may result in 
endocarditis, hepatitis, pneumonia and less commonly pericarditis and myocarditis 
(Williams and Sanchez 1994).  In general, young immunocompetent individuals 
tend  to  present  with  hepatitis  whilst  older  patients  are  more  likely  to  display 
pulmonary involvement (Fournier, Marrie et al. 1998).  In addition, patients with 
neither hepatitis nor pulmonary involvement tend to be female (Fournier, Marrie et 
al. 1998).  Stein and Raoult (1998) found that Q fever was a significant cause of 
morbidity and mortality in pregnant women in France.  They found evidence of Q 
fever  was present  in at least one pregnancy per 540 and that  it was the most 
significant public health problem related to intrauterine infections in the town of 
Martigues  (Stein  and  Raoult  1998).    Little  is  known  about  the  symptoms  and 
outcomes of Q fever in children (Barralet and Parker 2004).  Death is a rare result  
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of  acute  Q  fever  and  tends  to  be  associated  with  chronic  disease  such  as 
endocarditis in older, immunocompromised patients (Raoult, Tissot-Dupont et al. 
2000). 
Chronic Q fever has been defined as an infection that lasts for longer than six 
months  after  the  onset  and  typically  occurs  in  less  than  five  percent  of  cases 
(Raoult and Marrie 1995).  This form of Q fever may not develop for years after the 
primary infection and often targets the heart of the infected individual (Fournier, 
Marrie  et  al.  1998).    Coxiella  burnetii  is  probably  the  most  common  cause  of 
infective endocarditis with negative blood cultures (Delahaye, Hoen et al. 2002).  
Clinical features of Q fever endocarditis include aortic and/or mitral valve signs, 
fever, cardiac failure, hepatomegaly, splenomegaly, digital clubbing, purpuric rash, 
and/or arterial embolism (Williams and Sanchez 1994). 
1.3.4  Clinical manifestation in animals 
Animal coxiellosis is usually asymptomatic with no particular tissue predilection 
other than the female reproductive system unless an excessive dose of C. burnetii 
is given (Williams and Sanchez 1994).  Coxiellosis is an important cause of bovine 
reproductive  disorders  such  as  infertility,  metritis  and  mastitis  (Williams  and 
Sanchez 1994).  Reproductive disorders, including abortion, may occur in naïve 
animals  (Arricau  Bouvery,  Souriau  et  al.  2003;  Arricau-Bouvery,  Souriau  et  al. 
2005; Sanchez, Souriau et  al. 2006),  although in areas of high seroprevalence 
abortion is less common (Masala, Porcu et al. 2004).  A study in Japan showed 
that  58.8% and 60.4%  of  207 cattle with  reproductive disorders  had circulating 
antibodies to phase I and phase II C. burnetii respectively (To, Htwe et al. 1998).  
Infection of pregnant mice with C. burnetii normally results in uncontrolled growth 
of the organism in the utero-placental unit and lesions associated with the infection  
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are characterised by necrosis of placental tissues and microthrombosis.  However, 
despite infiltration of the placenta by Coxiella no antigen has been demonstrated in 
foetal tissue (Baumgartner and Bachmann 1992). 
A recent study in Canada found that cats which were serologically-positive for 
C. burnetii had an association with human cases of Q fever and had high phase I 
antibodies compared to serologically-positive cats that were not associated with 
human cases of Q fever (Marrie, Durant et al. 1988).  In animals, unlike humans, 
antibodies to phase I antigen predominate in acute infections (Fournier, Marrie et 
al. 1998).  Therefore it appears as though individuals with acute Q fever are more 
likely to transmit infection compared to individuals with chronic infections. 
1.4  Epidemiology 
1.4.1  Transmission 
It has been demonstrated in a guinea pig model that the infectious dose of 
phase I C. burnetii may be as low as one organism (Tigertt, Benenson et al. 1961; 
Ormsbee, Peacock et al. 1978), which may be similar in man (Tigertt, Benenson et 
al.  1961).    A  probalistic  model  developed  on  the  assumption  that  a  single  C. 
burnetii is sufficient for infection of humans via inhalation showed that a minimum 
of  200  cells/m
3  of  air  was  required  to  establish  an  infection  (Vorobeychikov, 
Vasilenko  et  al.  2005).    It  has  also  been  demonstrated  that  the  length  of  the 
incubation period following challenge by Coxiella is inversely proportional to the 
initial infectious dose (Tigertt, Benenson et al. 1961). 
Domestic  ruminants  appear  to  be  the  most  important  source  of  human 
infection  (Marrie  and  Raoult  1997,  Maurin  and  Raoult  1999)  with  inhalation  of 
contaminated  fomites  via  the  aerosol  route  being  the  most  common  mode  of  
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transmission (De Lay, Lennette et al. 1950; Abinanti, Welsh et al. 1955; Tigertt, 
Benenson et al. 1961; Riemann, Brant et al. 1975; Yanase, Muramatsu et al. 1998; 
Gardon, Heraud et al. 2001; Schulz, Runge et al. 2005).  However, many other 
animals have been implicated in the transmission of Q fever including; kangaroos 
(Pope, Scott et al. 1960), feral and domestic pigs (Adesiyun and Cazabon 1996; 
Barralet and Parker 2004) and camels (Soliman, Botros et al. 1992),.  Coxiella is 
most commonly isolated from parturient fluid and placental tissue (Baumgartner 
and Bachmann 1992; Masala, Porcu et al. 2004; Berri, Crochet et al. 2005) and 
placental tissue has been shown to have as many as 10
9 Coxiella cells per gram 
(Arricau-Bouvery,  Souriau  et  al.  2005).    Products  of  parturition  can  pose  a 
significant infection risk for humans when fresh (Enright, Franti et al. 1971) and 
possibly more so when they dry because the coxiellae may be spread by wind 
(Tissot-Dupont  et  al  1999).    However,  in  external  environments  wind  does  not 
always  seem  to  play  a  significant  role  in  dissemination  (Gardon,  Heraud  et  al. 
2001;  Porten,  Rissland  et  al.  2006)  and  a  proximity  of  less  than  six  meters  in 
enclosed  spaces  has  been  shown  to  be  important  for  transmission  (Porten, 
Rissland et al. 2006).  Due to the high concentration of bacteria in products of 
parturition  a  single  infected  animal  may  be  the  source  of  infection  for  large 
numbers of people (Porten, Rissland et al. 2006).   
Coxiella burnetii has also been shown to be shed in milk, vaginal secretions 
and  faeces  of  infected  animals  (Berri,  Souriau  et  al.  2002;  Arricau-Bouvery, 
Souriau et al. 2003; Arricau-Bouvery, Souriau et al. 2005; Guatteo, Beaudeau et 
al. 2006).  Indeed, there is evidence that goats and cows preferentially shed in milk 
while ewes are more likely to shed in faeces or vaginal mucus (Rodolakis, Berri et 
al.  2007).    However,  in  a  group  of  experimentally  infected  goats  Coxiella  was 
detectable by PCR in mammary gland and lung but not in liver or spleen eight days 
after the animals aborted (Sanchez, Souriau et al. 2006).  Coxiellae were still being  
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shed  in  vaginal  secretions  and  milk  26  and  30  days  post  abortion  respectively 
(Sanchez, Souriau et al. 2006).  This suggests that during pregnancy Coxiella may 
proliferate and invade several tissue types but following parturition the pathogen 
remains in certain tissues that are conducive to its dissemination.   
Ingestion of raw dairy products has been implicated in the transmission of Q 
fever (Babudieri 1959; Tylewska-Wierzbanowska, Rumin et al. 1991) although the 
actual level of risk from this form of transmission is debatable (Cerf and Condron 
2006).  However, Berri et al. (2001) found that in a small flock of sheep 25% of 
infected ewes shed C. burnetii in their milk indicating that raw dairy products could 
pose  a  real  risk  for  human  infection  (Berri,  Souriau  et  al.  2002).    A  study  in 
experimentally infected pregnant goats also found that Coxiella was shed in milk 
from the day of abortion until 52 days after abortion (Arricau-Bouvery, Souriau et 
al. 2003).  In addition, Coxiella remain infectious in milk for up to 42 months when 
it  is  stored  at  4-6
oC,  although  heating  to  63
oC  for  30  minutes  or  72
oC  for  15 
seconds inactivated the pathogen.  Indeed, these data were used for the basis of 
modern pasteurisation methods (Cerf and Condron 2006).   
Coxiella is resistant to drying and can remain infectious for long periods of 
time  in  the  environment  (PHAC  2001).    The  combination  of  the  long  term 
persistence of C. burnetii in the environment and the organism‟s transmission by 
aerosolised cells can result in cases of Q fever in individuals who have had no 
direct contact with livestock and therefore may confound diagnosis (Berri, Crochet 
et al. 2005). 
A key feature differentiating C. burnetii from members of the genus Rickettsia 
is that Coxiella does not require an arthropod vector for transmission (Woldehiwet 
2004).  Arthropods have been shown to harbour C. burnetii (Smith 1940; Pope,  
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Scott et al. 1960) in very high concentrations (Babudieri 1959) and ectoparasites 
have  been  demonstrated  to  be  capable  of  transmitting  this  pathogen  (Arricau-
Bouvery and Rodolakis 2005).  However, arthropods are not considered to be a 
significant vector for transmission of Coxiella to humans (Ransom and Huebner 
1951).  Vertical transmission of Coxiella has been reported in ticks (Aitken, Bogel 
et al. 1987; Reeves, Loftis et al. 2005), which may enable maintenance of this 
pathogen in the absence of a vertebrate host. 
Q fever has been shown to be a sexually transmissible disease in humans 
(Milazzo, Hall et al. 2001) and possibly in cattle (Tylewska-Wierzbanowska, Rumin 
et al. 1991; Kruszewska and Tylewska-Wierzbanowska 1997) and mice (Tylewska-
Wierbanowska and Kruszewka 1990).  Human to human transmission has been 
reported  through  placental  transmission  (Stein  and  Raoult  1998),  blood 
transfusions (Carrieri, Tissot-Dupont et al. 2002) and during autopsies (Marmion 
and  Stoker  1950).    Trans-placental  transmission  was  also  reported  in  three 
generations of mice where the first generation was vaccinated with attenuated M-
44 strain C. burnetii (Freylikhman et al 2003).  However, there is evidence that 
indicates that transmission of Coxiella may not occur via this mechanism in sheep 
(Berri, Crochet et al. 2005). 
1.4.2  Reservoirs of infection 
Coxiella burnetii has been shown to be capable of infecting such a wide range 
of vertebrates (Marrie 1990) that it may be considered to be a pathogen with no 
host specificity.  However, humans are dead-end hosts with regard to maintenance 
of the lifecycle of C. burnetii (Williams and Sanchez 1994).  While C. burnetii has 
also been found to be able to infect a great number and variety of arthropods 
(Babudieri 1959; Marrie 1990) the role they play in the lifecycle of Coxiella is more  
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likely to be related to maintaining this pathogen in the environment  rather than 
suggesting that it is primarily a vector-borne infection.  Haemophysalis humerosa 
and Amblyomma triguttatum ticks have been implicated in the maintenance and 
transmission of C. burnetii in Australia (Derrick 1939; Smith 1940; Pope, Scott et 
al.  1960).    The  geographic  range  of  A.  triguttatum  has  recently  expanded 
(McDiarmid, Petney et al. 2000), which suggests that the incidence of Q fever may 
also expand accordingly.   
Domestic  ruminants  have  historically  been  considered  to  be  the  primary 
reservoir for C. burnetii.  However, several studies have failed to show significant 
evidence  of  infection  in  common  livestock  species  (Dane  and  Beech  1955; 
Adesiyun and Cazabon 1996; Gardon, Heraud et al. 2001).  It is possible that host 
predilection  may  have  as  much  to  do  with  geography  and  regional  animal 
husbandry practices as it does with biology (Soliman, Botros et al. 1992).  
The  interaction  between  wild  and  domestic  cycles  also  appears  to  vary 
according  to  location.    A  study  in  California,  USA  indicated  that  there  was  no 
association between the presence of C. burnetii in wildlife and the seropositivity of 
sheep (Enright, Franti et al. 1971).  Conversely the same authors found that 17 of 
the 21 animal species tested, including coyotes, foxes, brush rabbits and deer, 
showed  evidence  of  exposure  to  Coxiella  burnetii  (Enright,  Franti  et  al.  1971).  
Indeed,  there  was  a  strong  relationship  between  the  seroprevalence  in  wild 
animals and their level of interaction with domestic livestock or small mammals 
(Enright, Franti et al. 1971).  An epidemiological study conducted in Cyprus found 
that the seroprevalence of C. burnetii in the human population was greater than 
the seroprevalence in the local ruminant population (Psaroulaki, Hadjichristodoulou 
et al. 2006).  The authors concluded that there could be another significant, as yet 
unidentified, reservoir of C. burnetii in Cyprus (Psaroulaki, Hadjichristodoulou et al.  
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2006).  In South Australia, Dane and Beech (1955) reported that with the exception 
of one small mob of sheep, they were unable to find evidence that Q fever was 
endemic in domestic animals.  The authors postulated that kangaroos may be an 
important permanent reservoir of Q fever and that the kangaroo tick may provide 
the vector for transmission of C. burnetii between kangaroos and livestock (Dane 
and Beech 1955). 
Native  Australian  marsupials  were  among  the  first  non-domestic  animals 
shown  to  be  infected  with  C.  burnetii.    Coxiella  burnetii  was  isolated  from 
bandicoots  (Isoodon  torosus  Ramsay)  and  the  ticks  infesting  them 
(Haemophysalis  humerosa)  from  Moreton  Island  (QLD)  (Smith  1940).  
Experiments conducted on Moreton Island a year earlier revealed that bandicoots 
were  susceptible  to  infection  with  C.  burnetii  with  no  apprarent  clinical  signs 
(Derrick 1939).  Furthermore, emulsions of ectoparasites removed from infected 
bandicoots  failed  to  produce  Q  fever  when  used  to  inoculate  naïve  animals 
(Derrick  1939).    The  authors  thus  proposed  that  the  carnivorous  nature  of  the 
bandicoots may be important to their acquisition of C. burnetii (Derrick 1939). 
Kangaroos and ornate kangaroo ticks in western Queensland have also been 
implicated as reservoirs of the causative agent of Q fever (Pope, Scott et al. 1960).  
Pope et al. (1960) found that in some locations the percentage of complement 
fixing antibodies in red kangaroos was as high as 54%. Interestingly, four of the 13 
ticks from which C. burnetii was isolated were collected from goats and sheep and 
not kangaroos (Pope, Scott et al. 1960).  Amblyomma triguttatum is a 3-host tick 
and  thus  may  be  able  to  act  as  a  vector  between  the  different  host  species.  
However, there has been insufficient research to accurately assess the role that 
Australian  marsupials  and  their  ectoparasites  play  in  maintenance  and 
dissemination of C. burnetii in Australia (Munday 1972).  
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1.4.3  Geographic distribution 
In 1990 a review of literature published since 1956 noted that Q fever exists in 
over  70  countries  covering  all  continents  (Marrie  1990).    The  only  region 
considered  to  be  free  from  C.  burnetii  is  the  Antarctic  (Woldehiwet  2004)  and 
possibly New Zealand (Greenslade, Beasley et al. 2003).  However, while Q fever 
is thought to be more prevalent in tropical climates (Woldehiwet 2004) the exact 
extent of its distribution is not known.  This is in part due to misdiagnosis (Arricau-
Bouvery and Rodolakis 2005) and under-reporting leading to an underestimation of 
the true global prevalence of this organism (Fournier, Marrie et al. 1998; Raoult, 
Tissot-Dupont et al. 2000).  It appears that exposure to C. burnetii is common in all 
areas  where  specific  surveillance  has  been  performed  (Arricau-Bouvery  and 
Rodolakis 2005).   
Within Australia southern Queensland and northern New South Wales have 
the highest number of Q fever cases in humans compared to other states with the 
lowest levels observed in the Northern (Garner, Longbottom et al. 1997). 
1.4.4  Incidence and seasonal variation 
There  is  evidence  indicating  that  the  incidence  of  human  exposure  to  C. 
burnetii is increasing.  During a 13 year period in Leszno, Poland (1973-1985) all 
28,066 cattle tested for C. burnetii antibodies were found to be negative and that 
further surveys have shown that  the number of seropositive cattle  in the same 
areas increased to 8.4% in 1987 and 21.6% by 1989 (Tylewska-Wierzbanowska, 
Rumin et al. 1991).  In 1988 a sero-survey performed on workers associated with 
livestock  in  the  area  found  that  32.1%  were  also  seropositive  for  Coxiella 
(Tylewska-Wierzbanowska, Rumin et al. 1991).  In addition, the sero-prevalence of 
C.  burnetii  in  humans  increased  from  3.1%  in  1997  to  23.5%  in  1999-2000  in  
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Newfoundland (Hatchette, Campbell et al. 2002).  The incidence of clinical cases 
of  Q  fever  in  Germany  has  also  increased  over  the  period  from  1947 to 1999 
(Hellenbrand,  Breuer  et  al.  2001).    Hellenbrand  et  al.  (2001)  proposed  that 
urbanisation of rural areas may be contributing to the increase in Q fever.  Indeed 
a study in France suggests that the incidence of Q fever is underestimated based 
on the correlation of results of testing over 74,000 human sera for anti-C. burnetii 
antibodies with clinical findings (Raoult, Tissot-Dupont et al. 2000).  However, it 
must also be considered that improved testing regimes and increased awareness 
of  medical  practitioners  may  be  contributing  to  the  trend  of  the  increasing 
incidence of Q fever. 
Reports  of  seasonal  trends  associated  with  the  incidence  of  Q  fever  vary 
depending on geographic location.  In Japan it was reported that the incidence of 
bovine coxiellosis increased in winter (Yanase, Muramatsu et al. 1997) while in 
Germany the seasonal variation of Q fever has changed from winter outbreaks to 
summer  outbreaks  (Hellenbrand,  Breuer  et  al.  2001).    In  sheep  in  California 
(Enright, Franti et al. 1971) and humans in France (Raoult, Tissot-Dupont et al. 
2000) and other parts of Europe (Fournier, Marrie et al. 1998) the peak incidence 
has been observed in spring or summer.  However, in Australia two independent 
studies found no relationship between season and an increased incidence of Q 
fever (McKelvie 1980; Garner, Longbottom et al. 1997).  In French Guiana it was 
found that over a four year period incidence of Q fever was strongly correlated with 
rainfall rather than season (Gardon, Heraud et al. 2001). 
1.4.5  Risk factors 
Q  fever  remains  mainly  an  occupational  hazard  for  people  who  work  with 
domestic  ruminants.    There  is  a  strong  association  seen  in  Australia  between  
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notifications of Q fever and the presence of livestock in the same area (Garner, 
Longbottom  et  al.  1997).    This  conclusion  supports  an  earlier  study  which 
examined  174  human  sera  for  the  presence  of  complement  fixing  antibodies 
against C. burnetii and found that all positive samples came from individuals that 
either worked in an abattoir or who worked with livestock (Dane and Beech 1955).  
However, a retrospective study of abattoir workers in Queensland, Australia over a 
nine  year  period  showed  an  average  incidence  of  1%  (McKelvie  1980).    In 
contrast, workers at an abattoir in Brazil had a seroprevalence of 29% overall but 
those individuals working in areas that promoted exposure to dust and hides had a 
prevalence of exposure of 40% (Riemann, Brant et al. 1975). 
A retrospective survey that used over 74,000 serum samples in France found 
that the age group most at risk of contracting Q fever was 30-69 years (Raoult, 
Tissot-Dupont et al. 2000).  The same study showed that the disease was more 
prevalent in males than females but when grouped according to sex there was no 
statistically  significant  association  between  disease  and  age.    The most  at  risk 
occupations for contracting acute Q fever included rural existence and contact with 
newborn  or  pregnant  animals  (Raoult,  Tissot-Dupont  et  al.  2000).    In  addition, 
23.3%  of  participants  who  had  eaten  farm  goat  cheese  were  sero-positive  for 
acute Q fever (as evidenced by the presence of a higher proportion of anti-phase II 
antibodies  compared  to  anti-phase  I  antibodies)  (Raoult,  Tissot-Dupont  et  al. 
2000). 
A  rural  existence,  or  an  occupation  that  results  in  exposure  to  rural 
environments, were identified as significant risk factors in Germany (Hellenbrand, 
Breuer et al. 2001; Sting, Breitling et al. 2004; Schulz, Runge et al. 2005) and the 
U.S.A. (Anderson, Smoak et al. 2005).    
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1.5  Diagnosis/tests 
1.5.1  Immunological 
Diagnosis of acute Q fever is based on clinical symptoms and a fourfold rise in 
anti-C. burnetii antibodies using one of several immunological tests (Williams and 
Sanchez 1994).  Several authors have recently suggested that the preferred test is 
the IFA (Peacock, Philip et al. 1983; Fournier, Marrie et al. 1998).  In humans, 
diagnosis of chronic Q fever is made after observation of clinical syndromes and a 
higher proportion of anti-phase I antibodies compared to anti-phase II antibodies 
(Wilson, Neilson et al. 1976; Hunt, Field et al. 1983; Peacock, Philip et al. 1983; 
Tissot-Dupont,  Thirion  et  al.  1994).    In  livestock,  C.  burnetii  infection  can  be 
diagnosed at the herd level by a combination of serological tests, clinical findings 
and microscopy of stained placental smears (OIE 2000). 
Effective  immunological  diagnosis  of  Q  fever  should  be  made  after  testing 
multiple  serum  samples  with  a  test  capable  of  detecting  anti-phase  I  and  anti-
phase II antibodies (Dupuis, Peter et al. 1985).  It has been shown that anti-phase 
II antibodies can persist in humans for long periods of time whereas anti-phase I 
antibodies begin to decline after 12 weeks (Dupuis, Peter et al. 1985).  Therefore 
testing for only anti-phase I antibodies may lead to a false negative result and a 
test which is solely focused on anti-phase II antibodies may indicate a positive in 
an individual who has already cleared the infection. 
Many  immunological  tests  for  Coxiella  have  been  developed  with  varying 
levels of specificity and sensitivity.  In general the immunological tests used for 
detecting exposure to C. burnetii fall into three categories: complement fixation, 
indirect immunofluorescence, and ELISA.  
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1.5.1.1  Complement-fixation test (CFT) 
Complement-fixation is very specific but lacks sensitivity (Peter, Dupuis et al. 
1985).  However it has the advantage that it can be adapted to test for exposure to 
C.  burnetii  without  the  requirement  for  host  species-specific  antibodies  (Peter, 
Dupuis  et  al.  1985).    Correct  interpretation  of  results  in  humans  requires  both 
convalescent and acute phase samples and diagnosis can be confounded by the 
nature  of  complement  fixing  antibodies  which  are  often  not  present  early  in 
infection but may persist for long periods after the primary illness (Peter, Dupuis et 
al. 1985).  In general it has been shown that phase I C. burnetii fixes complement 
much more weakly than does phase II (Enright, Longhurst et al. 1971).  It has also 
been found that the sensitivity (73%) and specificity (90%) of CFT is inferior to the 
same measures in an ELISA (99% and 88% respectively) when IFAT was used as 
the reference method (Field, Mitchell et al. 2000). 
1.5.1.2  Indirect immunofluorescence assay (IFA) 
The  IFA  is  currently  the  method  of  choice  for  detection  of  anti-C.  burnetii 
antibodies (Peacock, Philip et al. 1983; Field, Mitchell et al. 2000; OIE 2000).  IFA 
is superior to the CFT (Ascher, Greenwood et al. 1981; Dupuis, Peter et al. 1985; 
Peter, Dupuis et al. 1985; Peter, Dupuis et al. 1987) and can be used to detect 
antibodies to phase I and II antigens in the IgG, IgM and IgA fractions (Fournier, 
Marrie  et  al.  1998).    Dupont  et  al.  (1994)  found  that  in  the 
microimmunofluorescence test phase I IgA titres are not predictive of chronic Q 
fever whereas phase I IgG is highly predictive and sensitive.  The same group also 
found that while diagnosis of chronic Q fever can be made using phase II IgG and 
IgA  titres  the  sensitivity  is  very  low  (57%)  (Tissot-Dupont,  Thirion  et  al.  1994).  
Setiyono et al. (2005) stated that the IFA should be used with an “equivocal area” 
rather than a single cutoff value and that any sera in the equivocal area should be  
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tested with a secondary immunological assay to eliminate false positive and false 
negative results (Setiyono, Ogawa et al. 2005).  Diagnosis by this method may 
also be confounded by non-specific reactions with rheumatoid factor, therefore an 
adsorbent is required to remove IgG prior to testing for anti-C. burnetii IgM and IgA 
(Fournier, Marrie et al. 1998).  This method has also been assessed for cross-
reactivity with Legionella, one of the closest relatives of C. burnetii. Legionellosis 
and  Q  fever  may  both  present  with  identical  symptoms  but  require  different 
antimicrobial therapies to treat the infection.  Therefore correct diagnosis is of the 
utmost importance.  A study in France showed that there was no cross-reactivity 
between  antibodies  to  Coxiella  and  Legionella  in  clinically  affected  individuals 
detected  using  IFA  (Finidori,  Raoult  et  al.  1992).    However,  two  of  the  major 
criticisms of the IFA are that it has a subjective component and it is not easily 
standardised (Peter, Dupuis et al. 1988; Field, Mitchell et al. 2000). 
1.5.1.3  Enzyme-linked immunosorbent assay (ELISA) 
Several studies have found that the ELISA is superior to both the CFT and IFA 
(Peter, Dupuis et al. 1985; Peter, Dupuis et al. 1987; Soliman, Botros et al. 1992).  
Other studies have also suggested that it should be considered as a useful aid to 
diagnosis  by  IFA  (Field,  Mitchell  et  al. 2000)  or  perhaps has  application as an 
epidemiological tool (Peter, Dupuis et al. 1987).  The increased sensitivity that is 
achievable with ELISA is attractive but some consider that its diagnostic utility is 
limited by the technical proficiency required to conduct the test and interpret the 
results (Fournier, Marrie et al. 1998).   
Indirect ELISA, like IFA, is also limited in that species-specific antibodies are 
required for a particular application.  However, alternatives are available.  Soliman 
et  al.  (1992)  developed  a  competitive  ELISA  to  detect  C.  burnetii  in  camels  
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because  anti-camel  immunoglobulin  is  not  commercially  available.    The 
competitive  ELISA  was  shown  to  detect  more  positives  than  IFA  or  EIA  in  all 
animal sera used in this study (Soliman, Botros et al. 1992).  Field and company 
(2000)  compared  a  commercial  human  IgM  Q  fever  ELISA  manufactured  by 
PanBio  (Australia)  with  the  indirect  fluorescent  antibody  test  (IFAT)  for  anti-C. 
burnetii IgM and the complement fixation test (CFT).  Some cross-reactivity was 
seen in the ELISA with patients that had rickettsial infections (two of five patients) 
and  false  positives  were  recorded  for  two  out  of  five  sera  from  patients  with 
leptospirosis  and  one  out  of  four  samples  containing  rheumatoid  factor  (Field, 
Mitchell et al. 2000). 
A  critical  component  of  all  antibody-detection  ELISA‟s  is  the  antigen.    The 
sensitivity and specificity of antigens made from C. burnetii whole cells can vary 
considerably (Dane and Beech 1955; Kovacova, Kazar et al. 1998).  In addition, 
the validity of using Nine Mile strain C. burnetii in antigen preparations has been 
questioned (Rodolakis, Bouzid et al. 2007).  Production of an antigen from live 
organisms is made difficult and expensive by the high level of biosecurity required 
to work with C. burnetii.  Thus, production of a purified antigen which is cheap, 
safe  and  applicable  for  a broad geographic range may well be impossible and 
there  is  a  pressing  need  for  a  recombinant  antigen  that  can  overcome  these 
issues.  Currently, recombinant proteins that can serve as antigens have displayed 
only moderate immunogenicity (Zhang and Samuel 2003; Tyczka, Eberling et al. 
2005).  Although the use of two C. burnetii fusion proteins appears to produce a 
more pronounced immune response (Li, Niu et al. 2005).  
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1.5.2  Polymerase chain reaction (PCR) 
Assays  based  upon  PCR  technology  require  careful  design  to ensure they 
produce  meaningful  results.    Of  particular  importance  is  selection  of  the  gene 
sequence that the test will target.  Targets previously used for the detection of C. 
burnetii  include  the  outer  membrane protein gene com1  (Zhang, Nguyen et  al. 
1998; Brennan and Samuel 2003), the superoxide dismutase gene (Stein 1992; 
Masala, Porcu et al. 2004) and the IS1111a insertion sequence (Berri, Laroucau et 
al. 2000; Klee, Tyczka et al. 2006).  The IS1111a element makes an attractive 
target due to its high copy number and lack of significant homology to published 
sequences from other related organisms (Hoover, Vodkin et al. 1992). 
One disadvantage of PCR however, is that environmental matrices that have 
high  organic  content  such  as  faeces  and  soil  often  contain  factors  that  are 
considered to be inhibitory to PCR (REF).  To minimise the confounding effects of 
tannins, humic acid and other inhibitors of PCR it is critical to extract high quality 
DNA  from  the  sample  while  removing  the  majority  of  contaminants  (Jiang, 
Alderisio  et  al.  2005).    Current  DNA  purification  techniques  are  not  capable  of 
removing all confounding factors from varied and complex samples such as faeces 
and soil.  To ameliorate the affect of such factors facilitators of the PCR can be 
added prior to amplification.  The most effective PCR facilitators include bovine 
serum albumin and T4 gene 32 protein (Jiang, Alderisio et al. 2005). 
PCR-based assays to detect C. burnetii have been developed and applied on 
a herd or flock basis.  Guatteo et al. (2006) showed that 65% of dairy cattle from a 
herd of 242 had C. burnetii in milk, vaginal mucus or faeces using real-time PCR.  
The identification of C. burnetii in only one sample from each animal suggested 
that a prudent policy requires collection and testing of multiple types of samples  
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from each animal to enable consistent detection of animals which are shedding 
Coxiella (Guatteo, Beaudeau et al. 2006). 
PCR-based assays have also been used to detect Coxiella paraffin-embedded 
samples from humans with chronic endocarditis of unknown aetiology and enable 
a retrospective diagnosis of chronic Q fever (Yuasa, Yoshiie et al. 1996).  PCR has 
also been used for the direct identification of C. burnetii plasmids in human sera 
(Zhang, Hotta et al. 1998).  If plasmid type can truly be correlated with disease 
outcome, this test would allow more rapid administration of chemotherapy which is 
appropriate  to  the  chronic  or  acute  form  of  the  infection.    Zhang  et  al.  also 
published a PCR targeting the com1 gene which they proposed could be used 
diagnostically because it may allow diagnosis in the early stages of infection where 
a  detectable  immune  response  is  not  present  (Zhang,  Nguyen  et  al.  1998).  
However,  the  transient  nature  of  Q  fever  bacteraemia  (Williams  and  Sanchez 
1994) may limit the usefulness of this test to early acute infections. 
Further development of the basic principle of PCR has seen the advent of 
techniques that can estimate DNA concentration in the starting sample (Zhang, 
Wen et al. 2005; Klee, Tyczka et al. 2006), improve sensitivity by hybridisation with 
other  technologies  (Muramatsu,  Yanase  et  al.  1997),  determine  antibiotic  and 
disinfectant susceptibility of obligate intracellular bacteria (MacDonald, Sargent et 
al. 2002; Brennan and Samuel 2003) and enable gene expression and viability 
experiments (Fontaine and Guillot 2003; Coleman, Fischer et al. 2004). 
1.6  Viability 
The  perceived  need  for  bacterial  viability  assays,  partly  due  to  increased 
awareness of the potential of bioterrorism, has led to the development of many 
new techniques.  Fluorescence assays in particular have received attention with  
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the most common tests targeting respiratory activity (Bhupathiraju, Hernandez et 
al. 1999), membrane potential (Deere, Porter et al. 1995) and membrane integrity 
(Nebe-von-Caron, Stephens et al. 2000).  Laflamme et al. (Laflamme, Lavigne et 
al.  2004)  consider  that  all  of  these  assays  must  be  performed  to  adequately 
assess viability.  However, performing all of these tests is both time consuming 
and  expensive.    Therefore,  more  unequivocal  tests  are  required  for  routine 
monitoring  and  surveillance  applications.    Chemicals  that  pass  through 
compromised  cell  membranes  and  render  DNA  unavailable  to  replicative 
processes have also been used, in combination with quantitative PCR, to estimate 
viability (Rudi, Moen et al. 2005; Rueckert, Ronimus et al. 2005). 
1.6.1  Animal inoculation 
Animal models have been used to assess the efficacy of antibiotics against C. 
burnetii (Raoult 1993) and they remain the gold standard for estimating the viability 
and infectivity of this pathogen (Arricau-Bouvery, Souriau et al. 2005).  Scott and 
Williams (1990) used an adaptation of an earlier method (Ransom and Huebner 
1951)  consisting  of  infection  of  chick  embryos  and  sub-passage  in  mice  and 
detection  of  an  immunological  response  to  verify  the  infectivity  of  disinfectant-
treated samples.  This procedure took in excess of four weeks to produce results 
(Scott and Williams 1990).  Development of new techniques for estimating viability 
are  vitally  important  to  C.  burnetii  research  due  to  the  expense,  technical 
complexity  and  ethical  issues  associated  with  animal  assays  (Ransom  and 
Huebner 1951; Malloch and Stoker 1952; Sobsey and Leland 2001). 
1.6.2  Culture-based methods 
Plaque assays have been successfully applied to several rickettsial species 
(McDade and Gerone 1970; Wike, Tallent et al. 1972; Cory, Yunker et al. 1974;  
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Ormsbee, Peacock et al. 1978; Schneider 1989).  However, limited success has 
been achieved in the application of these techniques to C. burnetii (Kordova 1966; 
Cory, Yunker et al. 1974; Schneider 1989).  Indeed, the results that were obtained 
correlated  poorly  with  titrations  in  animals  and  took  longer  than  two  weeks  to 
complete (McDade and Gerone 1970; Wike, Tallent et al. 1972).  An adaptation of 
the plaque assay has been described, which enumerated stained vacuoles in vero 
cells rather than plaques in a confluent monolayer (Schneider 1989).  The authors 
proposed that this method was more rapid and economical and less laborious than 
previously described plaque formation assays. 
While an effort to grow C. burnetii in axenic media was unsuccessful the study 
did show that significant biosynthetic processes occurred in the pathogen when 
grown in a cell-free acidic medium (Zuerner and Thompson 1983).  These findings 
support an earlier study which demonstrated that the subcellular machinery of C. 
burnetii was able to synthesis coliphage protein in vitro when supplied with amino 
acids and mRNA (Donahue and Thompson 1980; Donahue and Thompson 1981).  
Furthermore,  Hackstadt  and  Williams  found  that  in  acidic  axenic  medium  C. 
burnetii produced RNA and DNA when supplied with an energy source and that 
glutamate  supplied to the organism was incorporated into  a trichloroacetic acid 
insoluble product.  These results indicate a functional protein synthetic mechanism 
exists in Coxiella (Hackstadt and Williams 1981) and that culture of this organism 
in axenic medium may be possible. 
Brennan  and  Samuel  (2003)  described  a  cell  culture-based  method  for 
evaluating  disinfection  efficacy,  a  task  made  difficult  by  the  intracellular  growth 
requirements of C. burnetii.  This type of assay has been used successfully for 
growth, viability and disinfection assays for Cryptosporidium parvum (Shin, Linden 
et  al.  2001;  MacDonald,  Sargent  et  al.  2002;  Rochelle,  Marshall  et  al.  2002;  
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Keegan, Fanok et al. 2003).  The shell-vial assay has also proven to be effective in 
this type of application (Raoult 1993). 
1.6.3  Molecular methods 
Detection of transcriptional activity is considered to be indicative of viability 
(Keer and Birch 2003).  Reverse transcriptase PCR is not a new technique but 
advances in quantitative estimation of nucleic acids has exponentially increased 
the power of this type of assay (Bustin and Nolan 2004).  Application of RT-qPCR 
has helped to elucidate the developmental cycle of C. burnetii (Coleman, Fischer 
et  al.  2004)  and  has  been  used  to  estimate  the  viability  of  other  organisms 
(Jenkins,  Trout et  al. 2003; Keer and Birch 2003; Ohashi, Inaoka et  al. 2003).  
However, while the transient nature of RNA makes it an ideal target for viability 
assays, such techniques require careful planning and a thorough knowledge of the 
potential  pitfalls  of  the  technology  before  they  can  be  applied  to  real  samples 
(Jenkins, Trout et al. 2003; Bustin and Nolan 2004; Huggett, Dheda et al. 2005). 
1.6.4  Membrane integrity and membrane potential-based methods 
The assumption that dead cells lose their membrane integrity has been the 
foundation for several methods of viability assessment.  Viable cells control the 
trans-membrane  traffic  of  solutes  and  therefore  any  indication  that  movement 
across  the  cell  membrane  is  not  regulated  is  a  proxy  measure  of  viability 
(Laflamme, Lavigne et al. 2004).  Ethidium monoazide bromide (EMA) is a nucleic 
acid binding dye which, once photolysed, covalently links to DNA thus preventing 
amplification by PCR (Waring 1965).  It has been proposed that EMA selectively 
crosses the membranes of dead cells but is unable to penetrate live cells (Rudi, 
Moen et al. 2005) thus providing a useful tool for determining viability.  However, 
this method may not be broadly applicable because it has been shown to be toxic  
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to some organisms and may also cross the membranes of live cells (Rueckert, 
Ronimus et al. 2005).  Other viability assays have also been developed which take 
advantage of the correlation between cell viability and membrane integrity.  The 
commercially available Live/Dead Baclight kit enables visualisation of viable/non-
viable cell populations under UV illumination following the penetration of the DNA-
binding dye SYTO9 through compromised cell membranes (Laflamme, Lavigne et 
al. 2004).  However, this method is limited by the resolution of a light microscope, 
thus  excluding  small  cells.    Like  EMA,  the  DNA-degrading  enzyme  DNase 
selectively crosses the membranes of dead cells only and subsequently degrades 
the DNA within (Frankfurt 1983), a property which has been exploited in PCR and 
flow cytometric viability assays (Frankfurt 1983; Rueckert, Ronimus et al. 2005). 
1.7  Treatment and control of Q fever infections 
1.7.1  Antibiotic therapy 
The acute form of Q fever is normally diagnosed retrospectively because it is 
a  febrile  self-limiting  illness  with  non-specific  symptoms  (Williams  and Sanchez 
1994).  However, recovery can be accelerated by treatment with tetracyclines or a 
variety of other antibiotics (Woldehiwet 2004) if the intervention is initiated in the 
first three days of infection (Raoult 1993).  Chronic Q fever, on the other hand, can 
be much more difficult to treat as it is refractory to antibiotics and has been shown 
cause mortality in  approximately  2% of cases (Raoult 1993) in some instances 
mortality  may  result  even  when  appropriate  antibiotic  treatment  is  administered 
(Williams and Sanchez 1994).  Currently the recommended treatment for chronic 
Q  fever  is  doxycycline  plus  hydroxychloroquine  for  a  minimum  of  18  months 
(Raoult, Houpikian et al. 1999).  
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1.7.2  Vaccination 
Several vaccine formulations are available, with the most common consisting 
of  formalin-inactivated  whole  cell  preparations  (Waag,  England  et  al.  1997).  
Despite the simple nature of this type of vaccine it has proven to be extremely 
effective at preventing Q fever (Ackland, Worswick et al. 1994).  In an effort to 
reduce  the  incidence  of  Q  fever  the  Australian  government  implemented  the 
National Q Fever Management Program in 2000.  This program aimed to reduce 
the  burden  of  disease  associated  with  Q  fever  and  included  subsidies  for 
vaccination of at-risk workers (Kermode, Yong et al. 2003).  It was estimated using 
data from 1993-94 that Q fever in Australia may cost the country A$1 million per 
year  (Garner,  Longbottom  et  al.  1997).    Therefore  it  is  not  surprising  that  an 
economic  evaluation  of  the  impact  of  Q  fever  on  workers  in  the  meat  and 
agricultural  industries  in  Australia  found  that  increasing  the  rate  of  vaccination 
yielded  significant  financial  benefits  to  employers.    It  was  suggested  that 
increasing Q fever vaccination of meat industry workers would prevent 400 cases 
of Q fever, four deaths and result in a gain of 43 discounted life years over a 20 
year period. This equates to a cost benefit of $20,000/life year gained (Kermode, 
Yong et al. 2003). 
The  vaccine  used  is  made  from  inactivated  whole  cell  phase  I  Henzerling 
strain  C.  burnetii  (Q-Vax,  CSL)  and  appeared  to  be  protective  for  at  least  five 
years, although repeated natural exposure may contribute to protection (Ackland, 
Worswick et al. 1994).  Administration is by a single subcutaneous injection of 30 
µg of vaccine following pre-vaccination antibody assay and skin test to ensure that 
the individual is unsensitised to C. burnetii.  Vaccination of individuals who have 
previously been exposed to the Q fever agent has resulted in serious side effects 
such as severe necrotic lesions or granuloma development at the injection site  
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(Marmion, Ormsbee et al. 1984; Fairweather, O'Rourke et al. 2005).  It was also 
demonstrated that when mice were infected with an attenuated strain of C. burnetii 
that is commonly used to make the vaccine, live organisms could be isolated not 
only  from  the  vaccinated  animals  but  also  from  their  F1  and  F2  offspring 
(Freylikhman, Tokarevich et al. 2003). 
Fractionation of whole cell preparations has been performed in an effort to 
develop a new Q fever vaccine (Fries, Waag et al. 1993).  The ineffectiveness or 
toxicity of fractionated and/or purified vaccines and the possibility that whole-cell 
vaccines may contain live Coxiella highlight the need for a recombinant alternative.  
Efforts to create a subunit vaccine have met with some success in mice but the 
response seen was still inferior to that generated by a formalin-fixed whole cell 
antigen of C. burnetii (Li, Niu et al. 2005).  Similarly, investigations into applying 
recombinant C. burnetii proteins as vaccine antigens has met with limited success 
(Zhang, Kiss et al. 2004; Tyczka, Eberling et al. 2005). 
1.7.3  Disinfection 
Coxiella burnetii is highly resistant to physical and chemical stress and thus 
poses a significant problem for both laboratory and industrial disinfection strategies 
alike.    Ultra  violet  irradiation  has  been  shown  to  be  effective  in  inactivating  C. 
burnetii at relatively low doses (Ransom and Huebner 1951; Little, Kishimoto et al. 
1980).  However, a more recent study demonstrated that C. burnetii has a fully 
functional  DNA  excision  repair  system  despite  lacking  some  of  the  genetic 
elements normally associated with repair of oxidative damage (Mertens, Lantsheer 
et  al.  2005).    Therefore,  it  remains  uncertain  whether  using  UV  radiation  to 
inactivate  C.  burnetii  is  a  valid  approach  for  disinfecting  water.    The  UV  dose 
typically  applied  in  wastewater treatment processes is in the order  of 30 to 40  
12/06/2009  School of Veterinary and Biomedical Sciences   
1-41 
mJ/cm
2 (Shin, Linden et al. 2001), which is nearly two orders of magnitude greater 
than  the  dose  that  appears  to  be  effective  for  inactivating  C.  burnetii  (Little, 
Kishimoto et al. 1980).  The damage induced at this level of radiation may well be 
too severe to be repaired by the mechanisms available to C. burnetii. 
Scott and Williams (1990) found that liquid suspensions of C. burnetii exposed 
to  0.5%  NaOCl,  2%  Roccal,  5%  Lysol  or  5%  formalin  for  24  hours  were  still 
infectious.  However, 30 minute exposure to 70% ethanol, 5% chloroform or 5% 
EnviroChem resulted in inactivation (Scott and Williams 1990).  The resistance of 
C. burnetii to other chemical agents such as formalin and phenol has also been 
found  to  be  superior  to  comparable  organisms  (Ransom  and  Huebner  1951).  
However,  the  availability  of  new  techniques  for  assessing  the  viability  of 
intracellular parasites may necessitate that the efficacy of some of these agents be 
reassessed. 
Current pasteurisation methods are predicated upon their ability to inactivate 
indicator organisms such as C. burnetii (Cerf and Condron 2006).  It has been 
demonstrated that C. burnetii remains viable for between 30 and 60 minutes when 
exposed to 60
oC in a liquid suspension of cells and that 65
oC for 30 minutes was 
sufficient  to  inactivate  both  strains  tested  (Ransom  and  Huebner  1951).    The 
energy required to generate temperatures of this magnitude in large-scale effluent 
streams  preclude  such  uses  but  heating  is  clearly  an  option  for  laboratory 
sanitisation. 
State-of-the-art technologies such as photocatalytic treatment of air (Vohra, 
Goswami  et  al.  2005)  may  provide  solutions  in  the  future  and  while  their 
application  to  agricultural  situations  is  currently  limited  it  may  be  beneficial  to 
implement such strategies in research situations.  
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1.7.4  Behavioural tools for Q fever control 
An epidemiological investigation into an outbreak of Q fever in a small town in 
the French Alps in 1996 indicated that the source of the infections was a pile of 
contaminated uncovered sheep waste in a local abattoir.  It was suggested that 
spread of Coxiella was facilitated by a nearby heliport (Carrieri, Tissot-Dupont et 
al. 2002).  This incident highlights that good work practices and basic knowledge 
of how Q fever can be spread is sufficient in many instances to prevent outbreaks 
of  the  disease.    Furthermore,  Hellenbrand  et  al.  (2001)  proposed  that  with 
increasing urbanisation of rural areas the most effective method for preventing Q 
fever is to limit sheep-related exposures.  In the event that contact with sheep, and 
indeed other ruminants, is unavoidable, crutch clipping of the ewe‟s wool prior to 
lambing and total confinement housing at lambing in winter and spring may lower 
the  chance  that  a  flock  would  be  seropositive  for  Coxiella  and  subsequently 
decrease  the  chance  of  zoonotic  transfer  (Lang,  Waltner-Toews  et  al.  1991).  
However, perhaps the most useful behavioural tool for the control of Q fever is 
awareness  of  this  disease  within  industries  associated  with  domestic  and  feral 
ruminants.  In this way effective disinfection and, if required, vaccination programs 
can  be  implemented.    Furthermore,  in  the  event  of  an  outbreak  of  Q  fever, 
adequate awareness will enable rapid diagnosis and thus the implementation of 
the appropriate intervention.  
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2.  The development and validation of a PCR-based detection 
system for Coxiella burnetii in environmental samples 
2.1  Introduction 
Q fever is a serious occupational hazard for people who work with or around 
livestock or marsupials including kangaroos and bandicoots.  This disease is rarely 
fatal but it can have a significant effect on the health and productivity of infected 
individuals.    The  agent  responsible  for  Q  fever,  Coxiella  burnetii,  has  a  strong 
association with domestic ruminants including sheep, goats and cattle (Raoult and 
Marrie 1995) as well as native Australian marsupials (Derrick 1939; Pope, Scott et 
al. 1960).  Inhalation of contaminated fomites via the aerosol route is the most 
common mode of transmission (Yanase, Muramatsu et al. 1998) with as few as 
one viable C. burnetii cell capable of causing clinical disease in humans (Tigertt, 
Benenson et al. 1961; Ormsbee, Peacock et al. 1978).  Coxiella can persist in the 
environment for an extended period because it is extremely resistant to physical 
and  chemical  damage  (PHAC  2001).    Therefore, environmental substrates  that 
have  been  contaminated  by  C.  burnetii  from  infected  domestic,  feral  or  wild 
animals can pose a risk of infection to humans for several months. 
Polymerase  chain  reaction-based  tests  to  detect  C.  burnetii  in  milk,  dust, 
urine,  faeces,  genital  swabs,  air,  clinical  samples  and  cell  culture  have  been 
published (Muramatsu, Yanase et al. 1997; Yanase, Muramatsu et al. 1998; Berri, 
Laroucau et al. 2000; Issartel, Gauduchon et al. 2002; Brennan and Samuel 2003; 
Klee, Tyczka et al. 2006).  There are no reports on the validation of a PCR-based 
test  detecting  C. burnetii  in environmental samples such as raw water, dust or 
faeces.    These  environmental  substrates  can  confound  PCR-based  detection 
assays because they contain inhibitors that are difficult to remove such as humic  
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and fulvic acids and tannins (Kreader 1996; Hartman, Coyne et al. 2005; Klerks, 
van Bruggen et al. 2006; Whitehouse and Hottel 2007).  Thus there is a need for a 
robust and broadly applicable PCR that has defined properties including sensitivity, 
specificity and repeatability. 
2.2  Materials and methods 
2.2.1  DNA extraction and standard curve preparation 
Q-Vax™  (CSL,  Parkville,  Australia),  which  comprises  formalin  inactivated 
whole C. burnetii (phase I Henzerling strain) was used to prepare all reference 
DNA standards and standard curves.  A suspension containing 25 µg of C. burnetii 
cells from Q-Vax™ vaccine was pelleted by centrifugation at 20,800 x g for 10 
minutes  and  whole  genomic  DNA  extracted  using  a  Qiagen  Tissue  Minikit 
according to the manufacturers instructions (Qiagen, Hilden, Germany) except with 
a 45 minute incubation at 55°C in buffer ATL with proteinase K and a final 30 
minute incubation at 70
°C prior to the addition of 70% v/v ethanol (Klee, Tyczka et 
al. 2006).  DNA was eluted in 100 µl of buffer AE, quantified with a Nanodrop 
spectrophotometer  (Nanodrop  Technologies  Wilmington  USA)  and  converted  to 
genome  copy  number  using  the  formula  described  by  Brennan  and  Samuel 
(Brennan and Samuel 2003).  Standard curves were prepared by making serial 10-
fold dilutions of the DNA extract in TE buffer. 
2.2.2  Primer design 
The primer and probe set named with the prefix TP1 were developed by the 
Australian  Rickettsial  Reference  Laboratory  (Geelong,  Victoria,  Australia).    The 
primer set named with the prefixes RAF and FAF are from previously published 
work (Brennan and Samuel 2003) and the primer and probe sets with the prefixes  
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ScvA and 16S were from a published study by Coleman et al. (2004).  All primers 
not obtained from published methods were designed using Primer3 online software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).    Primers  were 
synthesised  by  Invitrogen  (Mount  Waverley,  Victoria,  Australia)  and  the 
oligonucleotide probes were supplied by Geneworks (Hindmarsh, South Australia).  
A list of the primer and probe sequences used is shown in Table 2.1.  
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Table 2-1.  Primer and probe sequences used to detect Coxiella burnetii DNA in 
a real-time PCR format 
Name  Gene 
Targeted 
Sequence (5’ to 3’)  Labels 
IS1111aF  IS1111a   GTTTCATCCGCGGTGTTAAT  None 
IS1111aR  IS1111a  TGCAAGAATACGGACTCACG  None 
IS1111aP  IS1111a  CCCACCGCTTCGCTCGCTAA  5‟-6FAM 
3‟-BHQ-
1 
TP1f  Com1  AAAACCTCCGCGTTGTCTTCA  None 
TP1r  Com1  GCTAATGATACTTTGGCAGCGTATTG  None 
TP1p  Com1  AGAACTGCCCATTTTTGGCGGCCA  5‟-6FAM 
3‟-BHQ-
1 
FAF216  Com1  GCACTATTTTTAGCCGGAACCTT  None 
RAF290  Com1  TTGAGGAGAAAAACTGGATTGAGA  None  
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HspB-F  HspB  CTCCACGCGGTTTTTAATGT  None 
HspB-R  HspB  CGGGCGGTAAGGTTATTTCT  None 





SpoIIIE  CGCTAAATCCACGATGACTG  None 
SpoIIIE-
R 
SpoIIIE  GGAAATCGGTTATTGGTCTGG  None 
SpoIIIE-
P 
SpoIIIE  CGCCAACACTTCGTAAATCGTGACC  5‟-6FAM 
3‟-BHQ-
1 
ScvA-F  ScvA  TGGAAAGACAAAATGTCCAACAA  None 
ScvA-R  ScvA  GGTTAGAAGCACCCGGTCGT  None 
ScvA-P  ScvA  ACGTGGAAAAGACCAACG  5‟-6FAM 
3‟-BHQ-
1  
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16S-F  I6S  CCATGAAGTTGGAATCGCTAG  None 
16S-R  I6S  ACTCCCATGGTGTGACGG  None 
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For  primers  that  were  designed  in-house  whole  gene  sequences  were 
submitted  online  to  the  NCBI  database  searching  tool  BLASTn 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) for homology matching.  Regions with 
little or no homology to other submitted sequences were selected for subsequent 
design of oligonucleotide primers and probes.  All primers and probes were then 
compared  to  all  published  sequences  using  BLASTn  to  identify  any  significant 
matches. 
2.2.3  PCR optimisation 
Forward  and  reverse  primers  were  titrated  against  each  other  in 
concentrations  ranging  from  5  pmol  to  25  pmol  in  increments  of  5  pmol.    For 
assays with TaqMan probes the probe concentrations were titrated from 1.25 pmol 
to 5 pmol in increments of 1.25 pmol.  The optimum concentration of each primer 
and probe combination that yielded the lowest Ct value and the largest difference 
between  peak  fluorescence  and  background  fluorescence  were  selected.    All 
samples were performed in duplicate and no template  (negative)  controls were 
included for each primer set. 
TaqMan assays were optimised for magnesium chloride concentration in the 
range  1.5  mM  to  4.5  mM  in  increments  of  0.5  mM.    Once  optimum  primer 
concentrations were established some primer sets (IS1111a, TP1 and RAF/FAF), 
with no probe added, were titrated for optimum SYBR
® Green I (Sigma-Aldrich, 
Castle Hill, NSW, Australia) concentration and re-titrated for magnesium chloride 
in  light  of  the  requirements  of  this  detection  chemistry.    Magnesium  chloride 
concentrations ranged from 2 mM to 4.5 mM and dilutions of 1 in 25,000, 50,000, 
100,000, 200,000 and 400,000 of the 10,000X SYBR
® Green I stock were made.  
Melt curve analysis was performed on all primer sets to ensure the absence of  
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secondary  peaks  which  are  indicative  of  non-specific  amplification.    Annealing 
temperatures from 58 to 66°C in 1° increments were titrated against a set of serial 
10-fold dilutions of C. burnetii DNA for all primer sets except the RAF/FAF set for 
which the published annealing temperature was used (Brennan and Samuel 2003).  
Where the reaction efficiency for a particular assay deviated too far from the ideal 
value  higher  annealing  temperatures  were  not  tested.    Ideal  annealing 
temperatures were selected based upon reaction efficiencies, Ct values, lack of 
signal in NTC controls, amplification of low concentrations of template and linearity 
of standard curves. 
2.2.4  PCR conditions 
All SYBR
® Green reactions contained 0.01 µmoles of dNTP mixture (Fisher 
Biotech, West Perth, Western Australia, Australia) magnesium chloride, primers, 
5.5  units  of  Tth  Plus  DNA  Polymerase  (Fisher  Biotech),  10×  reaction  buffer, 
SYBR® Green I, SYBR
® Green buffer made according to the protocol described 
previously (Karsai, Muller et al. 2002), template DNA and water to a total reaction 
volume of 25 µl. 
TaqMan  real-time  PCR  reaction  mixtures  contained  0.01  µmoles  of  dNTP 
mixture  magnesium  chloride,  primers,  probe,  5.5  units  of  Tth  Plus  DNA 
Polymerase,  10×  reaction  buffer,  template  DNA  and  water  to  a  total  reaction 
volume of 25 µl. 
Real-time PCR assays were performed on a Rotorgene
® 3000 (Corbett Life 
science,  Mortlake,  New  South  Wales,  Australia)  according  to  one  of  the  two 
following cycling parameters:  
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TaqMan: one hold at 95°C for two minutes followed by 40 cycles of 95°C for 
20 seconds and 40 seconds at the relevant annealing temperature. 
SYBR: one hold at 95°C for two minutes followed by 40 cycles of 95°C for 20 
seconds, 35 seconds at the relevant annealing temperature, 72°C for 20 seconds, 
a final hold for  20 seconds at  52°C leading into a melt curve analysis up to a 
maximum temperature of 99°C. 
Following all qPCR amplification experiments the Rotorgene
® 3000 software 
was used to automatically select optimal cycle threshold cut-offs based upon the 
slope  of  the  standard  curve  and  the  R
2  value.    The  user-defined  DNA 
concentrations of the standards were then used by the software to fit a curve to the 
samples and subsequently estimate the concentration of DNA in each standard.  
Melt curve peaks were determined using the Rotorgene
® 3000 software with all 
digital  filters  turned  off  to  maximise  the  precision  of  oligonucleotide  melt 
temperature estimation. 
2.2.5  Reproducibility 
Each assay was used to amplify C. burnetii DNA that was prepared in seven 
serial  10-fold  dilutions  from  5.56  x  10
6  genomes  per  micro  litre  down  to  5.6 
genomes per micro litre.  All primer sets were evaluated using both SYBR
® and 
TaqMan detection systems with the exception of FAF216/RAF290 which was only 
used in the SYBR
® system.  Samples were performed in duplicate with two NTC‟s 
included in each run.  All assays were repeated six times and the data generated 
were  analysed  using  the  Statistical  Package  for  Social  Sciences  (version  15.0, 
SPSS Inc., Chicago, USA) to determine means and standard errors of the means 
(SEM) for each dilution point.  
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The effect of making bulk reaction mixtures (with all components added other 
than DNA, SYBR
® Green and primers) and storing them -80°C prior to use was 
assessed with the FAF216/RAF290 primer set.  The cycling conditions when using 
this master mix were identical to all other SYBR
® Green assays. 
A  commercial  TaqMan  master  mix  (Platinum
®  Quantitative  PCR  SuperMix-
UDG, Invitrogen) was also assessed for its ability to improve reproducibility when 
used  in  conjunction  with  the  IS1111a  primer  and  probe  set.    The  reaction 
concentrations used with this master mix were 12.5 µl of Invitrogen master mix, 
one micro litre of each primer and probe, 0.75 µl of 50 mM MgCL2, one micro litre 
of  DNA  template  and  water  to  25  µl.    The  cycling  conditions  when  using  this 
master mix were identical to the other TaqMan assays other than the addition of a 
two minute hold step at 50°C at the beginning of the run. 
2.2.6  Analytical sensitivity 
The analytical sensitivities of the IS1111a, TP1, HspB, JB153-3 and SpoIIIE 
TaqMan assays were determined by testing a standard curve consisting of eight 
serial  10-fold  dilutions  where  the  highest  dilution  point  had  a  calculated 
concentration  of  0.16  genomes  per  micro  litre.    Each  dilution  was  tested  in 
duplicate, each run had two NTC‟s included and each assay was repeated three 
times.  The data were analysed as described previously except the SPSS package 
was also used to provide descriptive statistics including mean, standard deviation, 
standard error of the mean and the coefficient of variation.  Microsoft Excel XP 
Professional  Edition  (Microsoft  Corp,  California,  USA)  was  used  to  graph  the 
relationship between C. burnetii DNA standard concentration and cycle threshold 
values for all tests.  
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2.2.7  Analytical specificity 
The analytical specificities of the IS1111a, TP1, HspB, JB153-3 and SpoIIIE 
TaqMan  assays  were  determined  by  attempting  to  amplify  10  ng  of  DNA  per 
reaction from the organisms listed in table 2.2.  All assays used the same reaction 
mixtures and cycling conditions as before.  
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Table 2-2.  Sources of organisms used to assess the specificity of qPCR assays 
Organism  Supplier  Source 
Staphylococcus aureus  MU  ARC mouse lesion 
Streptococcus equi  AgWA  Case No 196/81 Equine Nasal 
Pseudomonas aeruginosa  MU  Skin swab, general dermatitis 
Yersinia enterocolitica  AgWA  Case No AS-01-2175 #4 
Yersinia pseudotuberculosis  AgWA  Case No PR 3696/84 Porcine 
Brucella abortus  AgWA   
Brucella ovis  AgWA  Case No AS-06-2900 Ovine 
Klebsiella oxytoca  AgWA  Case No P-00-1599 Yabby Tissue 
Serratia marcescens  AgWA  Case  No  PR1584/81  Ovine 
Duodenum 
Proteus mirabilis  AgWA  Case No AS-06-2916 Murine Nasal 
Legionella pneumophila  Ecowise   
Rickettsia rickettsii  ARRL    
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Rickettsia prowazekii  ARRL    
MU = Murdoch University 
DAFWA = Department of Agriculture and Food, Western Australia 
ARRL = Australian Rickettsial Reference Laboratory 
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2.2.8  Culture, extraction and purification of Coxiella burnetii 
C.  burnetii  phase  II  Nine  Mile  clone  4  originally  isolated  from  a  tick  from 
Montana,  USA in 1935  (Denison, Massung et  al. 2007) was kindly supplied by 
Professor Jim Samuel from the Department of Intracellular Pathogens, Faculty of 
Medicine, Texas A&M University.  Confluent monolayers of Vero (Green monkey 
kidney) cells were infected by adding 2 µl of 3 mg/ml C. burnetii phase II to each 
25 cm
2  culture flask (TPP, Switzerland).   Cells were maintained in DMEM (MP 
Biomedicals,  Australia)  in  an  atmosphere  containing  5%  (vol/vol)  CO2 
supplemented with 200mM L-Glutamine (MP Biomedicals, Australia) and 2% v/v 
foetal  calf  serum.    Media  was  not  replenished  for  approximately four weeks to 
maximise the proportion of small cell variants (SCV) to large cell variants (LCV) 
(Coleman, Fischer et al. 2004) as the more physically resistant variant is the one 
most  likely  to  be  found  in  the  environment.    Prior  to  purification  the  residual 
monolayer was scraped from the flask surface and homogenised in the culture 
medium.    The cell suspension was then transferred to a 40 ml centrifuge tube 
which was centrifuged for 10 minutes at 40,000 × g.  
Two methods were employed to purify the coxiellae from host cells.  In the first 
method 5 ml of cell suspension in PBS was layered over 35 ml of a mixture of 30% 
sucrose and Urografin
® 76% (Schering, NSW, Australia) with PBS as diluent and 
centrifuged  at  18,000  x  g  for  30  minutes.    The  supernatant  was  removed  by 
aspiration and the pellet resuspended in 5 ml phosphate buffered saline with 0.25 
M sucrose (PBSS), pH 7.4 (Williams, Peacock et al. 1981). 
In the second method cells were resuspended in sterile MilliQ water to induce 
osmotic  shock  and  then  passed  through  a  25  gauge  needle  10  times  to  free 
coxiellae  from  host  cell  components  and  lyse  any  remaining  LCV‟s.  Coxiella  
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burnetii  cells  were  purified  from  host cell debris using differential centrifugation 
(Baca, Aragon et al. 1981) which consisted of three alternating 10 minute cycles of 
low  speed  (820  x  g)  centrifugation  followed  by  high  speed  (20,800  x  g) 
centrifugation.    Following the low speed centrifugation the pellet was discarded 
and the supernatant immediately subjected to the high speed step.  Following the 
high speed step the supernatant was discarded and the pellet was resuspended in 
500  µl  of  PBSS  and  then  the  cycle  was  repeated.    The  final  cell  pellet  was 
resuspended in 500 µl PBSS. 
2.2.9  Using optical density to estimate Coxiella burnetii genome number 
The  absorbance  of  32  individual  cell  suspensions,  prepared  as  described 
above, were measured on a Nanodrop spectrophotometer at three wavelengths; 
250nm, 420nm  and 600nm.   Genomic DNA was extracted from  equal amounts of 
each  sample  using  the  modified  Qiagen  Tissue  Mini-Kit  procedure  described 
previously.  The resulting DNA samples were used as template for quantitative 
PCR  using  the  IS1111a  TaqMan  assay.    All samples were tested in duplicate.  
Calculation of correlation coefficients and drawing of scatter plots were done with 
Microsoft Excel XP Professional Edition.  Results were expressed as genomes per 
micro litre of DNA eluate. 
2.2.10  DNA extraction from environmental matrices 
2.2.10.1  Extraction of DNA from bovine faeces and qPCR amplification 
Phase II C. burnetii was purified from infected tissue culture and purified as 
described previously.  Cells suspended in PBS plus 0.25 M sucrose were stored at 
4
oC until required.  Three 10-fold dilutions of the C. burnetii cell suspension were 
made just prior to use in PBS plus sucrose: 1 in 10, 1 in 100 and 1 in 1,000.  
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Approximately 25 grams of faeces was collected from four cows housed on 
the Murdoch University veterinary training farm that were shown to be serologically 
negative for C. burnetii infection using the CHEKiT Q fever ELISA (see Chapter 6 
for details).  One gram of each faecal sample was pooled and aliquots were made 
by dispensing 0.2 g of pooled faeces into each of 15 bead-beating tubes from a 
MO BIO UltraClean™ soil DNA isolation kit (MO BIO, Calsbad, California, USA) 
with the beads and bead solution removed and reserved in separate sterile tubes.  
A further 12 bead-beating tubes without faeces were prepared as above.  Twenty 
microliters  of  each  C.  burnetii  suspension  was  added  to  three  separate  tubes 
containing faeces and three containing no faeces.  Additionally, 20 µl of PBS plus 
sucrose was added to three tubes containing faeces.  Tubes containing faeces 
were  mixed  thoroughly  by  hand  using  a  200  µl  pipette  tip.    Beads  and  bead 
solution were returned to all tubes and the DNA extraction was performed as per 
the manufacturers‟ instructions. 
Five micro litres of DNA from each tube was amplified on a Rotorgene
® 3000 
machine using the TaqMan IS1111a assay described previously except with the 
addition  of  10  µg  of  bovine  serum  albumin  (Fisher  Biotec  Australia)  to  reduce 
inhibition by co-purified factors such as humic acid and tannins (Kreader 1996; 
Abu Al-Soud and Radstrom 2000).  Microsoft Excel XP Professional Edition was 
used manipulate and graph the data. 
2.2.10.2  Optimising DNA extraction conditions 
A series of experiments were performed to determine if the efficiency of the 
extraction  of  DNA  from  faeces  could  be  improved  by  using  the  MO  BIO 
PowerSoil™  DNA  isolation  kit.    A  pooled  bovine  faecal  sample  was  made  as 
described previously and 0.2 g aliquots were dispensed into 27 out of 36 bead  
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beating tubes with the beads and bead solution removed.  Purified C. burnetii cells 
were prepared as described previously but were not serially diluted.  Twenty micro 
litres  of  the  C.  burnetii  cell  suspension  was  dispensed  into  each  of  the  bead 
beating  tubes,  mixed  thoroughly  with  a  200μl  pipette  tip  the  beads  and  bead 
solution were returned to them. Solution „C1‟ from the DNA isolation kit was added 
and all tubes were mixed on a MO BIO vortex genie with 2 ml tube adaptor head 
for 30 seconds. 
The nine tubes containing C. burnetii cells without faeces were incubated at 
room  temperature.    The  remaining  27  tubes  containing  faeces  and  purified  C. 
burnetii cells were treated in one of four ways prior to continuing with the standard 
DNA extraction protocol.  Six samples were placed in a heating block set to 70°C; 
nine  samples  were  placed  in  a  boiling  water  bath;  nine  were  left  at  room 
temperature and three were subjected to three freeze/boil cycles with two minutes 
in  liquid  nitrogen  and  two  minutes  in  boiling  water.    With  the  exception  of  the 
freeze/boil samples all tubes, including those without faeces, were incubated for 
five minutes at  the designated temperature, mixed on the vortex genie for one 
minute and then incubated for a further five minutes at the same temperature as 
the first incubation.  The standard DNA isolation procedure, as described in the 
product  insert,  was  then  followed  from  step  five  for  all  tubes.    An  analysis  of 
variance  (ANOVA)  with  Tukey‟s  Honestly  Significant  Differences  test  at  a  95% 
confidence  limit  was  performed  to  determine  which of the methods yielded the 
most C. burnetii DNA using the Statistical Package for Social Sciences (SPSS v. 
15.0, SPSS Inc., Chicago, USA). 
DNA from each tube was amplified on a Rotorgene
® 3000 machine using the 
TaqMan IS1111a assay described previously with the addition of 10 µg of bovine 
serum  albumin.    Genomes  per  reaction,  as  estimated by the Rotorgene
®  3000  
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software were expressed as a percentage of the control samples using Microsoft 
Excel and the means and standard errors of the means were then calculated using 
SPSS. 
2.2.10.3  Extraction of whole genomic DNA from kangaroo faeces and qPCR 
amplification 
The DNA was extracted from kangaroo faeces using the MO BIO PowerSoil™ 
DNA isolation kit and with a minor modification.  Kangaroo faeces were collected 
from  animals  in  the  South  West  of  Western  Australia  (Capel)  as  part  of  a 
commercial harvesting program.  Details of the collection location can be seen in 
Chapter 6. Briefly, 0.2 g of faeces in bead-beating tubes were placed in a boiling 
water bath for five minutes, mixed on the Vortex Genie for one minute and then 
boiled  for  a  further  five  minutes.    The  standard  extraction  protocol  was  then 
followed from step five onwards. 
Two micro litres of each DNA sample was amplified on a Rotorgene
® 3000 
using the TaqMan IS1111a assay described previously.  Genomes per reaction, as 
estimated by the Rotorgene
® 3000 software were expressed as a percentage of 
the control samples using Microsoft Excel XP Professional Edition and the means 
and standard errors of the means were then calculated using SPSS.  Results were 
graphed using Microsoft Excel. 
2.2.10.4  Extraction of whole genomic DNA from soil and qPCR amplification 
The procedure described for extraction of DNA from spiked kangaroo faecal 
samples using the MO BIO PowerSoil™ DNA isolation kit was repeated for soil 
samples collected from a cattle holding yard on the Murdoch University farm.  
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Five  micro  litres  of  each  of  the  DNA  extractions  was  amplified  on  a 
Rotorgene
® 3000 machine using the TaqMan IS1111a assay described previously 
and data were analysed as described previously. 
2.2.10.5  Reduction of PCR inhibition 
The  set  of  DNA  samples  extracted  from  bovine  faecal  samples,  with  C. 
burnetii  cells  added,  and  controls  were  amplified  according  to  the  standard 
conditions  described  previously  except  without  the  addition  of  10  µg  of  bovine 
serum albumin to each reaction.  This experiment was performed to confirm that 
addition  of  BSA  improved  the  amplification  efficiency  of  DNA  in  the  system 
described. 
Dilution of template was also performed to alleviate the effect of inhibitors co-
extracted from the DNA samples.  This was examined by two methods.  First, 10 µl 
of each of the three bovine faecal samples which had the highest concentration of 
C. burnetii (1:10) added to them were pooled and diluted in two-fold steps to 1 in 
64.  Five micro litres of each was then subjected to qPCR amplification according 
to the conditions described previously except with the addition of 10 µg of bovine 
serum  albumin  to  each  reaction.    Microsoft  Excel  XP  Professional  Edition  was 
used to calculate a correlation coefficient between sample dilution and estimated 
C. burnetii genomes and from this a trend line was added to the scatter generated 
by the same program.    The SPSS statistical package was used to conduct an 
analysis of variance with Tukey‟s Test for Honestly Significant Differences at a 
95% confidence limit to determine if any level of template dilution was superior to 
the others. 
The last method used to investigate the possible cause of the inhibition that 
was present in the samples was to extract DNA again from one of each of the  
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dilutions,  including  controls  from  the  original  experiment  using  the  MO  BIO 
PowerSoil™ DNA Extraction Kit.  The exact volume of each sample was recorded 
before DNA extraction and this number was subsequently used to normalise qPCR 
results.  Standard qPCR conditions were used except with the addition of 10 µg of 
bovine serum albumin to each reaction. 
Pearson‟s correlation coefficient was calculated to determine the strength of 
the association between the sample dilution and estimated C. burnetii genomes.  
The  significance  of  any  differences  in  the  estimated  genomes  in  reactions 
containing different levels of template dilution were determined using an one-way 
ANOVA as described above. 
The last method used to investigate the possible cause of the inhibition that 
was present in the samples was to extract DNA again from one of each of the 
dilutions,  including  controls  from  the  original  experiment  using  the  MO  BIO 
PowerSoil™ DNA Extraction Kit.  The exact volume of each sample was recorded 
before DNA extraction and this number was subsequently used to normalise qPCR 
results.  Standard qPCR conditions were used except with the addition of 10 µg of 
bovine serum albumin to each reaction.  The mean estimated genome number per 
reaction for each sample was expressed as a percentage of the positive control 
sample and an independent sample t-test with equal variances assumed was used 
to  test  the  significance  of  any  differences  between  primary  and  re-extracted 
samples at a given dilution.  
12/06/2009  School of Veterinary and Biomedical Sciences   
2-63 
2.3  Results 
2.3.1  Optimising PCR Conditions 
The reaction efficiencies of all assays with increasing annealing temperatures 
are shown in Figure 2.1 and the „ideal‟ 1.0 efficiency is also plotted for comparison.  
Summaries  of  the  optimum  reaction  conditions  for  each  qPCR  assay  are 
presented in tables 2.3 to 2.5. 
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Table 2-3.  Optimum primer concentrations and annealing temperatures for 
qPCR assays 
Assay  Forward  Primer 
Conc. 
Reverse  Primer 
Conc. 
Anneal Temp 
IS1111a  25 pmol  20 pmol  64°C 
TP1  10 pmol  25 pmol  61°C 
FAF/RAF  20 pmol  25 pmol  60°C 
HspB  5 pmol  15 pmol  60°C 
SpoIIIE  10 pmol  15 pmol  60°C 
JB153-3  15 pmol  20 pmol  60°C 
ScvA  20 pmol  15 pmol  59°C 
16S  10 pmol  15 pmol  65°C 
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Table  2-4.    Optimum  magnesium  chloride  and  dual  labelled  probe 
concentrations for TaqMan qPCR assays 
Assay  Mg2+ Conc.  Probe Conc. 
IS1111a  4.5 mM  1.25 pmol 
TP1  3 mM  5.00 pmol 
HspB  3 mM  3.75 pmol 
SpoIIIE  3 mM  1.25 pmol 
JB153-3  3 mM  3.75 pmol 
ScvA  3 mM  3.75 pmol 
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Table 2-5.  Optimum SYBR
® Green and magnesium chloride concentrations 
for intercalating dye qPCR 
Assay  Mg2+ Conc.  SYBR Conc. 
IS1111a  5.5 mM  1 in 50,000 
TP1  3.5 mM  1 in 50,000 
FAF/RAF  5.0 mM  1 in 100,000 
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2.3.2  Reproducibility 
The standard error of the mean Ct values from the reproducibility experiments 
are summarised in tables 2.6 and 2.7.  Overall lower errors were observed in the 
results from the TaqMan assays compared to the SYBR
® Green assays.  Using a 
bulk  master  mix  marginally  improved  the  reproducibility  of  one  SYBR
®  Green 
assay.    There  was  a  significant  decrease  in  the  SEM  of  Ct  values  when  a 
commercial TaqMan master mix was used. 
 
  
12/06/2009  School of Veterinary and Biomedical Sciences   
2-68 
Table 2-6.  Cycle threshold and SEM values for samples with known Coxiella 
burnetii DNA concentrations using TaqMan qPCR assays 
Genomes/µl  IS1111a  TP1  IS1111a MM 
   Ct  SEM  Ct  SEM  Ct  SEM 
5.56  24.42  0.44  32.68  0.66  24.51  0.38 
5.56 x 10
1  24.85  0.16  30.73  0.38  22.07  0.14 
5.56 x 10
2  21.54  0.28  27.23  0.26  19.17  0.07 
5.56 x 10
3  18.37  0.17  23.20  0.21  15.73  0.05 
5.56 x 10
4  15.55  0.22  20.59  0.18  12.29  0.05 
5.56 x 10
5  12.25  0.12  16.99  0.19  8.70  0.06 
5.56 x 10
6  8.42  0.14  13.41  0.19  5.38  0.06 
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Table 2-7.  Cycle threshold and SEM values for samples with known Coxiella 
burnetii DNA concentrations using SYBR
® Green I qPCR assays 
Genomes/µl  IS1111a  TP1  FAF/RAF  FAF/RAF MM 
   Ct  SEM  Ct  SEM  Ct  SEM  Ct  SEM 
5.56  25.04  1.26  29.54  1.01  32.83  0.74  33.27  0.99 
5.56 x 10
1  25.37  0.82  28.35  0.46  31.06  0.52  32.57  0.54 
5.56 x 10
2  21.19  1.12  25.14  1.05  26.46  0.38  27.27  0.28 
5.56 x 10
3  18.27  1.44  21.22  1.00  22.74  0.44  24.84  0.12 
5.56 x 10
4  15.73  0.87  20.01  0.73  21.17  0.28  22.73  0.12 
5.56 x 10
5  10.32  0.53  15.35  1.08  16.79  0.32  19  0.17 
5.56 x 10
6  7.03  0.25  11.66  0.56  13.48  0.35  15.51  0.27 
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2.3.3  Analytical sensitivity 
The analytical sensitivity of all TaqMan assays was determined by analysing 
several factors; (1) the coefficient of variation of estimated genome equivalents for 
each dilution of DNA (Table 2.8); (2) the DNA dilution at which greater than, or 
equal to, 50% of the reactions failed (Figure 2.2) and; (3) the linearity of the Ct 
values for each assay (Figure 2.3).  Based on these criteria the IS1111a assay 
was the most sensitive with a theoretical detection limit of 0.16 genomes per micro 
litre of template added.  However, detection of this low concentration of DNA was 
not repeatable and did not give a reliable estimate of DNA concentration because 
the relationship between the cycle threshold value and the given C. burnetii DNA 
concentration was not linear.  The lowest DNA concentration that could be reliably 
detected (that is; produce detectable amplification greater than 50% of the time) 
with the IS1111a assay was 15.9 genomes per micro litre.  The JB153-3 test was 
also able to detect as few as 0.16 genomes per reaction but was less reliable and 
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Table 2-8.  Coefficients of variation (%) of estimated Coxiella burnetii genome 
equivalents  resulting  from  qPCR  amplification  of  a  set  of  DNA  standards 
diluted in 10-fold steps 
Genomes/µl  Tp1  HspB  SpoIIIE  IS1111a  ScvA TM  JB153-3 
1.59E+07  12.56  10.03  6.86  1.84  18.73  18.16 
1.59E+06  9.85  6.85  3.57  2.59  21.97  13.37 
1.59E+05  5.13  18.31  4.00  2.08  13.35  9.39 
1.59E+04  3.51  8.03  7.96  3.64  11.79  14.86 
1.59E+03  60.66  26.70  29.08  6.70  24.76  26.60 
1.59E+02  171.85  82.84  122.25  6.22  64.87  111.99 
1.59E+01  -  137.29  192.05  77.39  91.38  59.44 
1.59E+00  244.95  -  -  153.35  244.95  244.95 
1.60E-01  -  -  -  239.50  -  244.95 
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Figure 2-2.  Percentage of reactions that showed detectable amplification of 10-
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Figure  2-3.    Cycle  threshold  values  versus  Coxiella  burnetii  DNA  standard 
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2.3.4  Analytical specificity 
None of the DNA samples tested produced detectable amplification with the 
IS1111a,  JB153-3,  Tp1, HspB, ScvA or  SpoIIIE assays  by cycle 40.  The 16S 
assay  produced  detectable  amplification  for  DNA  samples  from  all  organisms 
except S. aureus, S. equii and R. rickettsii. 
2.3.5  Extraction of Coxiella burnetii DNA from environmental matrices 
2.3.5.1  Extraction  of  DNA  from  bovine  faeces  and  qPCR  amplification  of 
Coxiella burnetii DNA 
The qPCR results generated from this experiment indicate that there was over 
60 times as much amplifiable DNA present in the controls as in the corresponding 
spiked bovine faecal samples.  The relationship between C. burnetii genomes per 
micro litre and the dilution of a C. burnetii cell suspension is shown in Figure 2.4.  
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Figure  2-4.    Graph  showing  the  reduced  qPCR-estimated  Coxiella  burnetii 
DNA concentration in faecal samples in comparison to the DNA concentration 
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2.3.5.2  Reduction of PCR inhibition 
The addition of 10 µg of bovine serum albumin improved the efficiency of the 
PCR reaction from approximately 60% success to 100% success. 
Adjustment of the raw data showed that there was a direct correlation between 
the increasing dilution and decreasing inhibition as evidenced by an increase in the 
estimated C. burnetii DNA concentration in more dilute samples.  The R
2 value for 
the correlation between the previously mentioned factors was 0.6115.  A graph 
showing the relationship between DNA dilution and inhibition of PCR is shown in 
Figure 2.5.  The greatest relief of inhibition was obtained by diluting the template 
one to one with water.  Accurate correction for the dilution factor of each sample 
was only possible when the estimated genomes for a particular sample fall within 
the linear range of the standard curve used.  All PCR results for the samples in this 
experiment fell within the linear range of the standard curve.  
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Figure  2-5.    Correlation  between  the  dilution  of  template  and  estimated 
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A  maximum  reduction  in  inhibition  was  seen  with  template  that  had  been 
diluted 1 in 64 before being subjected to amplification.  Similar levels of relief of 
inhibition  were  observed  when  template  was  diluted  1:8,  1:16  and  1:32.    The 
greatest change in relative inhibition occurred between the neat and 1:2 samples 
where, after adjustment for the dilution factor, there was estimated to be nearly 4.5 
times as much C. burnetii DNA in the diluted sample than in the neat samples.  All 
qPCR  estimates  of  C.  burnetii  DNA  concentration  from  diluted  template  were 
significantly  greater  than for the undiluted sample but there were no significant 
differences between diluted samples (p<0.001). 
For samples that were subjected to a second round of DNA purification using 
the PowerSoil™ DNA isolation kit there was significantly more  C. burnetii DNA 
detected in the samples purified initially compared to the samples after a second 
purification was performed at a dilution of 1 in 100 (p<0.05). No other differences 
were observed. 
2.3.5.3  Optimising DNA purification conditions 
There  was  no  significant  difference  in  the  DNA  yield  when  samples  were 
purified  using  the  standard  procedure  with  and  without  the  addition  of  a  70°C 
incubation.  There was significantly more DNA purified when samples were boiled 
or  freeze–thawed  prior  to  purification  (p<0.001).    There  was  no  significant 
difference in the DNA yield obtained using either boiling or freeze-thawing before 
purification.  Due to its simplicity and the good recovery noted above the boiling 
method was used for further experiments.  
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2.3.5.4  Efficiency of purification of whole genomic DNA from kangaroo faeces 
and qPCR amplification 
The Ct values from the qPCR results from this experiment are displayed in 
Figure 2.6.  Overall, when using the modified DNA purification method described 
previously it was possible to purify then amplify greater than 70% of C. burnetii 
DNA from kangaroo faeces compared to DNA purification from buffer alone.  
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Figure 2-6.  Comparison of cycle threshold values for a quantitative PCR used 
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2.3.5.5  Purification of whole genomic DNA from soil and qPCR amplification 
The Ct values from the qPCR results from this experiment are displayed in 
figure 2.7.  Overall, when using the modified DNA purification method described 
previously it was possible to extract and amplify greater than 72% of C. burnetii 
DNA from kangaroo faeces in comparison to DNA purification from buffer alone.  
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Figure 2-7.  The differences between qPCR cycle threshold values for Coxiella 





























Soil samples Control samples
  
12/06/2009  School of Veterinary and Biomedical Sciences   
2-83 
2.3.6  Purification of Coxiella burnetii from vero cell monolayers 
The  method  of  Williams  et  al.  (1981)  provided  inconsistent  recovery  of  C. 
burnetii  from  infected  vero  cell  monolayers.    Residual  Urografin  in  the  cell 
preparation also interfered with the measurement of the  absorbance of the cell 
suspension required to quantifying C. burnetii. 
The differential centrifugation method was repeatable and resulted in a cell 
suspension that appeared to be free of host cell components.  This method was 
used to purify C. burnetii for the subsequent experiments and used to correlate the 
absorbance  of  the  cell  suspensions  with  genome  equivalents  estimated  with 
qPCR. 
2.3.7  Regression analysis of genome copy number versus Abs250nm 
There  was  a  strong  correlation  (R
2=0.89)  between  the  absorbance  at  a 
wavelength of 250 nm and estimated genome number obtained from testing DNA 
purified from C. burnetii with a qPCR (Figure 2.8).  Strong correlations were also 
observed  between  estimated  genome  number  and  absorbance  at  420  nm 
(R
2=0.88)  and  600  nm  (R
2=0.65),  which  are  shown  in  figures  2.9  and  2.10 
respectively.  
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Figure 2-8.  The correlation between the absorbance of a suspension of Coxiella 
burnetii cells at 250nm and the genome number estimated by qPCR 
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Figure 2-9.  The correlation between the absorbance of a suspension of Coxiella 
burnetii cells at 420nm and the genome number estimated by qPCR 
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Figure  2-10.    The  correlation  between  the  absorbance  of  a  suspension  of 
Coxiella burnetii cells at 600nm and the genome number estimated by qPCR 
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2.4  Discussion 
Two  different  detection  chemistries  were  compared  in  this  study:  the  non-
sequence specific SYBR
® Green I detection and the sequence specific TaqMan 
detection system.  The results of this study are in agreement with other studies 
that  showed  that  a  qPCR  using  sequence  specific  fluorophore-labelled 
oligonucleotide probes has greater specificity and reliability compared to a qPCR 
using intercalating dye-based methods (Bustin and Nolan 2004).  However, other 
DNA intercalating dyes such as SYTO9 appear to have improved reproducibility in 
comparison to SYBR Green I (Monis, Giglio et al. 2005) and these dyes may have 
produced a qPCR that compared better to the TaqMan qPCR.   
Optimising magnesium chloride concentrations was more critical and variable 
for  SYBR
®  Green-based  assays  compared  to  the  TaqMan  assays.    A  reaction 
concentration  of  3  mM  MgCl2  was  optimal  for  all  TaqMan  assays  except  the 
IS1111a primer/probe set which required 4.5 mM.  It was also found that titration of 
annealing  temperatures  had  a  noticeable  effect  on  both  the  specificity  and 
efficiency of the reactions.  Lower annealing temperatures in some cases resulted 
in no template control reactions producing detectable fluorescence while higher 
temperatures  were  deleterious  to  reaction  efficiency  as  evidenced  by  generally 
poor efficiencies observed for temperatures at or above 63°C   Therefore, it seems 
that  accurate  titration  of  annealing  temperature  has  the  largest  impact  on  the 
sensitivity and specificity of these quantitative PCR‟s. 
A range of gene targets have been used in different PCR assays to detect C. 
burnetii.  These targets include the outer membrane protein gene com1 (Brennan 
and Samuel 2003), the superoxide dismutase gene (Stein 1992; Masala, Porcu et 
al. 2004) and the IS1111a insertion sequence (Berri, Laroucau et al. 2000; Klee,  
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Tyczka et al. 2006).  There has been some debate over the usefulness of the 
IS1111a for detection of C. burnetii (Marmion, Storm et al. 2005; Rolain and Raoult 
2005).  However, it makes an attractive target due to its high copy number and 
lack of significant homology to published sequences from other related organisms 
(Hoover, Vodkin et al. 1992).  The variability exhibited by this element between 
strains  of  C.  burnetii  with  regards  to  copy  number  has  been  exploited  for  a 
genotyping method (Denison, Thompson et al. 2007), which suggests that a qPCR 
targeting this element may not be quantitative for unknown isolates.  There have 
also  been  conflicting  reports  regarding  whether  or  not  Coxiella-like  organisms 
possess the gene encoding the 27 kD outer membrane protein (Lee, Park et al. 
2004).  However, published data seem to suggest that the IS1111a transposon is 
specific for C. burnetii species (Hoover, Vodkin et al. 1992; Reeves, Loftis et al. 
2005). 
The  results  from  comparing  different  primer  sets  showed  that  the  qPCR 
targeting the IS1111a transposon was the most sensitive and reproducible.  The 
reproducibility of this test was further enhanced through the use of a commercial 
TaqMan master mix (Invitrogen Platinum
® Quantitative PCR SuperMix-UDG).  This 
master  mix  also  prevents  amplification  of  carried  over  PCR  products  by 
incorporating dUTP during strand synthesis and employing a pre-PCR digestion of 
dUTP-containing sequences (Kwok and Higuchi 1989).  The IS1111a assay was 
able to detect 15.9 genomes per micro litre of buffer in 100% of samples.  The 
variability  of  the  qPCR  increased  at  DNA  concentrations  lower  than  15.9 
genomes/µl.  In absolute terms the assay was able to detect 0.16 genomes/µl in 
one third of the samples tested.  This extremely low level of DNA would only be 
detected  confidently  if  the  number  of  replicates  tested  was  increased  or  the 
volume of template used was increased.  It is unlikely that this assay would still be 
quantitative when detecting such a low concentration of DNA.  
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During this study a qPCR utilising TaqMan detection chemistry was designed 
to ensure that any PCR positives detected did not result from contamination by the 
C.  burnetii  phase  II  strain  RSA439  (clone  4)  that  was  cultured  in  a  nearby 
laboratory for other experiments.  This PCR targeted an ORF putatively named 
JB153-3  which  is  present  in  all  eight  phase  I  C.  burnetii  isolates  for  which 
significant sequence data are available but is absent from clone 4, NM phase II 
clone 1, NM Baca and RSA 514 due to a chromosomal deletion (Hoover, Culp et 
al.  2002;  Denison,  Massung  et  al.  2007).    This  putative  ORF  has  very  little 
similarity to other sequences currently found in the NCBI GenBank database.  This 
was the only other qPCR that was sensitive enough to successfully amplify 0.16 
genomes in one of six samples.  Laboratories that perform diagnostic PCR for the 
detection  of  C.  burnetii  and  concurrently  culture  phase  II  coxiellae  for  other 
experiments need to be extremely careful that contamination of test samples does 
not  occur.    The  JB153-3  qPCR  described  here  could  be  a  valuable  tool  for 
ensuring the validity of test results because of the highly persistent nature of C. 
burnetii  (PHAC  2001)  and  the  ease  with  which  it  can  be  disseminated  in  a 
laboratory environment (Babudieri 1959).  However, it must be noted that this PCR 
targets a redundant sequence in the C. burnetii genome (Hoover, Culp et al. 2002) 
and this sequence may not be conserved in all wild-type strains.  To date some 
phase II and intermediate phase strains have been shown to retain this genomic 
region (Denison, Massung et al. 2007).  In addition, C. burnetii DNA extracted from 
Q-Vax vaccine was used to make standard curves for the qPCR assays described 
here  to  ensure  that  only  small quantities of template  DNA  were  present  in the 
laboratory.  This measure was taken to reduce the potential for contamination of 
samples, which can result from the high concentrations of DNA that are generated 
when  producing  cloned  sequences  for  standard  curve  construction  (Marmion, 
Storm et al. 2005).  
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Other than the 16S qPCR, none of the assays tested amplified DNA from any 
of the specificity controls used after a maximum of 40 PCR.  Beyond 40 cycles 
non-specific  amplification  sometimes  occurred,  particularly  with  SYBR
®  Green  I 
detection, but this was not investigated in any detail.  The 16S assay produced 
detectable amplification for DNA samples from all organisms except S. aureus, S. 
equii and R. rickettsii. 
The optimised IS1111a assay was used to evaluate the effectiveness of two 
MO BIO DNA extraction kits; the UltraClean™ kit and the PowerSoil™ kit.  DNA 
isolation kits produced by MO BIO have been found to be effective in isolating 
DNA from a variety of environmental substrates (Klerks, van Bruggen et al. 2006; 
Whitehouse and Hottel 2007).  However, all assessments have been based on 
data  produced  when  using  the  standard  procedures  provided  by  the 
manufacturers.    In  this  study  it  was  found  that  the  standard  procedure 
recommended by the manufacturer was insufficient for purification of DNA from a 
faecal  substrate.    Klerks  et  al.  (2006)  postulated  that  the  aggregation  of 
Salmonella enterica on or between substrate particles could make efficient DNA 
extraction from soil or faecal samples difficult.  A similar problem could exist with 
C. burnetii in soil and faeces and could have been exacerbated due to the use of 
phase II cells which have a tendency to clump together (Williams, Peacock et al. 
1981;  Coleman,  Fischer  et  al.  2007).    The  addition  of  a  boiling  step  at  the 
beginning  of  the  procedure  significantly  improved  the  efficiency  of  DNA 
purification.  The effect of co-purified inhibitors on the qPCR was also assessed 
and  alleviated  through  the  addition  of  bovine  serum  albumin  and  dilution  of 
template. 
The differential centrifugation method used in this study (Baca, Aragon et al. 
1981)  provided  reliable  recovery  of  C.  burnetii  from  vero  cell  monolayers.   
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However, the overall efficiency of the method was not investigated because it was 
outside  the  scope  of  the  current  study.    Experiments  could  be  conducted  to 
measure the amount of C. burnetii DNA present in each discarded fraction relative 
to the retained fraction to help quantify the recovery.  However, the results from 
this study suggest that this is a simple and relatively rapid way to purify C. burnetii 
from host cell components. 
It is difficult to perform quantitative in vivo and in vitro experiments using C. 
burnetii because it is small in size and an obligate intracellular pathogen.  The high 
correlation of the estimated genomes/µl with the absorbance at 250 nm and 420 
nm  shows  that  spectrophotometry  is  a  useful,  cheap  and  rapid  method  of 
enumerating  C.  burnetii.    These  results  show  that  the  optimum  wavelength  for 
estimating  Coxiella  cell  density  is  250  nm.  Spectrophotometric  methods  of 
quantifying  C.  burnetii  at  both  420  (Kovacova,  Kazar  et  al.  1998)  and  600  nm 
(Zhang and Samuel 2003) have also been employed but the methods employed 
are not described in detail.  It is possible that both groups based their methods 
upon  an  earlier  study  in  which  a  correlation  was  made  between  the  turbidity 
reading  obtained  with  a  Klett-Summerson  photoelectric  colorimeter  at  420  nm 
(blue  filter),  PFU  and  direct  counts  (Williams, Peacock et  al. 1981).    However, 
without the specialist equipment listed previously it is not possible to repeat the 
methods  referred  to.    Immuno-staining  (Schneider  1989)  and  plaque  assays 
(McDade and Gerone 1970) have also been used to estimate Coxiellae numbers 
but both assays are labour and time intensive.  Furthermore, phase II C. burnetii 
cells are highly hydrophobic due to the truncated nature of the LPS produced by 
this phase variant (Williams, Peacock et al. 1981; Coleman, Fischer et al. 2007).  
This  causes  the  cells  to  clump  together  and  may  confound  enumeration  by 
methods such as those mentioned previously.  
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2.5  Conclusions 
This study describes the thorough optimisation of several quantitative PCR 
assays and provides evidence to support the selection of one of these assays as 
superior to the others.  The qPCR targeting the IS1111a insertion sequence and 
utilising  the  TaqMan  detection  system  was  the  most  sensitive  and  reliable.    A 
commercial master mix further enhanced the reproducibility of the test.  The assay 
was compatible with DNA purified from both faeces and soil with little to no PCR 
inhibition.    This  study  also  developed  a  simple,  rapid  method  for  enumerating 
viable  C.  burnetii  cells  in  situ  based  on  spectrophotometric  measurement  of 
absorbance at 250 nm.  The findings of this study are specific for the C. burnetii 
cell purification and DNA isolation techniques that were used but would be readily 
adaptable to other procedures.  
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3.  A cell culture-based quantitative-PCR assay to determine the 
susceptibility of Coxiella burnetii to chemical and physical 
disinfectants 
3.1  Introduction 
Coxiella burnetii has at least two morphologically distinct cellular forms: the 
metabolically  active  large  cell  variant  (LCV)  and  the  chemically  resistant  and 
environmentally  stable  small  cell  variant  (SCV)  (Wiebe,  Burton  et  al.  1972; 
McCaul, Banerjee-Bhatnagar et al. 1991; Coleman, Fischer et al. 2004).  The SCV 
is very resistant to physical and chemical insults including elevated temperature 
and  pressure,  desiccation,  osmotic  shock  and  several  chemical  disinfectants 
(Ransom and Huebner 1951; Malloch and Stoker 1952; McCaul, Hackstadt et al. 
1981; McCaul, Banerjee-Bhatnagar  et  al. 1991; Cerf and Condron 2006).  The 
physically  resistant  nature  of  C.  burnetii  means  that  it  can  persist  in  the 
environment for a long time.  Therefore, environmental substrates such as soil, 
dust and water that have been contaminated by domestic livestock can pose a risk 
of infection to humans for many months after they were originally contaminated 
with C. burnetii. 
There are no validated methods for inactivating  C. burnetii in liquid wastes 
associated  with  domestic  livestock.    Therefore,  it  is  important  to  evaluate 
disinfection agents and treatments that can be used to inactivate C. burnetii on a 
large scale in the waste produced by livestock-associated industries. 
Animal bioassays are currently used for routine assessment of the viability and 
infectivity of C. burnetii (Arricau-Bouvery, Souriau et al. 2005) and other obligate 
intracellular organisms (Shin, Linden et al. 2001).  However, animal assays are  
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expensive, laborious, give variable estimates of infectious dose and raise ethical 
questions  about  the  use  of  animals  when  an  alternative  method  could  be 
developed (Ransom and Huebner 1951; Malloch and Stoker 1952; Sobsey and 
Leland  2001).    Previous  C.  burnetii  disinfection  studies  have  used  the 
immunological  response  of  infected  laboratory  animals  post-infection  and  serial 
passage through embryonated eggs to provide information on how effective an 
antimicrobial agent is (Ransom and Huebner 1951; Little, Kishimoto et al. 1980; 
Scott,  McCaul  et  al. 1989; Scott and Williams  1990).  These two methods are 
highly  sensitive  but  they  are  very  time  consuming  and  provide  only  indirect 
quantitative information on how effective a particular agent is.  The viability of C. 
burnetii can also be estimated using plaque assays (McDade and Gerone 1970; 
Wike, Tallent et al. 1972; Schneider 1989).  However, while this type of assay has 
been found to give results comparable with direct counts and 50% infectious dose 
methods (IC50), their use with C. burnetii is problematic because plaques take a 
long time to develop and can be difficult to identify due to their irregular shape and 
small size (Wike, Tallent et al. 1972).  Moreover, plaque assays are not able to be 
used with „dirty‟ samples without substantial sample sterilisation beforehand which 
may confound results.  The cell culture-based system described obviates the need 
to use laboratory animals or plaque assays and provides reliable quantitative data 
on the reduction in viability caused by an antimicrobial agent. 
3.2  Materials and methods 
3.2.1  Culture and extraction of Coxiella burnetii from tissue culture cells 
Vero (African green monkey kidney) cells infected with C. burnetii Phase II 
Nine  Mile  RSA439  (clone  4)  (see  section  2.2.8)  were  grown  in  25  cm
2  culture 
flasks (TPP, Switzerland) at 37°C with 5% CO2 (v/v) in DMEM (MP Biomedicals, 
Australia) supplemented with 200mM L-Glutamine (MP Biomedicals, Australia) and  
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2% v/v foetal calf serum.  Cultures were grown without replenishment of media for 
approximately four weeks to maximise the proportion of SCV to LCV (Coleman, 
Fischer et al. 2004).  Prior to purification the residual monolayer was scraped from 
the  flask  surface  and  homogenised  in  the  cell  culture  medium.    The  cell 
suspension  was  then  transferred  to  a  centrifuge  tube  and  centrifuged  for  10 
minutes at 40,000 × g.  Cells were resuspended in sterile MilliQ water to induce 
osmotic  shock  and  then  passed  through  a  25  gauge  needle  10  times  to  free 
Coxiellae from host cell components and lyse any remaining LCV‟s.  Coxiella cells 
were purified from host cell debris using differential centrifugation (Baca, Aragon et 
al.  1981)  which  comprised  three  cycles  of  low  speed  (820  g  for  10  minutes) 
centrifugation followed by high speed (20,800 × g for 10 minutes) centrifugation.  
The  final  resuspension  was  made  in  sterile  highly-pure  (HP)  water  and  the 
concentration  of  C.  burnetii  cell  suspensions  were  adjusted  to  approximately 
23,000 +/- 2,000 C. burnetii cells per microliter according to the method described 
in Chapter 2 and 50 µl aliquots were dispensed into 1.5 ml microfuge tubes. 
3.2.2  Treatment medium 
Disinfectant  treatments  were  initially  assessed  in  highly  pure  (HP)  sterile 
water.  Treatments that appeared to be effective were subsequently evaluated in 
wastewater collected from a drainage sump on the Murdoch University farm, which 
collected  runoff  from  fields  and  livestock  holding  yards.    The  water,  hereafter 
referred  to  as  „wastewater‟,  was  strained  through  100  micron  mesh  to  remove 
large particulate matter and autoclaved.  The resulting liquid was assessed for the 
following parameters: pH, turbidity, salinity/conductivity (S/C), total organic carbon 
(TOC) and total dissolved solids (TDS) by the Marine and Freshwater Research 
Laboratories  (MAFRL,  Murdoch  University).    Wastewater  was  kept  at  4°C  until 
required and then allowed to equilibrate to room temperature before being used.   
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The  pH  of  the  HP  water  and  wastewater  after  addition  of  each  chemical 
disinfectants  was  measured  using  a  TPS  WP-80  pH-mV-Temp.  Meter 
(Springwood, Brisbane, Australia). 
3.2.3  Treatment with disinfectants 
Each treatment and control group were assayed in triplicate.  Coxiella burnetii 
cells that had not been exposed to the treatment (NT) and C. burnetii cells which 
had  been  completely  inactivated  (Kill)  where  included  with  every  plate.    No 
treatment controls were exposed to the same conditions as the treated samples 
except the agent was not included.  Sterile HP water was added to the NT control 
in place of the chemical agent and NT controls were left in normal light conditions 
when UV treatment was used.  Four treatments were applied to C. burnetii cells in 
various  experiments  to  serve  as  complete  inactivation  (Kill)  controls  of:  (1) 
incubation in 3 M NaOH at room temperature for 30 minutes; (2) incubation in 20 
mM NaOCl at room temperature for 30 minutes; (3) exposure to 300 mJsec
-1 of 
ultra  violet  radiation  at  room  temperature  and  (4)  incubation  at  95°C  for  30 
minutes.    For  kill  control  (1)  the  samples  were  washed  in  warm  DMEM  twice 
following exposure.  For kill control (2) reactive oxygen species were neutralised 
with  20  µl  of  7g/L  sodium  thiosulphate  following  exposure.    The  kill  control 
treatment  that  was  used  for  each  experiment  is  shown  in  the  results  table 
corresponding to that treatment. All controls and treated samples were performed 
in triplicate. 
3.2.3.1  Experiment 1: sodium hypochlorite treatment 
Two separate experiments were performed to assess the efficacy of NaOCl in 
buffer at different concentrations with a constant exposure time.  Both followed the 
same general protocol as follows: an equal volume of NaOCl pre-diluted in sterile  
12/06/2009  School of Veterinary and Biomedical Sciences   
3-97 
HP water was added to 50 µl of C. burnetii suspension in 1.5 ml microfuge tubes.  
Tubes  were  mixed  and  allowed  to  stand  at  room  temperature  for  30  minutes.  
Addition of 20 µl of 7g/L sodium thiosulphate was used to neutralise the reactive 
species at the end of the 30 minute exposure.   For experiment 1.2 one set of 
samples was subjected to RNA extraction for assessment of viability using the RT-
qPCR that is described in Chapter 3.  Three hundred microliters of warm DMEM 
(with L-glutamine and 2% FCS) was then added to all remaining samples and each 
cell suspension was used to inoculate one well in a 24 well tissue culture plate 
containing confluent vero cells.  The same procedure was used for a subsequent 
experiment with the C. burnetii cells suspended in wastewater prior to the addition 
of NaOCl.   
The  relationship  between  NaOCl  efficacy  and  exposure  time  was  also 
evaluated  using  the  same  procedure  described  previously  as  follows:  cell 
suspensions  were  exposed  to  0.05  mM  NaOCl  and  20  µl  of  7g/L  sodium 
thiosulphate was added 5, 10, 20 and 30 minutes after to the addition of NaOCl to 
quench  oxidative  species.    The  concentrations  of  NaOCl  assessed  in  each 
experiment are shown in Table 3.2. 
3.2.3.2  Experiment 2: ultra-violet (UV) light treatment 
Three experiments were used to assess the susceptibility of C. burnetii to ultra 
violet (UV) light.  The dose of radiation delivered and the kill control treatments 
used in each experiment are presented in Tables 3.4 and 3.5 respectively.  The 
same  general  procedure  was followed for all experiments:  Coxiella burnetii  cell 
suspensions were dispensed into clear microcentrifuge tubes and exposed to UV 
light using a GeneLinker UV illumination chamber (BioRad, Regents Park, New 
South Wales, Australia).  For experiment 2.3 RNA was purified from one set of  
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samples for assessment of viability using RT-qPCR as described in Chapter 3.  
Three hundred microliters of warm DMEM (with L-glutamine and 2% FCS) added 
to each remaining cell suspension and each suspension used to inoculate one well 
in a 24 well tissue culture plate containing confluent vero cells.  To ensure that the 
UV dose delivered was consistent the GeneLinker UV tubes were pre-warmed by 
delivering a dose of 300 mJ/cm
2 before the test samples were exposed.  Cultures 
were  incubated  overnight  at  37°C  with  5%  CO2  (v/v)  to  allow  internalisation  of 
viable C. burnetii cells.  All wells were subsequently washed three times with warm 
culture medium to remove any dead C. burnetii cells.  Plates were incubated for a 
further seven days. 
3.2.3.3  Experiment 3: ozone treatment 
A  custom-made  ozone  generator  was  used  to  produce  ozone  for  these 
experiments.  The apparatus utilised a pair of electrodes to split O2 molecules into 
oxygen  radicals  via  corona  discharge.    The  aqueous  ozone  concentration 
produced by the apparatus when 500 ml/min of ambient air was passed between 
the electrodes was approximately 12 mg/L determined using the indigo method 
(Bader and Hoigne 1981).  When the same flow rate of compressed oxygen was 
passed between the electrodes the aqueous ozone concentration produced was 
43  mg/L.  Coxiella  burnetii  suspensions  were  made  up  to  30  ml  in  PBSS  and 
dispensed into the exposure chamber.  A mixture of air or compressed oxygen and 
ozone was then bubbled through the cell suspension.  Nine hundred and ninety 
micro litre samples were withdrawn at the desired time points and added to 20 µl 
of 7 g/L sodium thiosulfate solution to quench residual ozone. Cells were pelleted 
by centrifugation, resuspended in warm cell culture medium and inoculated onto 
confluent monolayers of vero cells as described previously.  No treatment controls  
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were  subjected  to  the  same  conditions  as  described  above  except  the  ozone 
generator was not turned on.  Cultures were incubated as described above. 
3.2.3.4  Experiment 4: Peracetic acid treatment 
Equal volumes of 32, 20 and 10 % v/v PAA diluted in sterile HP water were 
added  to  50  µl  of  C.  burnetii  suspension  in  1.5  ml  microfuge  tubes  (final 
concentrations were 16, 10 and 5 % v/v respectively).   Tubes were mixed and 
allowed to stand at room temperature for 60 minutes and subsequently washed, 
resuspended in 300 µl of warm DMEM (with L-glutamine and 2% FCS) added to 
them and each cell suspension was used to inoculate one well in a 24 well tissue 
culture  plate  containing  confluent  vero.  Cultures  were  incubated  as  described 
above. 
3.2.3.5  Experiment  5:  treatment  with  peracetic  acid  in  combination  with 
sodium hypochlorite 
The  synergistic  effect  of  treating  C.  burnetii  cells  with  a  combination  of 
peracetic acid (PAA) and NaOCl was investigated in both sterile HP water and 
wastewater.    Coxiella  burnetii  cells  were  purified  as  described  previously  and 
added to equal volumes of 6.4  x 10
-5%  PAA in 1.5 mL micro-centrifuge tubes, 
mixed well and incubated at room temperature for 60 minutes.  An equal volume of 
pre-diluted NaOCl was then added to each group of tubes to achieve the desired 
hypochlorite concentration.  All dilutions were made in either sterile HP water or 
wastewater depending on the experiment.  Sterile HP water or wastewater was 
added to no treatment and kill controls.  All treatment groups and the NT controls 
were mixed again and incubated at room temperature for 30 minutes and the kill 
control was incubated at 95°C for 30 minutes.  At the end of the incubation period 
20 µl of 7 g/l sodium thiosulphate and 100 µl of 4.8 mM sodium bicarbonate were  
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added to all tubes to neutralise the reactive oxygen species and acid respectively.  
All samples then had 300 µl of warm DMEM (with L-glutamine and 2% FCS) added 
to them and each cell suspension was used to inoculate one well in a 24 well 
tissue  culture  plate  containing  confluent  vero.  Cultures  were  incubated  as 
described above. 
3.2.3.6  Experiment 6: Virkon
® S treatment 
Equal volumes of 4, 2 and 1 % v/v Virkon
® S diluted in sterile HP water were 
added  to  50  µl  of  C.  burnetii  suspension  in  1.5  ml  microfuge  tubes  (final 
concentrations  were  2,  1  and  0.5%  v/v  respectively).    Sterile  HP  water  or 
wastewater was added to no treatment and kill controls.  All treatment groups and 
the  NT  controls  were  mixed  well  and  incubated  at  room  temperature  for  30 
minutes.  At the end of the incubation period 20 µl of 7 g/l sodium thiosulphate and 
100 µl of 4.8 mM sodium bicarbonate were added to all tubes to neutralise the 
reactive oxygen species and acid respectively.  All samples then had 300 µl of 
warm  DMEM  (with  L-glutamine  and  2%  FCS)  added  to  them  and  each  cell 
suspension  was  used  to  inoculate  one  well  in  a  24  well  tissue  culture  plate 
containing confluent vero.  Cultures were incubated as described above. 
3.2.3.7  Experiment 7: Hydrogen peroxide treatment 
Equal volumes of 4, 2 and 1 % v/v H2O2 diluted in sterile HP water were added 
to 50 µl of C. burnetii suspension in 1.5 ml microfuge tubes (final concentrations 
were 2, 1 and 0.5% v/v respectively).  Sterile HP water or wastewater was added 
to no treatment and kill controls.  All treatment groups and the NT controls were 
mixed well and incubated at room temperature for 30 minutes.  At the end of the 
incubation  period  20  µl  of  7  g/l  sodium  thiosulphate  was added to all tubes to 
neutralise the reactive oxygen species.  For experiment 7.1 RNA was purified from  
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one set of samples and the viability assessed using a RT-qPCR as described in 
Chapter 4.  Three hundred microliters of warm DMEM (with L-glutamine and 2% 
FCS) was added to each cell suspension and each suspension used to inoculate 
one well in a 24 well tissue culture plate containing confluent vero.  Cultures were 
incubated as described above. 
3.2.4  Extraction of genomic DNA from cell cultures 
Culture medium from each well was aspirated and reserved.  Wells were then 
washed with PBS and the PBS was removed and pooled with the media from that 
well.  All wells were trypsinised and pooled with the two previous fractions.  Each 
sample was centrifuged at 20,800 × g for 10 minutes and whole genomic DNA was 
purified from the pellet using a Qiagen Tissue Minikit (Qiagen, Hilden, Germany) 
according to the manufacturers instructions with a 45 minute incubation at 55°C in 
buffer ATL plus proteinase K and a final 30 minute incubation at 70°C prior to the 
addition of 70% v/v ethanol (Klee, Tyczka et al. 2006).  The purified DNA was 
eluted  in  100  µl  of  buffer  AE  and  the  DNA  concentration  determined  using  a 
Nanodrop spectrophotometer (Nanodrop Technologies Wilmington USA). 
3.2.5  TaqMan real-time PCR 
DNA samples were tested using a real-time PCR that targeted the IS1111a 
element using the TaqMan primer and probe set described in Chapter 2.  Briefly, 
the real-time PCR reaction mixture contained 12.5 µl UDG SuperMix (Invitrogen, 
Mount Waverley, Victoria, Australia), 4.5 mM magnesium chloride, 25 pmoles of 
forward primer (IS1111aF), 20 pmoles of reverse primer (IS1111aR), 1.25 pmoles 
of probe (IS1111aP) and 1 µl of template.  Real-time PCR assays were performed 
on  a  Rotorgene
®  3000  (Corbett  Life  science,  Mortlake,  New  South  Wales, 
Australia) according to the following cycling parameters:  
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One hold at  50
oC for two minutes, a second hold at 95
oC for two minutes 
followed by 40 cycles of 95
oC for 20 seconds and 40 seconds at 64
oC. 
Data  were  manipulated  and  analysed  using Rotorgene
®  software (Corbett).  
All  samples  were  run  in  duplicate  and  every  run  included  a  standard  curve 
consisting  DNA  purified  from  Q-Vax™ vaccine (CSL,  Parkville,  Australia).    The 
concentration  of  DNA  from  the  Q-Vax™  vaccine  was  determined  using  a 
Nanodrop  spectrophotometer  and  the  number  of  C.  burnetii  genomes  per 
microliter of cell suspension calculated according to the molecular weight of the C. 
burnetii genome (Coleman, Fischer et al. 2004).  Serial 10-fold dilutions of the neat 
standard in 0.01 M TE (pH 8.0) were made. Six 10-fold dilutions of standard were 
included in each PCR run spanning concentrations of 18 to 1.8 x 10
6 genomes per 
microliter.  Two no template controls (NTC) were included with each run. 
The Rotorgene
® 3000 software was used to automatically select optimal cycle 
threshold cut-offs based upon the slope of the standard curve and the R
2 value.  
The  user-defined  DNA  concentration  of  the  standards  was  then  used  by  the 
software to provide estimates of the DNA concentration of the unknown samples.  
Microsoft Excel  Professional Edition was used to format data prior to statistical 
analysis. 
3.2.6  Interpretation of data 
The  growth  of  C.  burnetii  in  culture  was  measured  using  the  previously 
described qPCR.  The efficacy of each treatment was calculated as the reduction 
of amplifiable DNA (C. burnetii genomes) in each treatment group as a proportion 
of the untreated control wells, expressed as „percentage reduction‟.  
12/06/2009  School of Veterinary and Biomedical Sciences   
3-103 
Comparisons  were  only  made  between  treated  samples  and  no-treatment 
controls from the same plate to reduce variability. 
3.2.7  Statistical analysis of data 
The statistical significance of observed differences in the percentage reduction 
of C. burnetii DNA in control and test samples from each disinfectant and between 
each concentration of disinfectant from the same experiments were determined 
using  a  one-way  analysis  of  variance  (ANOVA)  with  Tukey‟s  test  for  honestly 
significant difference at a 95% confidence limit. Comparisons between the same 
treatment concentration in different experiments were made using an independent 
sample T-test.  Analyses were performed using the Statistical Package for Social 
Sciences (SPSS Inc., Chicago, USA). 
3.3  Results 
3.3.1  Treatment medium 
The  water  used  was  collected  from  the  drainage  sump  on  the  Murdoch 
University farm and had a pH of 9.37 at 22°C, a turbidity of 73 NTU, an S/C of 1.77 
at 25°C, TOC of 200 mg.C/L and TDS of 1.3 g/L.  The change in pH caused by 
adding chemical disinfectants to HP water or wastewater at room temperature is 
shown in Table 3.1.  
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Table 3-1.  Change in pH of HP water or wastewater following the addition of 
a chemical disinfection agent at a temperature of 22°C 
Agent  Concentration  HP water  Wastewater 
  Blank  6.17  9.37 
NaOCl  0.0125 mM  5.91  9.35 
  0.025 mM  6.75  9.35 
  0.05 mM  7.45  9.35 
  0.10 mM  8.32  9.35 
  0.20 mM  8.73  9.35 
  0.40 mM  9.16  9.38 
  4.00 mM  10.52  9.43 
  40.00 mM  11.56  9.64 
PAA  3.2 x 10^-5%  4.68  9.20 
  5%  1.94  2.11 
  10%  1.68  1.74  
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  16%  1.26  1.28 
PAA  0.0125 mM  4.14  9.17 
(3.2 x 10^-5%) +  0.025 mM  4.16  9.18 
NaOCl  at  3 
concns  0.05 mM  4.10  9.20 
Virkon
®  0.05%  3.05  7.44 
  0.50%  2.66  5.57 
  1.00%  2.37  3.41 
   2.00%  2.18  2.52 
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3.3.2  Reduction in growth of Coxiella burnetii exposed to sodium hypochlorite 
Results from all experiments assessing the efficacy of disinfection with NaOCl 
are shown in Table 3.2 and the kill controls used for each experiment are shown in 
Table 3.3.  
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Table 3-2.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
NaOCl at varying concentrations, exposure times and  in different mediums 
measured using a qPCR 
Exp. 
Concentratio
n  Treated in  Exposure  % red. 
SEM  % 
red 
1.1  40 mM  PBSS  30 min  95.41  0.18  
  4 mM  PBSS  30 min  95.21  0.23  
  0.4 mM  PBSS  30 min  92.87  0.73  
1.2  0.4 mM  PBSS  30 min  98.32  0.59  
  0.2 mM  PBSS  30 min  97.57  0.24  
  0.1 mM  PBSS  30 min  92.38  1.16  
1.3  0.2 mM  Wastewater  30 min  93.33  0.80  
  0.1 mM  Wastewater  30 min  94.10  0.27  
  0.05 mM  Wastewater  30 min  90.42  0.64  
1.4  0.05 mM  PBSS  5 min  41.62  4.52  
  0.05 mM  PBSS  10 min  43.37  7.38   
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  0.05 mM  PBSS  20 min  72.70  2.21  
   0.05 mM  PBSS  30 min  70.87  3.95  
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Table  3-3.    The  reduction  in  growth  of  Coxiella  burnetii  (%  red)  in  “kill” 
controls used with each NaOCl disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
1.1  300mJ UV  80.08  1.24 
1.2  20mM NaOCl  99.95  0.02 
1.3  20mM NaOCl  96.63  0.11 
1.4  30min @95°C  98.90  0.48 
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The percentage reduction in amplifiable C. burnetii DNA measured for the no 
treatment controls (NT) in experiment 1.1 was significantly less than all treatment 
groups and the kill controls (p<0.001).  The percentage reduction in amplifiable 
DNA  in  the  “kill”  controls  was  significantly  greater  than  all  treatment  groups 
(p<0.05)  except  for  the  0.4  mM  NaOCl-treated  cells  (p=0.061).    The  treatment 
groups did not yield results that were statistically different from each other (p>0.9).  
When a comparison was made between the samples treated with 0.4 mM NaOCl 
in experiment 1.1 and the same concentration in experiment 1.2 the percentage 
reduction in DNA was found to be significantly greater in experiment 1.2 (p<0.001).  
The percentage reduction in amplifiable DNA for the no treatment controls (NT) 
was significantly less than all treatment groups and the kill controls (p<0.001) and 
the kill controls had significantly greater reduction in DNA than the 0.1 mM NaOCl-
treated cells (p=0.061) in experiment 1.2.  The percentage reduction of amplifiable 
DNA in the treatment groups within experiment 1.2 were not statistically different 
from each other (p>0.9).   
There was significantly less reduction in amplifiable DNA when C. burnetii was 
exposed  to  0.2  mM  NaOCl  in  wastewater compared to  (experiment 1.3)  PBSS 
(experiment 1.2) (p<0.001).  There was no significant difference in the amplifiable 
DNA when C. burnetii was exposed to 0.1 mM NaOCl in wastewater or PBSS.  
There was significantly less reduction in amplifiable DNA in C. burnetii not exposed 
to  NaOCl  (NT  controls)  in  wastewater  compared  to  all  other  treatments 
(experiment  1.3)  (p<0.001).    There  was  no  significant  difference  between  the 
reduction in amplifiable DNA in each of the treatment groups or the “kill” controls 
suspended in wastewater. 
When the efficacy of 0.05 mM NaOCl was examined over time it was found 
that there was significantly less reduction in amplifiable DNA in the NT controls  
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compared to the “kill” controls (p<0.001) and significantly less amplifiable DNA in 
cells exposed to 0.05 mM NaOCl for each incubation period (p<0.05).  There was 
significantly greater reduction in amplifiable DNA in the “kill” controls compared to 
cells exposed to 0.05 mM NaOCl for each incubation period (p<0.05).  There was 
significantly less reduction in amplifiable DNA in cells exposed to 0.05 mM NaOCl 
for five and 10 minute compared to cells exposed for 20 and 30 minute incubations 
(p<0.05).   
3.3.3  Reduction in growth of Coxiella. burnetii exposed to UV radiation 
Results  from  experiments  to  assess  the  efficacy  of  disinfection  with  UV 
radiation are shown in Table 3.4.  The results from the “kill” controls used in each 
experiment are shown in table 3.5.  
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Table 3-4.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
UV at varying doses and in two cell suspension mediums using a qPCR 
Exp.  Conc.  Treated in  Exposure  % red. 




mJ/cm^2  HP Water  NA  94.00  0.63 
 
10 
mJ/cm^2  HP Water  NA  94.67  0.21 
  1 mJ/cm^2  HP Water  NA  61.83  8.49 
2.2 
40 
mJ/cm^2  Wastewater  NA  54.32  3.96 
 
10 
mJ/cm^2  Wastewater  NA  51.55  1.73 
  1 mJ/cm^2  Wastewater  NA  28.40  8.01 
2.3 
10 
mJ/cm^2  HP Water  NA  95.22  0.56 
  5 mJ/cm^2  HP Water  NA  77.07  3.74  
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   1 mJ/cm^2  HP Water  NA  29.02  23.47 
 
Table  3-5.    The  reduction  in  growth  of  Coxiella  burnetii  (%  red)  in  “kill” 
controls used with each UV radiation disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
2.1  3 M NaOH  96.83  0.20 
2.2  100 mJ/cm^2  73.82  2.90 
2.3  200 mJ/cm^2  99.67  0.04 
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The percentage reduction in amplifiable DNA in the no treatment controls (NT) 
was  significantly  lower  than  all  treatment  groups  and  the  “kill”  controls  in 
experiment 2.1 (p<0.001).  There was significantly lower reduction in amplifiable 
DNA in the samples exposed to 1 mJ/cm
2 of UV radiation compared to the “kill” 
controls  and  samples  exposed  to  10  and  40  mJ/cm
2  of  UV  radiation  (p<0.05).  
There was no significant difference in the reduction of amplifiable DNA in samples 
exposed to 10 and 40 mJ/cm
2 compared to the “kill” controls and compared to 
each other.   
In  experiment  2.2  there  was  significantly  lower  percentage  reduction  in 
amplifiable  DNA  in  the  no  treatment  control  (NT)  samples  compared  to  all 
treatment groups and the “kill” controls (p<0.002).  There was significantly greater 
reduction in amplifiable DNA in the “kill” control samples compared all treatment 
groups (p<0.05).  There was significantly greater reduction in amplifiable DNA in 
samples  exposed  to  10  and  40  mJ/cm
2  of  UV  radiation  compared  to  samples 
exposed  to  1  mJ/cm
2  and  the  kill  controls  (p<0.05).    There  was  no  significant 
difference in the percentage reduction in amplifiable DNA in samples exposed to 
10 mJ/cm
2 compared to sample exposed to 40 mJ/cm
2 of UV radiation  
In experiment 2.3 the percentage reduction in DNA in the no treatment control 
(NT)  samples  was  significantly  less  than  in  samples  from  all  treatment  groups 
except those exposed to 1 mJ/cm
2 of UV radiation and the “kill: controls (p<0.003).  
There  was  significantly  greater  reduction  in  amplifiable  DNA  in  “kill”  control 
samples  compared  to  samples  exposed  to  1  mJ/cm
2  of  UV  radiation  (p<0.01).  
There was a significantly greater reduction in amplifiable DNA in samples exposed 
to 10 mJ/cm
2 compared to samples exposed to 1 mJ/cm
2 UV radiation (p<0.001).  
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There  was  significantly  less  reduction  in  amplifiable  DNA  in  samples 
suspended  in  wastewater  and  exposed  to  UV  radiation  compared  to  samples 
suspended in PBSS and exposed to UV radiation (p<0.001). 
3.3.4  Reduction in growth of Coxiella burnetii exposed to ozone 
Results from experiments assessing the efficacy of disinfection with ozone are 
shown in Table 3.6.  Results from the “kill” controls used in each experiment are 
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Table 3-6.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
ozone at varying concentrations and in two mediums using a qPCR 
Exp.  Conc.  Treated in  Exposure  % red. 
SEM  (% 
red.) 
3.1  43 mg/L  PBSS  10 min  100.00  0.00 
  43 mg/L  PBSS  20 min  100.00  0.00 
  43 mg/L  PBSS  30 min  100.00  0.00 
3.2  12 mg/L  PBSS  1 min  3.50  25.25 
  12 mg/L  PBSS  5 min  -84.67  50.42 
  12 mg/L  PBSS  10 min  64.17  9.99 
3.3  12 mg/L  Wastewater  1 min  -52.58  59.49 
  12 mg/L  Wastewater  5 min  17.38  2.42 
   12 mg/L  Wastewater  10 min  16.00  5.48 
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Table  3-7.    The  reduction  in  growth  of  Coxiella  burnetii  (%  red)  in  “kill” 
controls used with each ozone disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
3.1  3 M NaOH  97.87  0.48 
3.2  15 min in 12 mg ozone  98.67  0.49 
3.3  100 mJ/cm^2  66.85  4.87 
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There  was  significant  variation  in  the  results  obtained  from  exposing  C. 
burnetii cells to ozone.  In experiment 3.1 there was significantly less reduction in 
amplifiable DNA in the NT control samples compared to all other treatment groups 
and  the  “kill”  controls  (p<0.001).    In  experiment  3.2  there  were  no  significant 
differences in amplifiable DNA between any treatment or control group except that 
there was significantly less reduction in amplifiable DNA in cells exposed to ozone 
for 5 minutes compared to cells exposed for 10 minutes treatment group and the 
“kill” control group (p<0.005). 
In  experiment  3.3  there  was  significantly  less  reduction  in  DNA  in  cells 
suspended  in  wastewater  and  exposed  to  ozone  for  one  minute  exposure 
compared to cells suspended in wastewater and exposed to ozone for 10 minutes 
and the “kill” control samples (p<0.05).  There was significantly greater reduction in 
amplifiable DNA in samples suspended in pure buffer and exposed to 12 mg/L 
ozone  for  10  minutes  compared  to  samples  suspended  in  wastewater  and 
exposed to 12 mg/L ozone for 10 minutes (p<0.005). 
3.3.5  Reduction in growth of Coxiella burnetii exposed to peracetic acid 
Results from experiments assessing the efficacy of disinfection with peracetic 
acid  are shown in Table 3.8.  The results from the “kill” controls used in each 
experiment are shown in Table 3.9.  
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Table 3-8.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
peracetic acid at varying concentrations in HP water using a qPCR 
Exp.  Conc.  Treated in  Exposure  % red.  SEM (% red.) 
4.1  16%  HP Water  60 min  -150.70  24.15 
  10%  HP Water  60 min  -40.43  32.25 
   5%  HP Water  60 min  -10.65  12.67 
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Table  3-9.    The  reduction  in  growth  of  Coxiella  burnetii  (%  red)  in  “kill” 
controls used with the peracetic acid disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
4.1  3 M NaOH  81.85  3.08 
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In comparison to all other treatment groups and both controls, treatment with 
16%  PAA  resulted  in  a  significant  increase  in  replication  of  C.  burnetii  cells 
(p<0.05).  That is; the samples treated with 16% PAA were observed to have 50% 
more C. burnetii DNA in them than the NT controls.  The only other significant 
differences observed in this experiment were between the kill control, the 5% PAA 
treated group (p<0.05) and the 10% PAA treated samples (p<0.01), with the kill 
control resulting in significantly greater reduction of DNA in both cases. 
3.3.6  Reduction  in  growth  of  Coxiella  burnetii  exposed  to  peracetic acid in 
combination with hypochlorite 
Results from experiments assessing the efficacy of disinfection with PAA used 
in  combination  with  NaOCl  are  shown  in  Table  3.10.    Results  from  the  “kill” 
controls used in each experiment are shown in Table 3.11.  
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Table 3-10.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
3.2  ×  10-5%  peracetic  acid  combined  with  hypochlorite  at  varying 
concentrations in HP water and in wastewater using a qPCR 
Exp.  Conc.  Treated in  Exposure  % red.  SEM (% red.) 
5.1  0.05 mM  HP Water  60/30 min  99.93  0.04 
  0.025 mM  HP Water  60/30 min  99.60  0.05 
  0.0125 ]mM  HP Water  60/30 min  98.68  0.14 
  PAA only  HP Water  60/30 min  97.82  0.22 
5.2  0.05 mM  Wastewater  60/30 min  -76.57  20.21 
  0.025 mM  Wastewater  60/30 min  -21.53  10.64 
  0.0125 ]mM  Wastewater  60/30 min  -7.13  16.90 
   PAA only  Wastewater  60/30 min  -57.08  19.95 
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Table 3-11.  The reduction in growth of Coxiella burnetii (% red) in “kill” 
controls used with each PAA/NaOCl disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
5.1  30min @95°C  99.93  0.02 
5.2  30min @95°C  97.78  0.10 
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There was significantly less reduction in amplifiable DNA in cells suspended in 
HP water and exposed to a combination of PAA and NaOCl compared to the NT 
control samples and samples in all other test and control groups (p<0.001).  There 
was  no  significant  difference  in  the  reduction  of  amplifiable  DNA  in  samples 
treated with PAA alone and PAA in combination with NaOCl.   
There was significantly greater reduction of amplifiable DNA in the kill control 
samples suspended in wastewater compared to all treatment groups and the NT 
controls  suspended  in  wastewater  (p<0.001).    There  was  significantly  less 
reduction in amplifiable DNA in samples suspended in wastewater and exposed to 
3.2 × 10
-5% PAA in combination with 0.05 mM NaOCl compared to the NT control 
suspended in wastewater (p<0.05) and the samples suspended in wastewater and 
exposed to PAA and 0.0125 mM NaOCl (p<0.05).  There was significantly greater 
reduction of amplifiable DNA in samples that had been suspended in HP water for 
all  treatment  groups  and  the  kill  controls  compared  to  samples  suspended  in 
wastewater (p<0.005).  There was no significant difference between the reduction 
in  amplifiable  DNA  in  the  NT  controls  suspended  in  HP  water  and  wastewater 
(p=1). 
3.3.7  Reduction in growth of Coxiella burnetii exposed to Virkon
® S 
Results from experiments assessing the efficacy of disinfection with Virkon S
® 
are shown in Table 3.12.  Results from the “kill” controls used in each experiment 
are shown in Table 3.13.  
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Table 3-12.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
Virkon
® S at varying concentrations in HP water and in wastewater using a 
qPCR 
Exp.  Conc.  Treated in  Exposure  % red.  SEM (% red.) 
6.1  2.00%  HP Water  30 min  99.93  0.02 
  1.00%  HP Water  30 min  99.38  0.16 
  0.50%  HP Water  30 min  99.44  0.10 
  0.05%  HP Water  31 min  97.27  0.52 
6.2  2.00%  Wastewater  30 min  99.8  0.01 
  1.00%  Wastewater  30 min  99.75  0.02 
  0.50%  Wastewater  30 min  99.33  0.04 
   0.05%  Wastewater  30 min  96.00  0.23 
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Table 3-13.  The reduction in growth of Coxiella burnetii (% red) in “kill” 
controls used with each Virkon
® S disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
6.1  3 M NaOH  97.77  0.96 
6.2  30min @95°C  99.88  0.02 
  
12/06/2009  School of Veterinary and Biomedical Sciences   
3-127 
There  was  significantly  greater  reduction in amplifiable DNA in samples  all 
treatment and “kill” control groups compared to the NT controls suspended in HP 
water and waster water (p<0.001).  There was significantly greater reduction in 
amplifiable DNA in cells suspended in HP water and exposed to 2% w/v Virkon S
® 
compared to cells suspended in wastewater and exposed to 2% w/v Virkon S
® 
(p<0.005). 
3.3.8  Reduction in growth of Coxiella burnetii exposed to hydrogen peroxide 
The  results  from  all experiments assessing the efficacy of disinfection with 
H2O2 are shown in table 3.14 and the kill controls used in each experiment are 
shown in table 3.15.  
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Table 3-14.  Reduction in growth of Coxiella burnetii (% red) after exposure to 
hydrogen peroxide at varying concentrations in HP water using a qPCR 
Exp.  Conc.  Treated in  Exposure  % red.  SEM (% red.) 
7.1  2.00%  HP Water  30 min  90.78  1.06 
  1.00%  HP Water  30 min  90.73  0.65 
   0.50%  HP Water  30 min  90.30  0.83 
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Table 3-15.  The reduction in growth of Coxiella burnetii (% red) in “kill” 
controls used with the hydrogen peroxide disinfection experiment 
Exp.  Kill control  Kill Ctrl % red.  SEM (Kill Ctrl) 
7.1  20mM NaOCl  99.85  0.03 
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There was significantly greater reduction in amplifiable DNA in cells exposed 
to all  concentrations of  H2O2  and the  “kill”  control  compared to cells in the NT 
control  groups  (p<0.001).    There  was  significantly  less  reduction  in  amplifiable 
DNA in samples exposed to 0.5 % H2O2 compared to the “kill” control, 1 % H2O2 
and  2  %  H2O2  groups  (p<  0.005).    There  was  no  significant  difference  in  the 
reduction  of  amplifiable  DNA  in  samples  exposed  to  1  %  and  2%  H2O2  and 
between either of these groups and the “kill” control (p= 1). 
3.4  Discussion 
3.4.1  Controls 
The physical and chemical resistance of  C. burnetii  was highlighted in this 
series of experiments by the difficulty that was experience in finding a treatment 
that, when applied to viable cells, could achieve complete inactivation.  Treatment 
with a strong base (NaOH) achieved only partial inactivation of C. burnetii and high 
doses of UV radiation produced variable results.  Treatment with heat or relatively 
concentrated  NaOCl  proved  to  be  the  most  reliable  and  effective  of  the  “kill” 
controls used.  However, chronologically these treatments were only used in the 
later experiments.  Ransom and Huebner (1951) showed that heat inactivation of 
C.  burnetii  was  a  valid  disinfection  method  but  it  is  probably  not  viable  on  a 
commercial  scale  because  of  the  energy  required  to  attain  sufficiently  high 
temperatures in large volumes of effluent. 
3.4.2  Sodium hypochlorite 
Sodium hypochlorite is the most widely used chlorine-releasing agent (CRA) in 
disinfection applications (McDonnell and Russell 1999) but it has previously been 
shown to have limited effectiveness for inactivating C. burnetii (Scott and Williams  
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1990).    The  results  from  this  study  indicate  that  phase  II  C.  burnetii  is  highly 
sensitive  to  treatment  with  NaOCl  at  a  concentration  approximately  100  times 
more dilute than that used by Scott and Williams (1990) and with a much shorter 
contact time.  The disparity between our results and those of Scott and Williams 
(1990) may be due to the method used in the earlier study to assess viability of 
Coxiella.  Scott and Williams (1990) used mouse inoculation and proposed that the 
presence of anti-C. burnetii antibodies was evidence that the inoculum contained 
viable organisms.  This is a flawed assumption as animals will produce an immune 
response to foreign cells regardless of their viability.  Additionally, this method of 
evaluating viability is likely to be less reproducible than the tissue culture assay 
described here because the host immune response to challenge with C. burnetii 
can be unpredictable (Berri, Souriau et al. 2002).  
The addition of NaOCl to pure water maintained a pH in the proposed effective 
range up to a concentration of 0.025 mM.  However, the addition of NaOCl  to 
wastewater  had  a  negligible  affect  on  the  starting  pH  (9.37)  across  the  whole 
hypochlorite concentration range tested.  Previous studies have shown that NaOCl 
is  most  effective  in  a  pH  range  of  4-7  where  hypochlorous  acid  species 
predominate (McDonnell and Russell 1999).  Hypochlorous acid has been shown 
to  cause  a  range  of  biocidal  effects  including  cell  membrane  damage  and 
susceptibility  to  subsequent  stress  (Cortezzo,  Koziol-Dube  et  al.  2004),  DNA 
damage via the formation of the highly reactive singlet oxygen and inhibition of 
enzyme action (Mokgatla, Gouws et al. 2002).  However, at the concentrations 
used in this study inhibition of protein, RNA and DNA synthesis, and consequently 
cell division, appear to be the most likely affects (McKenna and Davies 1988).  In 
high pH conditions (above 9.0) the hypochlorite ion predominates but it is thought 
that  this  chemical  species  does  not  significantly  contribute  to  disinfection 
(McDonnell  and  Russell  1999).    Hypochlorite  ions  are  naturally  produced  in  
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monocytes following phagocytosis (Clark 1990; Hawkins and Davies 1998), which 
may  serve  as  a  biological  trigger  for  cellular  differentiation  for  intracellular 
pathogens such as C. burnetii whose reproductive niche is the phagolysosome. 
The  results  of  these  experiments  show  that  there  was  significantly  less 
inactivation of C. burnetii cells exposed to 0.2 mM NaOCl in wastewater compared 
to HP water.  This suggests that organic matter in the wastewater inhibited the 
disinfectant action, which is in agreement with past studies (Scott and Williams 
1990).    However,  no  significant  differences  were  observed  in  the  viability  of 
Coxiella exposed to 0.1 mM NaOCl in wastewater compared to HP water, which 
could indicate that the chemical equilibrium reached with a lower concentration of 
NaOCl was more favourable to the inactivation process.  Overall it appears that 
sodium hypochlorite treatment is an appropriate disinfectant for a laboratory and, 
more importantly, retains its efficacy in water contaminated with organic matter. 
3.4.3  Sodium hypochlorite in combination with peracetic acid 
A combination of peracetic acid and hypochlorite was evaluated because it 
was  assumed  that  NaOCl  would  have  higher  disinfectant  efficacy  in  acidic 
conditions.    Peracetic  acid  in  combination  with  of  NaOCl  maintained  an 
approximate pH of 4 in HP water which is in the optimal range for hypochlorous 
acid formation.  However, the same combination of disinfectants in wastewater did 
not reduce the pH below 9.1.  There was close to 100% retardation of C. burnetii 
growth in samples exposed to each NaOCl concentrations in HP water.  However, 
in wastewater and PAA alone, or in combination with NaOCl, there appeared to be 
an enhancement in the replication of coxiellae.  While PAA is considered to be a 
more effective biocide than hydrogen peroxide it functions in much the same way 
and  has similar  limitations relating to efficacy in solutions with organic content.   
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Both act as oxidants and generate OH radicals which attack lipids, proteins and 
DNA but high concentrations and contact times are often required, particularly in 
the presence of organic matter (Baldry, French et al. 1991; McDonnell and Russell 
1999;  Koivunen  and  Heinonen-Tanski  2005).    The  apparent  dose-dependent 
increase in replicative ability of C. burnetii cells treated with PAA in wastewater is 
difficult to explain given its proposed mode of action.  One possible explanation is 
that the quenching effect of organic compounds in the wastewater combined with 
the  relatively  high  pH  reduced  the  concentration  of  reactive  peroxide  species 
(Baldry  1983)  to  a  level  that  was sub-inhibitory.  This  may have replicated the 
respiratory  burst  and  subsequent  peroxide  formation  that  takes  place  in  the 
lysosomes of phagocytic cells (McKenna and Davies 1988; Clark 1990).  This may 
serve  as  a  trigger  for  initiation  of  cell  differentiation  of  C.  burnetii  into  the 
metabolically  active  LCV  and  thus  decrease  the  lag  period  before  exponential 
division can occur in host cells  (Coleman, Fischer et  al. 2004).    Moreover, the 
combined use of these agents did not appear to produce a synergistic affect in 
pure water.  In wastewater the results of using NaOCl and PAA in combination are 
more difficult to interpret and suggest that this combination  does not provide a 
disinfection solution able to inactivate C. burnetii in agricultural effluent. 
3.4.4  Ultra-violet radiation 
The results from this study support earlier work that showed that C. burnetii 
was  susceptible  to  inactivation  by  ultra-violet  radiation  (Ransom  and  Huebner 
1951; Little, Kishimoto et al. 1980).  This study provides new data with regards the 
end-point  of  the  effectiveness  of  UV  exposure.  However,  it  appears  that  it  is 
difficult  to  achieve  complete  inactivation  using  UV  radiation.    Indeed,  even 
relatively  high  doses  of  radiation  left  approximately  five  percent  of  cells  viable 
when treatment was performed in pure water.  Using UV radiation to inactivate C.  
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burnetii  in  wastewater  was  found  to  be  significantly  less  effective  than  in  pure 
water.  These results are not surprising and support other work suggesting that 
cell  clumping,  shadowing  and  aggregation  within  suspended  solids  can  protect 
microorganisms  from  this  method  of  disinfection  (Hill,  Kantardjieff  et  al.  2002; 
Koivunen  and  Heinonen-Tanski  2005).    Commercial  scale  treatment  of  effluent 
with  UV  radiation  is  typically  done  with  a  dose  of  approximately  30-40  mJ/cm
2 
(Shin, Linden et al. 2001).  This study showed that only approximately 50% of C. 
burnetii  cells  were  inactivated  at  this  level  of  irradiation  when  treatment  was 
undertaken  in  wastewater.    Therefore,  significant  pre-treatment  of  wastewater 
would be required prior to administering UV treatment if inactivation of C. burnetii 
was a primary aim for the treatment of effluent. 
While UV treatment does not form dangerous by-products and its efficacy is 
independent of factors such as pH and temperature (Quek and Hu 2008) some 
organisms are able to reverse the damage done by this form of radiation.  Ultra 
violet radiation causes the formation of pyrimidine dimers in the organisms DNA 
which prevents replication (Rubin, Menshonkova et al. 1981) but these dimers can 
be repaired (Shin, Linden et al. 2001; Quek and Hu 2008) allowing the normal 
cellular  division  to  occur.    A  recent  study  by  Mertens,  Lantsheer  and  Samuel 
(Mertens,  Lantsheer  et  al.  2005)  found  that  while  certain  genetic  elements 
commonly associated with DNA repair after oxidative stress were absent in the C. 
burnetii genome, the organism displays a fully functional nucleotide excision repair 
system.  Therefore, C. burnetii may be able to excise and repair pyrimidine dimers 
caused by UV radiation.  If UV irradiation were to be considered as a method for 
inactivating  C.  burnetii  it  would  first  be  necessary  to  evaluate  this  organism‟s 
capability for repairing pyrimidine dimers.  
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3.4.5  Ozone 
The disinfectant efficacy of ozone was inconsistent in this study.  This was 
probably due to the simple nature of the apparatus used to generate and dispense 
ozone.  It may have been possible to obtain better results with a more precise 
delivery mechanism and accurate concentration control.  The experiments seemed 
to  indicate  that  ozone  was  very  effective  at  inactivating  C.  burnetii  at  high 
concentrations but no end point dose could be determined because of limitations in 
the  equipment  used.    However,  ozone  is  a  strong  oxidising  agent,  which  can 
generate  dangerous  by-products  when  used  in  high  concentrations  in  water 
containing bromide or iodide (von Gunten 2003).  Therefore, treatment of water 
with this agent must be considered carefully before being implemented. 
3.4.6  Virkon
® S 
Treatment of C. burnetii cells with Virkon
® S produced significant inactivation 
at all concentrations used in both pure water and wastewater.  This suggests that 
Virkon
® S may be appropriate for small-scale use in an agricultural or laboratory 
setting.    Virkon
®  S  is  a  commercially  available  oxidative  disinfectant  that  is 
purported  to  contain  a  balanced,  stabilised  blend  of  peroxygen  compounds, 
surfactant,  organic  acids  and  an  inorganic  buffer  system,  which  in  solution  is 
activated to form hypochlorous acid (DuPont 2008).  The mode of action of Virkon
® 
S will thus be similar to the other oxidants described previously.  However, the 
combination  of  these  oxidants  with  a  surfactant  in  a  stable  composition  may 
produce greater bactericidal action in a variety of conditions.  Virkon
® S appeared 
to maintain its activity in the presence of organic matter and suspended solids.  
However, the efficacy of Virkon
® S has been shown to be variable in conditions of 
high organic load (McCormick and Maheshwari 2004).  The low pH that resulted 
from adding Virkon
® S to both of the water types used in these experiments is  
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likely  to  have  played  a  significant  role  in  the  disinfection  efficacy  observed, 
particularly in relation to hypochlorous acid.  It appears that the resistance of C. 
burnetii  to  the  normally  peroxide-rich  host  cell  phagolysosome  (Clark  1990)  is 
attributed to inhibition of the respiratory burst by acid phosphatase activity (Baca, 
Roman et al. 1993).  In light of the metabolic effort C. burnetii assigns to inhibit 
host  cells  production  of  peroxide,  peroxygens  may  be  ideal  candidate 
disinfectants.  However, Virkon
® S is becoming more difficult to obtain in Australia 
and  its  cost  is  prohibitive  for  large-scale  use.    Therefore,  its  use  may  only  be 
applicable to laboratories and small volumes of animal-associated effluent. 
3.4.7  Hydrogen peroxide 
Hydrogen  peroxide  produced  a  reasonable  reduction  in  the  growth  of  C. 
burnetii at all the concentrations assessed in this experiment.  This agent acts as 
an oxidant and generates hydroxyl radicals, which are extremely effective biocides 
but it is considered to be a less effective bactericide than other oxidising agents 
(Baldry 1983; McDonnell and Russell 1999).  Hydrogen peroxide is also relatively 
unstable  and  requires  higher  concentrations  to  achieve  penetration  through  a 
medium  with  high  organic  load  (Hawkins  and  Davies  1998)  and  thus  it  has 
relatively little use as a biocide (Baldry 1983).  Hydrogen peroxide is not a potential 
candidate for disinfection of wastewater. 
3.4.8  Conclusions 
Application  of  the  cell  culture–PCR  method  to  assess  the  efficacy  of 
disinfectants  identified  several  candidates  that  may  be  used  to  inactivate  C. 
burnetii in wastewater in commercial settings.  In particular, sodium hypochlorite 
appears  to  be  an  attractive  option.    The  technology  for  administering  this 
disinfectant  is  already  established  and  could  be  adopted  immediately  for  C.  
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burnetii-specific use.  However, wastewater treated with sodium hypochlorite may 
only be compatible with re-use in certain situations where the potential toxic affects 
of chlorination by-products are not an issue. 
It is important to note that the data presented in this study showed that none 
of the agents were able to completely inactivate C. burnetii.  This is likely to pose a 
problem for re-use of wastewater that potentially contains C. burnetii because of 
the low infectious dose of the organism (Tigertt, Benenson et al. 1961; Ormsbee, 
Peacock et al. 1978).  It is not likely to be feasible to achieve complete inactivation 
of C. Burnetii in dynamic waste streams with the large volumes of water found in 
agricultural industries.  This is mainly due to the „tailing‟ phenomenon, which is 
characterised by a linear decrease in viable organisms remaining in response to 
exponential  increases  in  disinfectant  concentration  (Koivunen  and  Heinonen-
Tanski 2005).  Instead disinfection should be considered to be part of a broader 
risk reduction process that takes into account the dilution and settling effects that 
may greatly reduce the concentration of pathogens such as C. burnetii in the end-
point effluent.  
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4.  A RT-qPCR for detection of viable Coxiella burnetii cells in 
environmental matrices 
4.1  Introduction 
The  need  for  bacterial  viability  assays  has  led  to  the  development  of  new 
methods  for  discrimination  between  „live‟  and  „dead‟  pathogens.    Several 
fluorescence-based  assays  have  been  developed,  mostly  aimed  at  detecting 
respiratory  activity  (Bhupathiraju,  Hernandez  et  al.  1999),  membrane  potential 
(Deere, Porter et al. 1995) and membrane integrity (Nebe-von-Caron, Stephens et 
al.  2000)  in  viable  cells.    Some  researchers  consider  that  all  of  the  assays 
described above must be performed to adequately assess viability of pathogenic 
microorganisms (Laflamme, Lavigne et al. 2004).  However, performing all of these 
tests is both time consuming and expensive.  Therefore, more unequivocal tests 
are required for routine monitoring and surveillance applications. 
The viability of C. burnetii has been estimated using plaque assays (McDade 
and  Gerone  1970;  Ormsbee,  Peacock  et  al.  1978;  Schneider  1989)  similar  to 
those used to detect the viability of viruses.  However, C. burnetii is relatively slow 
growing  and  the  assays  may  take  more  than  10  days  to  complete  and  may 
produce variable results (Cory, Yunker et al. 1974; Schneider 1989).  In addition, 
the  results  from  plaque  assays  are  not  always  comparable  with  results  from 
experimental  infection  of  laboratory  animals  and  are  not  always  analogous  to 
titrations in animals (Wike, Tallent et al. 1972). 
Therefore, animal inoculation remains the gold standard test to determine the 
viability of C. burnetii (Arricau-Bouvery, Souriau et al. 2005).  However, the method 
has limitations in terms of the time required, expense, consistency of results and  
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ethical  issues  concerning  treatment  of  animals  (Ransom  and  Huebner  1951; 
Malloch and Stoker  1952; Scott and Williams  1990; Sobsey and Leland 2001).  
Furthermore,  animal  infection  procedures  have  not  been  applied  directly  to 
environmental samples which have high organic and microbial loads.  Similarly, the 
cell  culture-qPCR  system  described  in  Chapter  3  (Shin,  Linden  et  al.  2001; 
Rochelle,  Marshall  et  al.  2002;  Brennan  and  Samuel  2003)  would  require 
significant modification before it could be used to test soil or faecal samples. 
Detection of transcriptional activity to verify the viability of a pathogen is an 
established technique (Stinear, Matusan et al. 1996; Jenkins, Trout et al. 2003).  
However,  the  technique  cannot  be  directly  applied  to  organisms  such  as  C. 
burnetii, which can remain viable but metabolically dormant in the environment for 
months  or  longer  without  significant  modification  (PHAC  2001).    Alternative 
approaches have been applied to detect the viability of Cryptosporidium, which is 
similar to C. burnetii in that it is an obligate intracellular parasite with a high level of 
environmental stability.  Attempts have been made to use reverse transcriptase 
PCR  to  detect  the  transcribed  RNA population for  heat  shock protein following 
heat treatment of C. parvum oocysts (Fontaine and Guillot 2003).  Hackstadt and 
Williams (1981) showed that the metabolic activity, and hence RNA transcription, 
of  C.  burnetii  was  stimulated  by  exposing  the  organism  to  acidic  conditions.  
However, it would not be feasible to use this method with environmental samples 
because of the time taken to test and adjust the pH of a variety of environmental 
substrates  and  the  increased  the  risk  of  cross-contamination  of  samples.  
Therefore,  heat  treating  environmental  samples  prior  to  RNA  extraction  and 
subsequent detection by quantitative PCR may be the most robust and sensitive 
method for detecting and viable C. burnetii cells in substrates such as soil.  
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4.2  Materials and methods 
4.2.1  Culture and extraction of Coxiella burnetii from tissue culture cells  
Vero (African green monkey kidney) cells infected with C. burnetii Phase II 
Nine  Mile  RSA439  (clone  4)  were  grown  in  25  cm
2  culture  flasks  (TPP, 
Switzerland)  at  37°C  with  5%  CO2  (v/v)  in  DMEM  (MP  Biomedicals,  Australia) 
supplemented with 200mM L-Glutamine (MP Biomedicals, Australia) and 2% v/v 
foetal  calf  serum.    Cultures  were  grown  without  replenishment  of  media  for 
approximately four weeks to maximise the proportion of SCV to LCV (Coleman, 
Fischer et al. 2004).  The residual monolayer was manually scraped from the flask 
surface  and  homogenised  in  cell  culture  medium.    The  cell  suspension  was 
transferred  to  a  40  ml  centrifuge  tube  and  centrifuged  at  40,000  ×  g  for  10 
minutes.  The cell pellet was resuspended in sterile MilliQ water to induce osmotic 
shock and passed through a 25 gauge needle 10 times to free coxiellae from host 
cell components and lyse any remaining LCV‟s.  Coxiella cells were purified from 
host  cell  debris  using  differential  centrifugation  according to Baca  et  al.  (Baca, 
Aragon  et  al.  1981),  which  consisted  of  three  cycles  of  low  speed  (820  g) 
centrifugation for 10 minutes followed by high speed (20,800g) centrifugation for 
10 minutes.   The final cell pellet  was resuspended in PBS (pH 7.4) containing 
0.25M sucrose.  The concentration of C. burnetii cell suspensions were adjusted to 
approximately  23,000  +/-  2,000  C.  burnetii  cells  per  microliter  according  to  the 
method used by Baca et al. (1981) and 50 µl aliquots were dispensed into 1.5 ml 
microfuge tubes and stored at 4°C until required. 
4.2.2  Heat treatment of cells 
A total of 48 aliquots of the purified C. burnetii cell suspensions were placed in 
separate heating blocks set at 37, 40, 44 and 48°C.  Three tubes were removed  
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from each heating block after 10, 20, 30 and 40 minutes.  A further 3 aliquots of 
purified  C.  burnetii  cell  suspensions were left at  room temperature to serve as 
unheated controls. 
4.2.3  Extraction and purification of RNA from cell culture-derived Coxiella 
burnetii 
Whole cellular RNA was extracted from each heat-treated and untreated C. 
burnetii  cell  suspension  using  TRI  Reagent  according  to  the  manufacturer‟s 
instructions (Ambion, Inc., Austin, Texas, USA).  The final suspension of RNA was 
made in 89 µl of RNase-free water containing 10 µl of Turbo DNA-free 10× buffer 
and 1 µl of Turbo DNA-free DNase (Ambion).  Samples were mixed gently and 
then incubated at 37°C for 45 minutes.  The DNase was removed following DNA 
digestion  with  Turbo  DNA-free  inactivation  reagent  (Ambion)  according  to  the 
manufacturer‟s instructions and purified using the RNA cleanup protocol described 
in the Qiagen RNeasy Minikit (Qiagen, Hilden, Germany). RNA was eluted from 
the spin column membrane with 50 µl of RNase-free water.  To maximise the yield 
of  RNA  the  first  eluate  was  returned  to  the  spin  column  and  the  column  was 
centrifuged  a  second  time,  then  the  RNA  sample  was  quantified  as  described 
below. 
4.2.4  Reverse transcription Polymerase Chain Reaction (RT-PCR) 
The concentration of RNA in each of the samples was measured using the 
Nanodrop spectrophotometer (Nanodrop Technologies Wilmington USA).  A total 
of  75  ng  of  RNA  was  used  for  each  reverse  transcription  reaction  to  produce 
complimentary DNA (cDNA) using the High Capacity cDNA Archive Kit (Applied 
Biosystems, Foster City, California, USA) as per the manufacturer‟s instructions.  
Reverse transcription reactions without reverse transcriptase enzyme were made  
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for all samples to ensure that no DNA had been carried over during the purification 
procedure.   
4.2.5  Preparation of soil samples containing Coxiella burnetii 
Soil was collected from cattle holding yards on the Murdoch University farm 
(Murdoch Drive, Murdoch, Western Australia).  Two hundred micrograms (0.2g) of 
soil was added to each of 12 bead-beating tubes from a MO BIO Powersoil DNA 
Isolation Kit (MO BIO Laboratories, Solana Beach, California, USA) from which 
beads  and  bead  solution  had  been  removed  and  reserved.    Ten  microliters  of 
purified DNA extracted from a single dose of Q Vax™ vaccine (CSL, Parkville, 
Australia),  containing  an  estimated  concentration  of  180,000  genomes  per 
microliter, was added to each of nine bead beating tubes containing soil.   Ten 
microliters of sterile water was added to each of 3 further tubes as controls.  
Two grams of soil was added to 21 bead beating tubes from a MO BIO Power 
Soil RNA Isolation kit from which the beads had been removed.  Fifty microliters of 
a cell suspension containing approximately 1 × 10
6 cell culture-derived C. burnetii 
cells  was added to 18 bead beating tubes containing soil and 18 bead-beating 
tubes not containing soil and vortexed to mix.  The C. burnetii cells were grown in 
tissue culture and purified as described previously.  The absorbance value of the 
purified cells at 250nm was used to adjust the concentration of the cell suspension 
such that each 50 µl contained approximately 1 × 10
6 cells as described in Chapter 
2.  Fifty microliters of sterile water was added to 3 bead-beating tubes and kept as 
controls.  All  sample  tubes  were  stored  in  the  dark  at  room  temperature  until 
required.  
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4.2.6  Extraction of genomic DNA from soil samples 
Every  seven  days  the  reserved  beads  and  bead  solution  were  returned  to 
each of three tubes containing soil and C. burnetii DNA.  Whole genomic DNA was 
then  purified  from  each  tube  using  the  MO  BIO  PowerSoil  DNA  Isolation  Kit 
according to the manufacturer‟s instructions. 
4.2.7  Extraction and reverse transcription of RNA from soil samples 
Every seven days three tubes containing soil and three tubes without soil were 
heated at 40°C for 20 minutes to stimulate transcription.  The reserved beads were 
returned  to  each  tube  and  the  RNA  was  purified  immediately.    On  the  first 
occasion RNA was also extracted from the water-only controls.  The standard MO 
BIO  RNA  purification  protocol  was  followed  and  the  final  RNA  pellet  was 
resuspended in 86 µl of RNase-free water containing 10 µl of Turbo DNA-free 10× 
buffer and 2 µl of Turbo DNA-free DNase enzyme (Ambion).  Samples were mixed 
gently and then incubated at 37°C for 30 minutes followed by the addition of a 
further 2 µl of DNase enzyme.  The tubes were again mixed gently and incubated 
at  37°C for  another 30 minutes. Following DNA digestion DNase was removed 
using  Turbo  DNA-free  inactivation  reagent  according  to  the  manufacturer‟s 
instructions (Ambion) and subsequently purified using the RNA cleanup protocol 
described in the Qiagen RNeasy Minikit (Qiagen).  Elution of RNA from the spin 
column membrane was performed using 50 µl of RNase-free water.  To maximise 
the yield of RNA the first eluate was returned to the spin column and centrifuged a 
second time and then the concentration of RNA in each sample was measured 
using the Nanodrop spectrophotometer.  Ten micrograms of RNA was used for 
each  reverse  transcription  reaction  using  the  High  Capacity  cDNA  Archive  Kit.  
Seventy five nanograms of total RNA from soil free of C. burnetii were subjected to 
reverse  transcription.    Reverse  transcription  reactions  without  reverse  
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transcriptase enzyme were performed for all samples to ensure that no DNA was 
carried  over  during  the  purification  procedure.    Reverse  transcription  was 
performed using an Applied Biosystems GeneAmp® PCR System 2700 according 
to the High Capacity cDNA Archive Kit instructions. 
4.2.8  Blocking of RNA Transcription with Rifampicin 
Coxiella burnetii cells were grown and purified as described previously.  The 
concentration of C. burnetii cells was standardised by adjusting the absorbance at 
250 nm to a value of 0.05 and aliquots of 40 µl were added to each of 30 tubes.  
Ten microliters of 500 µg/ml rifampicin in dimethylsulphoxide (DMSO) was added 
to 15 of the tubes and 10 µl of DMSO alone was added to the remaining 15 tubes.  
All tubes were mixed well and incubated at room temperature for 20 minutes.  Fifty 
microliters of water containing 8.3, 0.2, 0.1 and 0.05 mM of sodium hypochlorite 
was added to three tubes from the rifampicin-treated group and 3 tubes from the 
untreated group.  Fifty microliters of sterile high-pure water was added to each of 3 
tubes  from  the  rifampicin-treated  and  the  untreated  groups  to  serve  as  no 
treatment controls.  All tubes were incubated at room temperature for 30 minutes 
and the oxidative dissociation products of NaOCl were neutralised by addition of 
30 µl of 7 g/L sodium thiosulphate with mixing.  RNA was extracted from all tubes 
by  addition  of  500  µl  of  TRI  Reagent  using  the  same  procedure  described 
previously. Reverse transcription was also performed as described previously. 
4.2.9  Assessing disinfectant efficacy based on DNA and RNA quantification 
Purified  C.  burnetii  cells  were  treated  with  sodium  hypochlorite,  hydrogen 
peroxide and ultraviolet radiation according to the procedures described in Chapter 
3.  The final concentrations of NaOCl were 0.4, 0.2, 0.1 mM and4.7 mM (100% kill 
control),  the concentrations of H2O2  were 2,  1 and 0.5% and the doses of UV  
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radiation delivered were 10, 5 and 1 mJ/cm
2.  Following treatment with the two 
chemical  agents  oxidative  species  were  quenched  by  addition  of  30µl  of  7g/L 
sodium  thiosulphate  with  mixing.    RNA  was  extracted,  purified  and  reverse 
transcribed  as  described  previously  and  results  from  these  experiments  will 
hereafter be referred to as being generated from quantifying „cDNA‟.  In addition, 
whole  genomic  DNA  was  concurrently  isolated  and  purified  according  to  the 
supplementary protocol described in the technical literature on the Ambion website 
(www.ambion.com/techlib/append/supp/tri.pdf,  accessed  on  August  12
th,  2007) 
and estimates of disinfectant efficacy based upon DNA purified in this way will be 
referred to as „TRI DNA‟ results.  The efficacy of each disinfectant was compared 
to the results generated using the same assays performed in Chapter 3.  The 
results of these assays will be referred to as „tissue culture‟. 
4.2.10  TaqMan Quantitative PCR for DNA and cDNA 
DNA  extracts  were  tested  by  real-time  PCR  using  the  protocol  described 
previously for the IS1111a TaqMan primer and probe set.  All cDNA samples from 
the heat response experiment were interrogated using the TaqMan primer/probe 
oligonucleotide sets ScvA, HspB, 16S and SpoIIIE.  Conditions for each test can 
be seen in Chapter 2.  All other cDNA samples were assessed using only the ScvA 
primer and probe set according to the conditions described previously. 
Standards  were  constructed  as  described  previously  and  were  included,  in 
duplicate, in all qPCR runs.  No template controls were also included with every 
run to ensure the absence of contamination.  
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4.2.11  Data Analysis 
The Rotorgene
® 3000 software was used to automatically select optimal cycle 
threshold cut-offs based upon the slope of the standard curve and the R
2 value.  
The  user-defined  DNA  concentration  of  the  standards  was  then  used  by  the 
software to provide estimates of the DNA or cDNA concentration of the unknown 
samples.    Where  appropriate,  Microsoft  Excel  was  used  to  perform  basic 
calculations and to display results graphically. 
The estimated cDNA concentrations at each time point for samples that had 
been incubated at a particular temperature were normalised by dividing them by 
the  time  zero  concentration.    The  statistical  significance  of  any  differences 
observed in the normalised cDNA concentrations at each temperature and time 
point  and the mean cDNA copy number at  each time point  and effect  of  were 
determined by performing a one-way analysis of variance (ANOVA) and Tukey‟s 
honestly significant differences test at a 95% confidence limit using the statistical 
package for social sciences (SPSS version 15.0, SPSS Inc., Chicago, USA).   
Quantitative  PCR  was  used  to  estimate  the  C.  burnetii  nucleic  acid 
concentration  (in  copies/genome  equivalents  per  reaction)  of  a  test  sample  (t), 
each of which was then compared to the nucleic acid concentration of the no-
treatment controls (NT) to give a proxy measure of disinfectant efficacy hereafter 
referred  to  as  „percentage  reduction  in  DNA/RNA‟  (R).    The  equation  for 
calculating this measure can be expressed as: 
  100 /   NT t R  
The statistical significance of any differences in the mean Ct value from each 
treatment group was determined using a one-way analysis of variance (ANOVA)  
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and post hoc analysis using Tukey‟s honestly significant differences test at a 95% 
confidence limit and the independent samples t-test with assumed equal variance 
was used when comparisons were made between only two data sets. 
4.3  Results 
4.3.1  Changes in RNA Transcription in Response to heat 
When the average 16S transcript copy numbers for each temperature, over all 
time points, were compared it was found that the samples incubated at 40°C had 
significantly  greater  relative  abundance  of  mRNA  compared  to  estimates  from 
samples incubated at 37°C and 48°C (p<0.05).  There was significantly greater 
relative abundance of HspB transcripts from samples incubated at 40°C compared 
to  samples  incubated  at  44°C  and  48°C  (p<0.05).    There  was  a  significant 
decrease  in  the  relative  abundance  of  icd  and  SpoIIIE  transcripts  in  samples 
incubated at 37°C compared to samples incubated at 40°C and 48°C (p<0.05).  
There was a significant increase in the relative abundance of ScvA transcripts in 
samples  incubated  at  40°C  compared  to samples incubated  at  37°C and 48°C 
(p<0.005). 
4.3.1.1  Changes in RNA Transcription observed at 37°C 
Changes in the relative abundances of each transcript at 37°C over time and 
changes in the estimated copy number of each transcript over time at 37°C are 
shown in Figures 4.1 and 4.2 respectively. There were no significant changes in 
the normalised abundance of any of the five transcripts over time at 37°C (p>0.05).  
There were significantly more copies of 16S mRNA compared to the number of 
copies of each transcript over all (p<0.001).  No other significant differences were 
observed at this temperature.  
12/06/2009  School of Veterinary and Biomedical Sciences   
4-148 
Figure  4-1.    Changes  in  the  abundance  of  five  Coxiella  burnetii  RNA 
transcripts estimated by qPCR over time at 37°C and expressed as a ratio of 
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Figure 4-2.  Changes in the absolute abundance of five Coxiella burnetii RNA 
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4.3.1.2  Changes in RNA Transcription observed at 40°C 
Changes in the normalised abundances of each transcript at 40°C over time 
and the estimated copy number of each transcript over time at 40°C are shown in 
Figures 4.3 and 4.4 respectively.  The normalised abundance of the 16S and HspB 
transcripts  were  significantly  increased  in  samples  incubated  at  40°C  for  20 
minutes compared to samples at time zero (p<0.05).  There was a significantly 
greater SpoIIIE mRNA population in samples 10 minutes after incubation at 40°C  
compared  to  samples  incubated  for  zero,  30  and  40  minutes  (p<0.05)  and  in 
samples incubated for 20 minutes compared to samples incubated for 40 minutes 
(p<0.005).    The  mean  abundance  of  16S  mRNA  was  significantly  greater 
compared  to  all  other  transcripts  at  all  time  points  (p<0.001).    The  ScvA 
concentration was significantly greater compared to all transcripts other than 16S 
(p<0.01).  
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Figure  4-3.    Changes  in  the  abundance  of  five  Coxiella  burnetii  RNA 
transcripts estimated by qPCR over time at 40°C and expressed as a ratio of 
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Figure 4-4.  Changes in the absolute abundance of five Coxiella burnetii RNA 
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4.3.1.3  Changes in RNA Transcription observed at 44°C 
Changes in the relative abundances of each transcript in samples incubated at 
44°C over time and the estimated copy number of each transcript in samples over 
time are shown in Figures 4.5 and 4.6 respectively.  There were no significant 
changes in the normalised abundance of any of the five transcripts at each time 
point  (p>0.05).    The  number  of  copies  of  the  16S  and  ScvA  mRNA  were 
significantly greater than all other transcripts (p<0.001).  There was no significant 
difference between the number of copies of 16S and ScvA mRNA (p<0.001).  
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Figure  4-5.    Changes  in  the  abundance  of  five  Coxiella  burnetii  RNA 
transcripts estimated by qPCR over time at 44°C and expressed as a ratio of 
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Figure 4-6.  Changes in the absolute abundance of five Coxiella burnetii RNA 
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4.3.1.4  Changes in RNA Transcription observed at 48°C 
Changes in the normalised abundances of each transcript at 48°C over time 
and the estimated copy number of each transcript over time at 48°C are shown in 
Figures  4.7  and  4.8  respectively.  The  normalised  abundance  of  the  HspB 
transcript was significantly decreased in samples incubated at 48°C for 30 minutes 
compared to samples at time zero (p<0.05).  There was a significant decrease in 
the abundance of the ScvA transcript in samples incubated at 48°C for 30 and 40 
minutes compared to samples incubated for zero and 10 minutes (p<0.05).  There 
were significantly more copies of 16S mRNA compared to each other transcript at 
each time point (p<0.001).  
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Figure  4-7.    Changes  in  the  abundance  of  five  Coxiella  burnetii  RNA 
transcripts estimated by qPCR over time at 48°C and expressed as a ratio of 
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Figure 4-8.  Changes in the absolute abundance of five Coxiella burnetii RNA 
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4.3.2  RNA and DNA extracted from soil over time 
Figure 4.9 shows the amount of DNA and cDNA that was detectable by qPCR 
in soil over time.  The amount of cDNA that was detectable in buffer alone was 
also plotted for comparison.  No detectable naked DNA was present in the soil 
sample after day seven while cDNA was present in both soil and buffer at the last 
time point (35 days) of the experiment.  
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Figure 4-9.  Copy number of Coxiella burnetii cDNA and DNA purified from 
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4.4  Assessment of Disinfectant Efficacy of Sodium Hypochlorite 
The  percentage  reductions  in  DNA/RNA  from  cultures  using  C.  burnetii 
exposed to 0.4, 0.2, 0.1 mM sodium hypochlorite and 100% kill estimated using 
qPCR of cDNA, TRI extracted DNA and DNA extracted from tissue culture are 
displayed in Figure 4.10.  
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Figure  4-10.    Comparison  of  measurements  of  NaOCl  disinfectant  efficacy 
using qPCR of „cDNA‟, „TRI DNA‟ and DNA purified from C. burnetii after 
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4.4.1  Differences  between  disinfection  efficacy  of  varying  NaOCl 
concentrations 
4.4.1.1  Quantified with qPCR of cDNA 
There  was  a  significant  decrease  in  the  number  of  C.  burnetii  cDNA 
transcripts detected in samples that were exposed to each NaOCl concentration 
and  the  100%  kill  control  compared  to  the  NT  control  (p<0.05).    There  were 
significantly more C. burnetii cDNA transcripts detected in samples exposed to 0.1 
mM NaOCl compared to the 100% kill control, 0.2 mM NaOCl and 0.4 mM NaOCl 
(p<0.05).  There was no significant difference in the genome equivalents detected 
in samples of C. burnetii exposed to 0.2 mM, 0.4 mM NaOCl and the 100% kill 
control (p>0.05). 
4.4.1.2  Quantified with qPCR of DNA co-purified during RNA extraction 
There was a significantly lower concentration of C. burnetii DNA in samples 
exposed to all NaOCl concentrations and the 100% kill control compared to the NT 
control (p<0.001).  There was a significantly higher DNA concentration in samples 
exposed to 0.1 mM NaOCl compared to the 100% kill control and significantly less 
DNA compared to the samples exposed to 0.2 mM and 0.4 mM NaOCl (p<0.05).  
There  were  no  significant  differences  in  the  estimated  number  of  genome 
equivalents in the 0.2 mM and 0.4 mM NaOCl treatments or the 100% kill control 
(p>0.05).  
12/06/2009  School of Veterinary and Biomedical Sciences   
4-164 
4.4.1.3  Quantified with qPCR of DNA extracted from Coxiella burnetii after in 
vitro culture for seven days 
There  were  significantly  less  C.  burnetii  genome  equivalents  detected  in 
samples that were exposed to each NaOCl concentration and the 100% kill control 
compared to the NT control (p<0.05).  The samples treated with 0.1 mM NaOCl 
were found to contain significantly more C. burnetii genome equivalents than the 
100% kill control (p<0.01). 
4.4.2  Differences  between  measurement  of  percentage  reduction  of  cDNA, 
DNA co-purified with RNA and DNA extracted from tissue culture 
The estimated reduction in the number of C. burnetii genome equivalents in 
samples exposed to 0.1 mM NaOCl was significantly lower when data from the 
tissue culture method was used compared to data from the cDNA or TRI DNA 
methods (p<0.05). 
The estimated reduction in the number of C. burnetii genome equivalents in 
samples exposed to 0.2 mM NaOCl was significantly greater when data from the 
cDNA method was used compared to data from the tissue culture method or the 
TRI DNA method (p<0.001). 
The estimated reduction in the number of C. burnetii genome equivalents in 
samples exposed to 0.4 mM NaOCl was significantly greater when data from the 
tissue culture method was used compared to data from the cDNA and TRI DNA 
methods (p<0.001). 
The estimated reduction in C. burnetii transcript numbers in samples exposed 
to the 100% kill control was significantly greater than the reduction quantified when  
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data from the tissue culture method was used compared to data from the TRI DNA 
method (p<0.005). 
4.5  Assessment of Disinfectant Efficacy of Hydrogen Peroxide 
The  percentage  reductions  in  DNA/RNA  from  cultures  using  C.  burnetii 
exposed to hydrogen peroxide and the 100% kill control estimated using qPCR of 
cDNA, TRI extracted DNA and DNA extracted from tissue culture are displayed in 
Figure 4.11.  
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Figure 4-11.  Comparison of measurements of hydrogen peroxide disinfectant 
efficacy using qPCR of „cDNA‟, „TRI DNA‟ and DNA purified from Coxiella 
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4.5.1  Differences between disinfection efficacy of varying H2O2 concentrations 
4.5.1.1  Quantified with qPCR of cDNA 
There  was  a  significant  decrease  in  the  number  of  C.  burnetii  cDNA 
transcripts detected in samples that were exposed to each H2O2 concentration and 
the  100%  kill  control  compared  to  the  NT  control  (p<0.001).    There  were 
significantly  less  C.  burnetii  cDNA  genome  equivalents  detected  in  samples 
exposed to 0.5 mM H2O2 compared to samples exposed to the 100% kill control 
and 1% H2O2 but significantly more genome equivalents than was estimated for 
samples exposed to 2% H2O2 (p<0.005).  The estimated genome equivalents in 
samples exposed to 1 % and 2% H2O2 were not significantly different from each 
other or from samples exposed to the 100% kill control. 
4.5.1.2  Quantified with qPCR of DNA co-purified during RNA extraction 
There  was  a  significantly  lower  concentration  C.  burnetii  DNA  in  samples 
exposed  to  all  concentrations  of  H2O2  and  samples  exposed  to  the  100%  kill 
control compared to the NT control (p<0.001).  There was a significantly higher 
DNA  concentration  in  samples  exposed  to  0.5  %  H2O2  compared  to  samples 
exposed  to  the  100%  kill  control,  1%  and  2%  H2O2  (p<0.05).    There  were  no 
significant differences in the estimated number of genome equivalents in samples 
exposed to 1 % and 2 % H2O2 treatments compared to samples exposed to the 
100% kill control (p>0.05).  
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4.5.1.3  Quantified with qPCR of DNA extracted from Coxiella burnetii after in 
vitro  culture for seven days 
There  was  significantly  more  C.  burnetii  DNA  in  samples  exposed  to  all 
concentrations  of  H2O2  and  the  100%  kill  control  compared  to  the  NT  control 
samples (p<0.001). 
4.5.2  Differences  between  measurement  of  percentage  reduction  of  cDNA, 
DNA co-purified with RNA and DNA extracted from tissue culture 
The estimated number of C. burnetii genome equivalents in samples exposed 
to  all  concentrations  of  H2O2  and  the  100%  kill  control  were  significantly  lower 
when data from the tissue culture method was used compared to data using the 
cDNA and TRI DNA methods (p<0.05). 
4.6  Assessment of Disinfectant Efficacy of Ultraviolet Light 
The percentage reductions in DNA/RNA resulting from treatment with UV light 
as estimated using qPCR of cDNA, TRI extracted DNA and DNA extracted from 
tissue culture are displayed in figure 4.12.  
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Figure  4-12.    Comparison  of  measurements  of  UV  radiation  disinfectant 
efficacy using qPCR of „cDNA‟, „TRI DNA‟ and DNA purified from Coxiella 
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4.6.1  Differences between disinfection efficacy of varying UV doses 
4.6.1.1  Quantified with qPCR of cDNA 
No significant differences were observed between any treatments or controls 
using this measurement method. 
4.6.1.2  Quantified with qPCR of DNA co-purified during RNA extraction 
Samples exposed to 10 mJsec
-1 of UV radiation had a significantly lower DNA 
concentration compared to samples exposed to the 100% kill control (p<0.05).  No 
other significant differences were observed. 
4.6.1.3  Quantified with qPCR of DNA extracted from Coxiella burnetii after in 
vitro culture for seven days 
There was a significantly greater reduction in C. burnetii genome equivalents 
in samples exposed to all UV treatment doses, except 1 mJsec
-1, and the 100% kill 
control compared to the NT control (p<0.005).  Samples exposed to 10 mJsec
-1 
had  significantly  more  C.  burnetii  genome  equivalents  compared  to  samples 
exposed to 1 mJsec
-1 (p<0.05). 
4.6.1.4  Statistical differences between measurement of percentage reduction of 
cDNA, DNA co-purified with RNA and DNA extracted from tissue culture 
The  estimated  reduction  in  C.  burnetii  genome  equivalents  observed  for 
samples treated with 10 mJsec
-1, 5 mJsec
-1 UV and the 100% kill control using 
data from the tissue culture method were significantly greater than the reduction 
quantified  using  the  cDNA  and  TRI  DNA  methods  (p<0.001).  No  significant 
differences  were  observed  in  the  estimated  reduction  in  genome  equivalents  
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between the three methods when the C. burnetii cells were treated with 1 mJsec
-1 
UV radiation and in the NT controls. 
4.7  Blocking RNA Transcription with Rifampicin 
The reductions in C. burnetii RNA in cultures using C. burnetii treated with 
rifampicin prior to exposure with NaOCl and C. burnetii which had not been pre-
treated with rifampicin are shown in figure 4.13.  
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Figure  4-13.    Quantitative  PCR  measurement  of  Coxiella  burnetii  cDNA 
reduction in comparison to a no treatment control in response to insult with 
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4.7.1  Differences  between  samples  pre-treated  with  rifampicin  and  samples 
not pre-treated with rifampicin 
The  estimated  reduction  in  RNA  was  significantly  less  in  cultures  using  C. 
burnetii that had been pre-treated with rifampicin and exposed to 0.2 mM NaOCl, 
0.1  mM  NaOCl  and  the  kill  controls  compared  to  cells  that  had  not  been  pre-
treated (p<0.005).  There were no significant differences in the estimated reduction 
in RNA for the no treatment controls or the 0.05 mM NaOCl-treated samples. 
4.7.2  Differences  between  disinfection  efficacy  of  varying  NaOCl 
concentrations where all samples were pre-treated with rifampicin 
There was significantly greater reduction of RNA in all samples that were pre-
treated with rifampicin and exposed to 0.2 and 0.1 mM NaOCl compared to the 
100% kill control (p<0.05). 
4.8  Discussion 
4.8.1  Transcription of Coxiella burnetii genes in response to heat 
The most dramatic and sustained increase in C. burnetii transcriptional activity 
was  observed  at  a  temperature  of  40°C  where  cDNA  quantity  remained  at,  or 
above,  the  time  zero  mark  for  all  RT-PCR  targets  examined.    However,  the 
greatest  post-heat  treatment  increase  in  RNA  quantity  was  observed  from  the 
SpoIIIE and icd genes when C. burnetii was exposed to 48°C for 10 minutes.  At 
this time point the amount of RNA was almost double that found in the time zero 
controls indicating a substantial increase in the transcription of these two genes.  It 
is interesting to note that the relative transcription of HspB was at, or below, a 
sample to time zero control ratio of 1.05 for all time points at 44°C and 48°C.  It  
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was anticipated that transcription of heat shock genes would increase in response 
to elevated temperature so this result was unexpected.  This trend may indicate 
that heat resistance of the SCV of C. burnetii is due to the increased peptidoglycan 
content of its cell wall in comparison to the LCV (Amano, Williams et al. 1984) 
rather  than  an  active  transcriptional  response  to  heat  stress.    Additionally,  the 
condensed, protein-stabilised state of the SCV chromatin (Nermut, Schramek et al. 
1968) may provide protection for the organisms genetic material, again precluding 
the need for an active response to a heat-challenge. 
Inducing  an  increase  in  transcriptional  activity  is  useful  for  definitively 
identifying viable cells and increasing the chance of detecting them.  However, an 
assay of this nature is limited by the abundance of each RNA species.  For this 
reason the total copy number of each transcript present in the cell is also important 
for the development of a sensitive viability assay. 
For all temperatures and time points the number of 16S RNA transcripts was 5 
to  10-fold  greater  than  any  other  RNA  tested  for.    However,  the  RT-qPCR 
targeting cDNA from this RNA was found to have unacceptably poor specificity 
(see  Chapter  2)  for  an  assay  that  would  be  applied  to  environmental  samples 
containing  mixed  microbial  communities.    Furthermore,  ribosomal  RNA  is 
stabilised by proteins which may enable it to persist after the death of the cell 
(Jenkins, Trout et al. 2003) and this could confound a viability assay targeting this 
type of RNA.  
The next most abundant transcript was produced from the ScvA gene which in 
turn was 50 to 300 fold more abundant than any of the other transcripts at all time 
points and temperatures tested.  The PCR targeting the reverse transcribed RNA 
for the ScvA gene was also highly specific and theoretically capable of detecting  
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as few as 1.6 transcripts per reaction, although at this concentration only one out 
of  every  six  reactions  produced  detectable  amplification  (see  Chapter  2).    The 
protein encoded by the ScvA gene is believed to be involved in the condensation 
of chromatin (Heinzen and Hackstadt 1996) and is most transcriptionally active at 
the  onset  of  the  lifecycle  phase  of  C.  burnetii  that  has  been  likened  to  the 
stationary phase of other bacteria (Coleman, Fischer et al. 2004).  However, it is 
not known how long this RNA remains detectable in the cell. 
4.8.2  Purification and quantification of Coxiella burnetii ScvA RNA from soil 
over time 
To determine if a RT-qPCR targeting the ScvA transcript was useful for the 
detection  of  viable  C.  burnetii  cells  in  environmental  samples  a  longitudinal 
experiment that involved extracting RNA from soil containing  Coxiella cells was 
performed at seven day intervals.  The finding that RNA from both the buffer and 
soil samples was still detectable for the entire length of the experiment (35 days) 
despite  the  absence  of  naked  DNA  after  the  first  7  days  was  important.    The 
observation that RNA decreased over time may be attributable to cell death and 
subsequent degradation or down regulation of transcriptional activity.  If the former 
is true it must be considered that, in this instance, phase II C. burnetii may not be 
an ideal model for wild-type cells.  Lipopolysaccharide contributes to the intrinsic 
resistance  exhibited  by  Gram-negative  bacteria  to  environmental  stressors 
(McDonnell and Russell 1999) but the truncated LPS of phase II C. burnetii cells 
may not afford the same level of protection.  Therefore, if the decrease in RNA 
concentration over time observed in this experiment was due to cell death rather 
than  metabolic  dormancy  phase  I  cells  in  environmental  matrices  may  well  be 
detectable  for  a  longer  duration.    Conversely,  if  the  downward  trend  in  RNA 
quantity is due to reduction in transcriptional activity but not cell death the results  
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would  indicate  that  the  method  is  not  applicable  indefinitely  but  has  a  useable 
range of at least 35 days.  This interpretation is supported by the results of work 
conducted with C. parvum that showed that while cells were undetectable by RT-
qPCR after three months storage they were still infectious according to cell culture-
PCR and mouse inoculation tests (Jenkins, Trout et al. 2003). 
4.8.3  Comparison of methods to evaluate Coxiella burnetii viability 
To challenge the above interpretation of the data from this study a series of 
experiments was conducted to compare the RT-qPCR described here to the cell 
culture-PCR described in Chapter 3.  For the purposes of these experiments a 
proxy  measure  was  used  to  estimate  C.  burnetii  viability.    By  comparing  the 
amount of C. burnetii DNA in a disinfectant-treated sample with the amount of C. 
burnetii DNA in an untreated control the ability of the coxiellae to infect and divide 
within  the  host  cells  could  be  measured.    This  measure  was  referred  to  as 
„percentage reduction in DNA/RNA‟ but the comparison between treated samples 
and untreated controls can more accurately be seen as an indirect measure of 
infectivity and replicative competence.  Similarly, comparison of the abundance of 
a particular mRNA species in treated samples with the abundance in untreated 
controls  can  give  a  measure  of  the  effect  that  a  disinfectant  has  on  the 
transcriptional ability of C. burnetii.  Transcriptional activity is considered to be a 
measure of cellular  viability in many instances  (Keer and Birch 2003) and thus 
here „percentage reduction in RNA‟ can be used to quantify disinfectant efficacy. 
For both DNA and RNA a „reduction‟ of 100% indicates that the treated sample 
contains  an  amount  of  DNA  or  RNA  that  is  less  than  0.01%  of  the  amount 
measured in the untreated controls.  Overall the results showed that there was 
good  agreement  between  the  level  of  cDNA  and  DNA  co-purified  during  the 
procedure  to  extract  RNA  from  C.  burnetii  cells  exposed  to  NaOCl,  hydrogen  
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peroxide  and  UV  radiation.    This  observation  is  not  surprising  given  that  the 
reduction caused by the treatments probably resulted in dramatic damage to the 
cell wall and therefore unregulated traffic between the cell interior and the external 
environment.  Therefore, RNA and DNA are likely to be degraded in the same 
manner.  This is supported by the results from the experiment performed with UV 
radiation  where,  with  one  exception,  none  of  the  treatments  or  controls  were 
significantly different from each other or the controls when measured using cDNA 
or DNA co-purified during the RNA extraction.  Exposure to UV radiation causes 
the  formation  of  thiamidine  dimers  in  DNA  which  makes  it  impossible  for  the 
affected  cell  to  divide  or  gain  access  to  single  stranded  nucleotides  for 
transcription of RNA (Shin, Linden et al. 2001).  Ultra violet light-treated cells retain 
metabolic function, which was evidenced by the lack of difference in the amount of 
RNA or DNA that was detected immediately after treatment.  In contrast, the in 
vitro culture assay showed that UV radiation inhibited the replicative ability of the 
cells.    These  observations  serve  to  highlight  that  a  viability  assay  based  upon 
relative RNA abundance can only be used to measure agents that are bactericidal 
in nature, not bacteristatic.  However, while measurement of viability using RNA 
was, in most instances, different from the measurement provided by the in vitro 
cell culture-PCR assay, significant differences were observed between treatment 
concentrations and controls using the RT-qPCR method.  This indicates that the 
assay has the dynamic capacity to discriminate between varying levels of viability 
for a given number of cells. 
4.8.4  The effect of blocking Coxiella burnetii transcription with rifampicin on 
the RT-qPCR viability assay 
The transcripts from housekeeping genes appear to be the most promising 
targets for a viability assay for C. burnetii because transcription of these genes,  
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while not completely stable between tissue types, occurs at a relatively stable rate 
irrespective  of  any  external  stimuli  (Vandesompele,  De  Preter  et  al.  2002).  
However,  assays  targeting  these  highly  conserved  oligonucleotides  can  lack 
specificity as seen in the results of this study.  Choosing a more unique gene such 
as ScvA can produce a more specific test but the transcript may not be produced 
in detectable numbers at all times thus potentially decreasing the sensitivity of the 
test.  The results of this study show that the ScvA transcript can be used as a 
proxy measure of viability but it was not clear whether the amplified RNA was from 
a static pool or was constantly being degraded and then synthesised de novo in 
response  to  the  external  stimuli  applied.    Results  from  attempts  to  block 
transcription  with  rifampicin  showed  that  treating  the  C.  burnetii  cells  with  this 
antibiotic prior to exposure to chemical insult appears to arrest the synthesis of 
new  RNA.    This  result  was  expected  because  rifampicin  inactivates  RNA 
polymerase (Stryer 1995).  Furthermore, degradation of RNA does not seem to 
occur following treatment with this antibiotic.  It is possible that the time frame 
between the addition of rifampicin and the RNA extraction solution was insufficient 
for RNases and passive RNA decay to break down the transcripts present in the 
cells (Deutscher 2006) or perhaps that while the concentration of DMSO used to 
dissolve the rifampicin was sub-inhibitory to cell growth (Karlson and Ulrich 1969) it 
may  have  had  a  deleterious  effect  on  enzymes  normally  involved  in  RNA 
degradation (Deutscher 2006).  It is likely that the reduction in RNA abundance 
seen in samples not exposed to rifampicin and subsequently exposed to NaOCl is 
due to active degradation by the cells.  This response may be a result of the cell 
reallocating resources to mobilise a defence against the chemical stressor.  This 
response  may  be  involved  with  altering  the  permeability  of  the  membrane  to 
exclude  the  chemical  or  perhaps  the  up  regulation  of  repair  mechanisms  for 
oxidative  damage  (Mertens,  Lantsheer  et  al.  2005).    Alternatively,  the  reduced  
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RNA quantity may have been due to damage of the RNA itself and of the enzymes 
involved in de novo synthesis of new RNA (McKenna and Davies 1988).  It is more 
difficult to explain the observation that RNA abundance was increased in cells that 
were  pre-treated  with  rifampicin  and  exposed  to  the  „100%  kill  control‟ 
concentration  of  NaOCl  (4.17  mM).    This  response  was  not  observed  in  the 
previous NaOCl experiment so it is most likely an anomaly caused by an unequal 
distribution of C. burnetii cells into tubes prior to treatment. 
4.8.5  Conclusions 
The results from this study show that an RT-qPCR-based approach to prove 
viability  in  C.  burnetii  is  appropriate  in  most  circumstances.    However,  certain 
improvements  could  be  made  to  the  method  described  here  because  reverse 
transcription of RNA utilises random primer technology which, while resulting in 
high yields, is thought to reduce assay specificity (Bustin and Nolan 2004).  This 
may  also  impact  on  assay  sensitivity  due  to  its  selective  amplification  of  high-
abundance RNA‟s such as rRNA (Bustin and Nolan 2004).  Thus, it may now be 
beneficial  to  design  sequence-specific  reverse  transcriptase  primers  to  improve 
the sensitivity of the assay.  It may also be prudent to verify the results presented 
here with phase I wild type C. burnetii.  However, there are limited facilities with a 
sufficient  level  of  biological  safety  classification  to  perform  these  experiments.  
Some inherent characteristics of the reverse transcription process must also be 
taken into account when assessing the potential applications for an assay such as 
is described here.  The reverse transcriptase enzyme itself has been shown to be 
inhibitory to PCR (Suslov and Steindler 2005) and high-abundance transcripts are 
preferentially  reverse  transcribed  to  the  exclusion  of  low-abundance  transcripts 
(Bustin and Nolan 2004).  The implications of these findings are that a potential 
mRNA viability marker must be carefully chosen to ensure that it is not excluded  
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from  the  RT  process  and  that  the  conditions  of  the  RT  reactions  must  be 
maintained  within  strict  limits  to  enable  quantitative  comparisons  between 
samples. 
Furthermore, as mentioned in Chapter 3, validation of these results against a 
mouse inoculation model may be required before the technique can be recognised 
as a valid approach for determining viability of this environmental pathogen.  Even 
without validation against a mouse inoculation model with phase I cells the assay 
presented here may prove to be a useful tool for application in livestock-associated 
industries.  Often real-life industrial applications work on risk-reduction strategies 
as absolute disinfection is not realistic.  The RT-qPCR described could be used to 
provide  quantifiable  information  with  defined  limitations  in  regard  to  detecting 
viable C. burnetii in environmental matrices such as soil.  
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5.  An indirect enzyme-linked immunosorbent assay for the 
detection of anti-Coxiella burnetii antibodies in kangaroos 
5.1  Introduction 
It  has  been  demonstrated  that  C.  burnetii  has  a  strong  association  with 
domestic  ruminants  (Raoult  and  Marrie  1995)  as  well  as  native  Australian 
marsupials (Derrick 1939; Pope, Scott et al. 1960).  Thus, the causative agent of Q 
fever is recognised as a serious occupational hazard for people who work with or 
around  waste  and  birth  products  of  livestock  or  marsupials  which  can  harbour 
infective C. burnetii cells (Garner, Longbottom et al. 1997).  Despite this there have 
been  no  recent  studies  into  the  sylvatic  reservoirs  for  C.  burnetii  in  Australia.  
Previous studies used either complement fixation (Dane and Beech 1955; Pope, 
Scott et al. 1960; Munday 1972) or agglutination tests (Derrick 1939) to detect anti-
C. burnetii antibodies in marsupial sera.  These two tests have advantages over 
more specific assays such as ELISA because they do not require specific anti-
species antibodies and therefore do not require samples from confirmed infected 
and  uninfected  animals  to  serve  as  controls.    However,  these  assays  have 
relatively poor sensitivity and specificity in comparison with ELISA (Peter, Dupuis 
et al. 1987; Peter, Dupuis et al. 1988; Fournier, Marrie et al. 1998; Field, Mitchell et 
al. 2000).  A competitive ELISA has been used for detecting the exposure of herds 
of  camels  to  C.  burnetii  (Soliman,  Botros  et  al.  1992)  but  competitive  ELISA's 
require  monoclonal  antibodies  (Nielsen  2002)  and  can  be  time  consuming  to 
develop (Crowther 2000).  While the current reference method for detection of Q 
fever  is  the immunofluorescence assay (Field, Mitchell et al. 2000) it has been 
criticised  on  two  points;  it  has  a  subjective  component  and  it  is  not  easily 
standardised (Peter, Dupuis et al. 1988; Field, Mitchell et al. 2000). It is therefore  
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desirable to develop an indirect ELISA that is compatible with marsupial sera in 
general, but more specifically with kangaroo sera. 
5.2  Materials and methods 
5.2.1  Animal serum 
Serum  and  faeces  were  collected  from  western  grey  kangaroos  (M. 
fuliginosus) commercially harvested in Western Australia and stored as described 
in Chapter 6.  A “positive” control bovine serum sample was obtained from the 
CHEKiT  ELISA  (IDEXX Laboratories Inc., Switzerland).  Samples from  western 
barred  bandicoots,  Perameles  bougainville,  were  collected  from  Dorre  Island 
(25°03‟S, 113°06‟E) and Bernier Island (24°50‟S; 113°08‟E) in Western Australia. 
5.2.2  Development  of  an  enzyme-linked  immunosorbent  assay  to  detect 
infection with Coxiella burnetii in kangaroos  
Serum from kangaroos with known exposure status to C. burnetii were not 
available so the development of this test was performed in two stages.  In the first 
stage  the  compatibility  of  the  reagents  was  established  and  a  selection  of 
kangaroo test sera was screened to identify high reacting samples.  This stage 
was completed using the ruminant “positive” and “negative” control sera included 
in the CHECKiT ELISA and Protein G-HRP (Sigma-Aldrich, Saint Louis, Missouri, 
USA)  as  a  secondary  detection  antibody.    Protein  G-HRP  binds  to  ruminant 
antibodies and also binds to rabbit antibodies.  Therefore, an assay utilising rabbit 
anti-kangaroo antiserum and Protein G-HRP can be used to test ruminant and 
kangaroo sera on the same plate with minimal modifications.  This enabled initial 
screening of kangaroo sera that had high and low OD values (termed high and low 
“reactors”).  The high and low reactors were then used in the second stage of  
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development to optimise the assay conditions and evaluate other aspects of the 
test such as repeatability and compatibility with bandicoot serum. 
5.2.3  Stage 1:  
5.2.3.1  Selection of optimum secondary antibody concentrations 
One kangaroo serum sample was randomly selected from the above collection 
and diluted 1:400 in Tris EDTA buffer with 0.05% Tween 20 (TEN-T, pH 8).  One 
hundred microliters of the diluted serum and 100 µl of TEN-T were added to each 
well of alternating columns of a Maxisorp flat bottom microtitre plate (Nalge NUNC 
International, New York).  The plate was incubated at 4°C overnight in a humid 
chamber.  The plate was then allowed to equilibrate to room temperature and the 
serum and buffer were discarded and the plate washed three times with TEN-T.  
One hundred and fifty microliters of Tris EDTA buffer containing 3 % w/v skim milk 
powder  and  0.05%  Tween  20  (TEN-T,  pH  8)  was  added  to  each  well  and 
incubated at 37°C for 60 minutes.  The blocking buffer was then discarded and 
excess  buffer  removed  by  gently  tapping  the  plate  on  absorbent  towel.    A 
chequerboard titration of rabbit anti-kangaroo IgG heavy and light chains (Bethyl 
Laboratories  Inc.,  Montgomery,  Texas,  USA)  and  Protein  G-HRP  were  then 
performed.  The plate was incubated at 37°C for 60 minutes in a humid chamber 
after addition of each antibody and the plate was washed as described previously 
between incubations.  After the final wash 100μl of TMB substrate (Pierce, Thermo 
Scientific Inc., Rockford, Illinois, USA) was added to each well and incubated at 
room temperature for 15 minutes and the reaction stopped by adding 100μl of 1M 
H3PO4 to each well.  The plate was read using a BioRad Microplate Reader 6800 
(BioRad, Regents Park, New South Wales, Australia) and the final OD of each well 
determined  by  subtracting  the  OD570nm  from  the  OD450nm.    The  ratio  of  the  OD 
values  of  the  wells  containing  kangaroo  serum  to  the  OD  values  of  the  wells  
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without kangaroo serum was calculated. A relatively high ratio was considered to 
be superior. 
5.2.3.2  Evaluating methods of immobilising Coxiella burnetii antigen onto the 
microtitre plate 
Lyophilised  phase  I and phase II  C. burnetii  antigens (Institut Virion/Serion 
GmbH,  Germany)  manufactured  for  use  in  the  complement  fixation  test  were 
reconstituted according to the manufacturer‟s instructions.  The 2 antigens were 
mixed in equal quantities and diluted in carbonate/bicarbonate buffer (pH 9.6) to 
produce  solutions  containing  doubling  dilutions  of  each  antigen.    One  hundred 
microliters of each antigen dilution was added to the wells of two columns on two 
Nunc Maxisorp microtitre plates and the plates incubated in a humid chamber at 
4°C  overnight.    The  antigen  was  discarded  from  one  plate  and  excess  buffer 
removed by tapping the plate on absorbent towel.  The plate was then inverted and 
allowed to dry at 37°C for 30 minutes.  When the first plate was dry the second 
plate was removed from the humid chamber and the antigen solution discarded 
and the plate tapped on absorbent towel to remove excess buffer.  Each plate was 
blocked by addition 150 µl of TEN-T containing 3% w/v skim milk powder to each 
well  followed  by  incubation  in  a  humid  chamber  for  60  minutes  at  37°C.    The 
blocking solution was then discarded and the plates tapped on absorbent towel to 
remove  excess  buffer.    One  hundred  microliters  of  the  bovine  positive  and 
negative control sera supplied with a CHECKiT Q Fever ELISA diluted 1 in 400 in 
TEN-T  buffer  was  added  to  alternating  columns  and  the  plates  incubated  in  a 
humid chamber for 60 minutes at 37°C.  Unbound antibodies were removed by 
washing each plate three times with TEN-T.  A titration of Protein G-HRP was then 
performed.  The plate was incubated in a humid chamber for 60 minutes at 37°C 
after addition of each antibody and the plate was washed as described previously  
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between incubations.  After the final wash 100 µl of TMB substrate was added to 
each  well  and  incubated  for  15  minutes  at  room  temperature  and  the  reaction 
stopped by adding 100μl of 1M H3PO4 to each well.  The plate was read using a 
BioRad  Microplate  Reader  6800  and  the  final  OD  of  each  well  determined  by 
subtracting the OD570nm from the OD450nm.  For each combination of antibodies the 
ratio of the OD value for the well containing serum to the OD value of the well with 
buffer alone was used to compare the two coating methods examined.  A relatively 
high ratio was considered to be superior. 
5.2.3.3  Confirmation of binding of kangaroo antibodies to  Coxiella burnetii 
antigen  
One hundred microliters of the combined phase 1 and phase 2  C. burnetii 
antigen diluted 1 in 100 in carbonate/bicarbonate buffer (pH 9.6) was added to six 
columns of a Nunc Maxisorp microtitre plate with each column consisting of four 
wells.  In addition, 100 µl of carbonate/bicarbonate buffer containing no antigen 
was  added  to  one  well  in  each  column.    The  microtitre  plate  was  incubated 
overnight in a humid chamber at 4°C.  The antigen was then discarded and the 
plates inverted and dried at 37°C for 30 minutes and each well blocked with skim 
milk powder as described previously.  One hundred microliters of 6 different sera 
diluted  1  in  400  in  TEN-T  buffer  were  then  added  to  four-wells  in  individual 
columns.  The sera were; CHECKiT ruminant positive control; CHECKiT ruminant 
negative control; and four kangaroo samples (1269,  1270, 1271 and 1420).  A 
solution of rabbit anti-kangaroo IgG heavy and light chains was diluted 1 in 1,000 
in TEN-T and 100 µl was added to all wells before incubating in a humid chamber 
for 60 minutes at 37°C.  Washing was performed as described previously and the 
optimal concentration of protein G-HRP was titrated.  The plate was incubated in a 
humid chamber for 60 minutes at 37°C after addition of each antibody and the  
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plate was washed as described previously between incubations.  After the final 
wash  100  µl  of  TMB  substrate  was  added  to  each  well  and  incubated  for  15 
minutes  at  room  temperature  and  the reaction stopped by adding 100μl of 1M 
H3PO4 to each well.  The plate was read using a BioRad Microplate Reader 6800 
and  the  final  OD  of  each  well  determined  by  subtracting  the  OD570nm  from  the 
OD450nm. 
5.2.3.4  Reduction of non-specific binding of kangaroo antibodies  
One hundred microliters of the combined phase 1 and phase 2  C. burnetii 
antigen diluted 1 in 100 in carbonate/bicarbonate buffer (pH 9.6) was added to four 
wells  in  each  of  4  columns  of  a  Nunc  Maxisorp.  In  addition,  100  µl  of 
carbonate/bicarbonate buffer alone was added to one well in each column.  The 
microtitre plate was incubated overnight in a humid chamber at 4°C.  The antigen 
was then discarded and the plates inverted and dried for 30 minutes at 37°C and 
all wells were blocked with skim milk powder as described previously.  For this 
experiment each serum sample (CHECKiT positive, CHECKiT negative, kangaroo 
1274 and kangaroo 1275) was diluted 1 in 400 in each of 1, 2 and 4% w/v skim 
milk powder in TEN-T and 1, 2 and 4% bovine serum albumin (Sigma, Castle Hill 
NSW,  Australia)  in  TEN-T  or  TEN-T  alone  and  allowed  to  stand  at  room 
temperature for 30 minutes.  Subsequently, 100 µl of each diluted sample was 
added to one well of a microtitre plate and incubated in a humid chamber for 60 
minutes at 37°C.  A solution of rabbit anti-kangaroo IgG heavy and light chains 
was  diluted  1  in  1,000  in  TEN-T  and  100  µl  was  added  to  all  wells  before 
incubating in a humid chamber for 60 minutes at 37°C. Washing was performed as 
described  previously  following  which  protein  G-HRP  concentration  was  titrated.  
The plate was incubated in a humid chamber for 60 minutes at 37°C after addition 
of  each  antibody  and  the  plate  was  washed  as  described  previously  between  
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incubations.  After the final wash 100μl of TMB substrate was added to each well 
and incubated for 15 minutes at room temperature and the reaction stopped by 
adding 100 μl of 1M H3PO4 to each well.  The plate was read using a BioRad 
Microplate Reader 6800 and the final OD of each well determined by subtracting 
the OD570nm from the OD450nm. 
5.2.3.5  Identification  of  high-responder  kangaroo  serum  samples  and 
assessing the affect of adding a blocking agent to secondary antibody diluents 
One  hundred  microliters  of  the  combined  phase  I  and  phase  II  C.  burnetii 
antigen diluted 1 in 100 in carbonate/bicarbonate buffer (pH 9.6) was added to all 
wells  of  a  Nunc  Maxisorp  microtitre  plate.    The  microtitre  plate  was  incubated 
overnight in a humid chamber at 4°C.  The antigen was then discarded and the 
plates inverted and dried for 30 minutes at 37°C and all wells were blocked with 
skim milk powder as described previously.  Control sera (ruminant positive and 
negative  controls)  and  40  kangaroo  test  sera  (kangaroo  samples  1265,  1266, 
1268-1285, 1287, 1407-1425) were diluted 1 in 400 in TEN-T plus 4% w/v skim 
milk powder and mixed on an orbital shaker for 30 minutes at room temperature 
prior  to  being  added  to  the  previously  prepared  microtitre plate.    One hundred 
microliters of each control samples was added to four wells on each plate and 100 
µl of each test samples was added to duplicate wells.  Plates were incubated in a 
humid chamber for 60 minutes at 37°C.  Rabbit anti-kangaroo IgG heavy and light 
chains antiserum was diluted 1 in 1,000 in TEN-T and 100 µl added to each well 
and the plate then incubated in a humid chamber for 60 minutes at 37°C.  Protein 
G-HRP was diluted 1 in 8,000 in TEN-T and 100 µl added to each well and the 
plate incubated in a humid chamber for 60 minutes at 37°C.  Washing steps were 
performed after each incubation as described previously.  After the final wash 100 
µl of TMB substrate was added to each well and the plate incubated for 15 minutes  
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at room temperature and the reaction stopped by adding 100 µl of 1M H3PO4 to 
each well.  The plate was read using a BioRad Microplate Reader 6800 and the 
final  OD  of  each well determined by subtracting the OD570nm  from  the OD450nm.  
Raw data from screening the kangaroo serum samples are presented in Appendix 
A. 
The experiment described above was repeated the following day except 1% 
w/v skim milk powder was added to the Rabbit anti-kangaroo IgG heavy and light 
chains antiserum and protein G-HRP diluents immediately prior to use.  The OD 
values from the samples tested without a blocking agent added to the secondary 
antibodies was compared to the OD values from the test run with a blocking agent 
added.    The  difference  between  the  values  was  expressed  as  a  percentage 
reduction in absorbance caused by the addition of the skim milk powder.  These 
data are displayed in Appendix A.  Visual interpretation of the data from the test 
results without a blocking agent added to the secondary antibody diluent allowed 
two populations to be defined based on the samples‟ relative reactivity.  The „low 
reacting‟  sample  population  had  absorbance  values  less  than  1  and  the  „high 
reacting‟  sample  population  had  absorbance  values  of  1  or  greater.    An 
independent sample t-test was then used to determine if the percentage reduction 
in  absorbance  calculated  for  the  „high  reacting‟  population  was  significantly 
different from that calculated for the „low reacting‟ population. 
5.2.4  Stage 2: 
5.2.4.1  Antigen and antibody titration using high and low kangaroo reactors 
as controls  
Three  kangaroo  samples  (1278,  1412  and  1417)  that  were  found  to  have 
relatively high OD values when tested with the ELISA were pooled and used as a  
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positive control for this and all subsequent tests.  Three kangaroo samples (1274, 
1408 and 1418) that were found to have relatively low OD values when tested with 
the ELISA were pooled and used as a negative control for this and subsequent 
tests.  Raw OD values for these samples are presented in Appendix A.  Three 
separate titrations were performed to determine the optimal concentration of each 
reagent as follows: antigen was diluted in carbonate/bicarbonate buffer (pH 9.6) 
and 100 µl added to each well of a Nunc Maxisorp microtitre plate and the plate 
was incubated overnight at 4°C.  The antigen was discarded and excess buffer 
removed by tapping the plate on absorbent towel.  The plate was then inverted and 
allowed to dry at 37°C for 30 minutes.  Each plate was blocked by addition 150 µl 
of TEN-T containing 3% w/v skim milk powder to each well followed by incubation 
in  a  humid  chamber  for  60  minutes  at  37°C.    The  blocking  solution  was  then 
discarded and the plates tapped on absorbent towel to remove excess buffer.  All 
incubations  with  antibodies  were  performed  for  60  minutes  at  37°C  and  were 
followed by washing as described previously.  After the final wash 100μl of TMB 
substrate  was  added  to  each  well  and  incubated  for  15  minutes  at  room 
temperature and the reaction stopped by adding 100 µl of 1M H3PO4 to each well.  
The plates were read using a BioRad Microplate Reader 6800 and the final OD of 
each well was determined by subtracting the OD570nm from the OD450nm. 
Selection of optimum conditions from all titrations was based on the amount of 
background absorbance observed in negative and blank control wells and the ratio 
of the OD values of the positive to the OD values of the negative serum with a high 
ratio was considered to be superior.  
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5.2.4.2  Titrating control serum against antigen 
In the first experiment the concentration of control serum diluted in TEN-T plus 
3% w/v skim milk powder was titrated against the concentration of antigen.  For 
this titration controls containing no serum and no antigen were included and all 
combinations  were  tested  with  rabbit  anti-kangaroo  heavy  and  light  chain 
antiserum diluted at 1 in 1000 and 1 in 2000 in TEN-T plus 1% w/v skim milk 
powder. 
5.2.4.3  Titrating rabbit anti-kangaroo antiserum against protein G-HRP 
For this titration the antigen concentration was kept standard at 1 in 50 and 
serum was diluted 1 in 400 in TEN-T plus 4% w/v skim milk powder.  Rabbit anti-
kangaroo heavy and light chain antiserum diluted in TEN-T plus 1% w/v skim milk 
powder was then titrated against protein G-HRP diluted in TEN-T plus 1% w/v skim 
milk powder. 
5.2.4.4  Titrating rabbit anti-kangaroo antiserum against donkey anti-rabbit-
HRP 
In the final optimisation experiment antigen concentration was kept standard 
at 1 in 50 and serum was diluted 1 in 400 in TEN-T plus 4% w/v skim milk powder.  
Rabbit anti-kangaroo heavy and light chain antiserum in TEN-T plus 1% w/v skim 
milk  powder  was  then  titrated  against  donkey  anti-rabbit-HRP  (Bethyl, 
Montgomery, Texas, USA) diluted in TEN-T plus 1% w/v skim milk powder. 
5.2.4.5  Reproducibility of optimised kangaroo Q fever indirect ELISA 
A total of 42 samples of serum that had high OD‟s (high reactors) and 42 
serum samples that had low OD‟s (low reactors) when tested with the optimised  
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ELISA were selected and tested once per day for three consecutive days.  A one-
way  ANOVA  with  Tukey‟s  honestly  significant  differences  test  with  a  95% 
confidence  limit  was  performed  to  determine  the  statistical  significance  of  any 
differences in the mean OD values for „high reacting‟ and „low reacting‟ sets from 
three consecutive days.  The same analysis was also used to test the statistical 
significance  of  any  differences  between  the  three  days  when  the  absorbance 
results  were  expressed  as  a  percent  of  the  OD  value  of  the  positive  control 
absorbance (PP).  All statistical analyses were performed using the SPSS version 
15.0 (SPSS Inc., Chicago, USA). 
5.2.4.6  Evaluation  of  an  antibody  ELISA  to  detect  exposure  to  Coxiella 
burnetii in serum from western barred bandicoots (Perameles bougainville) 
A  selection  of  36  sera  from  the  western  barred  bandicoot,  (Perameles 
bougainville) bandicoot were tested in exactly the same manner as described for 
kangaroo serum samples to determine if the immunological test described here 
could be used for detecting exposure to C. burnetii in this marsupial. 
5.2.5  Comparison  of  different  cut-off  strategies  to  maximise  ELISA 
performance 
Several strategies were employed to determine the most appropriate method 
of  selecting  a  cut-off  OD  that  would  discriminate  between  “infected”  and 
“uninfected” kangaroos.  A scatter plot was initially constructed to determine if a 
cut-off OD value could be visually identified.  Attempts were made to correlate the 
data from testing genomic DNA purified from the faeces of each kangaroo with the 
qPCR (see Chapter 6) and the results from testing the sera from each animal with 
the ELISA using 5 different cut-off OD values.  Spearman‟s rank correlation was 
calculated  for  all  cut-offs  and  qPCR  results.    The  cut-off  OD  values  were  
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equivalent to; (1) the OD equivalent to 30% of the OD of the positive control serum 
(30% PP) (OIE, 2000), (2) the OD equivalent to 40% of the OD of the positive 
control serum (40% PP) (OIE, 2000); (3) the sample OD divided by the mean OD 
of  the  negative  control  samples  from  the  same  plate  was  greater  than  1.4 
(NEG1.4) and (4) the mean OD of a population of uninfected animals (assumed to 
be represented by animals sampled from Capel which is discussed in Chapter 6) 
plus two times the standard deviation of the mean OD (2SD). 
5.2.6  Immunological reactivity of kangaroo test sera with phase I or phase II 
Coxiella burnetii antigen individually 
All 343 kangaroo serum samples were tested with an ELISA using each phase 
of the  C. burnetii antigen separately diluted 1 in 50 according to the optimised 
protocol  developed  here  and  also  described  in  Chapter  6.    The  positive  and 
negative  kangaroo  control  sera  described  previously  were  also  used  in  this 
experiment.  Each serum sample was diluted 1 in 400 and tested in duplicate and 
the  control  samples  (positive,  negative  and  no  serum)  were  tested  in 
quadruplicate.    The  mean  OD  values  of  each  test  sample  was  normalised  by 
dividing them by the mean absorbance value of the negative controls and then the 
results  were  expressed  as  a  ratio  of  phase  I-specific  absorbance  to  phase  II-
specific absorbance. 
A one-way ANOVA was used  to determine the statistical significance, at  a 
95%  confidence limit,  of any  differences between the ratio  of OD values using 
phase  I  and  phase  II  antigen  and  four  factors;  (1)  sample  collection  location 
(Capel, Manjimup, Badgingarra, Eneabba, Preston Beach and Whiteman Park); 
animal  sex;  animal  age  and  the  month in which the sample was collected.    In 
addition, samples were classified as positive or negative according to the results  
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presented in Chapter 6 and the data were analysed to determine differences in 
relation to the phase I/phase II antigen absorbance ratio.  The Poptools Microsoft 
Excel add-in (Hood 2006) was used to produce summary statistics for the data and 
to create a frequency histogram. 
5.3  Results 
5.3.1  Development  of  an  enzyme-linked  immunosorbent  assay  to  detect 
infection with Coxiella burnetii in kangaroos: stage 1 
5.3.1.1  Selection of optimum secondary antibody concentrations 
The optimum concentrations of rabbit anti-kangaroo antiserum protein G-HRP 
and  that  provided  the  maximum  OD  value  for  the  positive  control  serum  and 
acceptable level of background (OD value of the “no-serum” controls) were 1 in 
1,000 and 1 in 8,000 respectively  
5.3.1.2  Evaluating  methods  of  immobilising  C.  burnetii  antigen  onto  the 
microtitre plate 
It was determined that drying the plate at 37°C for 30 minutes, after overnight 
coating at 4°C and then blocking with 3% w/v skim milk powder for 60 minutes at 
37°C  produced  optimum  results.    These  results  also  indicated  that  an  antigen 
dilution of 1 in 100 (where each phase of antigen had been diluted 1 in 100) was 
superior to the other dilutions examined and that a protein G-HRP dilution of 1 in 
8,000 was close to optimum.  
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5.3.1.3  Confirmation of binding of kangaroo antibodies to  Coxiella burnetii 
antigen 
There was a dose-dependent relationship between the OD values for each 
serum sample and the protein G-HRP dilution.  The OD values for all kangaroo 
samples and the ruminant positive control were greater than the OD value for the 
ruminant negative control.  The relationship between OD values and protein G-
HRP dilution for each serum sample is shown in Figure 5.1. 
Figure 5-1.  OD values from testing two ruminant control serum samples and 
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5.3.1.4  Reduction of non-specific binding of kangaroo antibodies 
The addition of blocking agents appeared to have a concentration-dependent 
effect on the OD values obtained after testing kangaroo serum samples with the 
ELISA but did not have a similar effect on the ruminant controls.  Four percent w/v 
skim milk powder in TEN-T (pH 8.0) was chosen as the final blocking agent based 
on  the  affect  that  each  blocking  agent  had  on  the  OD  values  of  the  positive, 
negative, kangaroo and blank samples. 
5.3.1.5  Identification of high-responder kangaroo serum samples and 
assessing the affect of adding a blocking agent to secondary antibody diluents 
The raw OD values from testing a panel of kangaroo sera with the ELISA are 
presented in Appendix A.  Adding blocking agent to the diluent for the rabbit anti-
kangaroo antiserum and the protein G-HRP produced a marked decrease in the 
absorbances of all samples.  There was a significantly greater change in the OD 
values caused by the addition of skim milk powder for the „low reacting‟ population 
compared to the „high reacting‟ population (p<0.01). 
5.3.2  Development  of  an  enzyme-linked  immunosorbent  assay  to  detect 
infection with Coxiella burnetii in kangaroos: stage 2: 
5.3.2.1  Antigen and antibody titration using high and low kangaroo reactors 
as controls  
Optimum test performance was achieved when the antigen was diluted 1 in 50 
and the serum was diluted 1 in 400.  When rabbit anti-kangaroo antiserum was 
used with protein G-HRP the optimal concentrations of these two antibodies was 1 
in 1,000 and 1 in 4,000 respectively.  The use of donkey anti-rabbit-HRP in place  
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of protein G-HRP also reduced background absorbance.  A combination of a 1 in 
500 dilution of rabbit anti-kangaroo antiserum and a 1 in 4,000 dilution of donkey 
anti-rabbit-HRP gave the best compromise between low background OD values 
and high positive control OD values. 
5.3.2.2  Reproducibility of optimised indirect ELISA to detect Coxiella burnetii 
in kangaroos 
The  mean  OD  values  of  „high  reacting‟  samples  tested  on  day  2  were 
significantly higher than the absorbance values recorded for the same samples 
tested on day 1 and day 3 (p<0.01).  When the absorbance values for positive 
samples were converted to a PP it was observed that the values calculated for 
samples tested on day 3 were significantly higher than the values calculated for 
samples tested on day 2 (p<0.001).  For the „low reacting‟ samples it was found 
that the PP values for samples tested on day 1 were significantly lower than the 
PP values calculated for samples tested on day 2 (p<0.05). 
5.3.2.3  Evaluation of an antibody ELISA to detect exposure to Coxiella 
burnetii in serum from bandicoots 
The results of testing bandicoot sera with the ELISA showed a similar ability to 
discriminate between high and low responding individuals. 
5.3.3  Comparison  of  different  cut-off  strategies  to  maximise  ELISA 
performance 
Significant correlations were found between all ELISA cut-off points applied to 
the  data  (p<0.01).    However,  correlations  between  qPCR  results  and  the  four 
ELISA  cut-offs  were  not  as  strong.    The  JB153-3  qPCR  assay  was  found  to  
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correlate  significantly only with the „2SD‟ cut-off (p<0.05) although the  IS1111a 
qPCR correlated weakly with all cut-offs (p<0.05) except „30%PP‟ (p>0.1). 
The PP of the samples classified as positive using the „30%PP‟ cut-off was 
significantly lower than all other cut-offs employed (p<0.05) but no other significant 
differences were found. 
The mean OD value of the kangaroo sera collected in Capel, expressed as a 
PP, were significantly different from the mean OD values of kangaroo sera from all 
other collection locations except Badgingarra (p<0.01).  Of the samples collected 
from Capel it was found that those collected in July 2007 had significantly higher 
PP values than those collected in March and May 2007 (p<0.05). 
5.3.4  Immunological reactivity of kangaroo test sera with phase I or phase II 
Coxiella burnetii antigen individually 
A  frequency  histogram  showing  the  number  of  samples  displaying  phase 
I/phase II antigen-specific absorbance values is shown in Figure 5.2.  One sample 
(1481) was considered to be an outlier with a ratio of 4.56 and was omitted from 
further  analysis.    The  mean  ratio  for  samples  collected  in  Capel  (1.08)  was 
significantly  greater  than  the  mean  ratio  for  samples  collected  in  Manjimup 
(mean=0.87, p<0.01) and the mean ratio of samples collected in Whiteman Park 
(mean=0.85,  p<0.05).    The  ratio  for  samples  collected  in  March  (1.24)  was 
significantly higher compared to the ratio for samples collected in all other months 
(p<0.05).  
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Figure 5-2.  The ratio of phase I Coxiella burnetii antigen OD values to phase II 
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5.4  Discussion 
5.4.1  Assay development 
The  absence  of  serum  from  kangaroos  with  known  C.  burnetii  status 
complicated  the  optimisation  of  the  ELISA  developed  in  this  study.    Initial 
development  with  protein  G  and  ruminant  control  sera  enabled  a  basic  assay 
configuration to be determined that could be applied to kangaroo sera of unknown 
exposure  status.    Identification  of  high  and  low  responder  kangaroo  sera  then 
allowed the further development and optimisation of the assay.   
The assay could be further improved.  In particular, attempts could be made to 
improve the reproducibility of the test, which was relatively poor.  It is quite likely 
that the observed poor reproducibility was caused by using an antigen that was not 
designed for use in an ELISA.  It has been shown that the detection of anti-C. 
burnetii antibodies is greatly affected by the quality of the antigen used (Dane and 
Beech  1955;  Kovacova,  Kazar  et  al.  1998).    Unfortunately,  no information was 
available from the manufacturers with regards the method of antigen preparation 
used.    It  is  reasonable  to  assume  that  the  antigen  is  a  simple  highly  purified 
sample of whole cells and therefore basic mechanical treatment such as sonication 
(Peter, Dupuis et al. 1987) may expose more antigenic epitopes and thus improve 
the diagnostic capabilities of this ELISA.  However, purification after mechanical 
treatment  may  be  necessary  to  avoid  masking  of  specific  antigens  by  cellular 
debris (Kenny and Dunsmoor 1983).  Furthermore, a recent study suggested that 
antigen made from Nine Mile strain C. burnetii is not appropriate for serodiagnosis 
of coxiellosis in ruminants due to regional differences in strain antigenic reactivity 
(Rodolakis,  Bouzid  et  al.  2007).    Therefore,  the  Nine  Mile  strain  used  in  the 
Virion/Serion  antigen  may  not  be  representative  of  the  antigenic  profile  of  C. 
burnetii found in Australian marsupials.  If a true wildlife-to-domestic animal cycle  
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exists in Australia then this also has implications in regards to the utility of Nine 
Mile antigens for surveillance of C. burnetii exposure in domestic ruminants in this 
country.    Therefore  it  is  important  to  isolate  and  characterise  C.  burnetii  from 
Australian marsupials.   
To minimise the affect that the variability of the antigen had on the results, all 
absorbance values needed to be normalised so that comparisons could be made 
between  samples  tested  at  different  times.    In  most  cases  this  was  done  by 
expressing test sample absorbance values as a percentage of the positive control 
absorbance mean (PP) from the same plate.  Initially, statistical analyses were 
performed on both mean absorbance and PP values but the increased variability 
seen when the results were expressed in mean absorbance form masked most 
differences in the comparison. 
Further improvement to the ELISA may also be possible by linking a detection 
enzyme, such as horseradish peroxidase, directly to the rabbit anti-kangaroo IgG 
heavy and light chain antibodies.  This would decrease the duration of the assay 
by 60 minutes and could lower the amount of background absorbance observed. 
It is also encouraging that the indirect ELISA developed as part of this project 
appears  to be compatible with serum from the western barred bandicoot.  The 
relationship between C. burnetii and Australian marsupials was established soon 
after this zoonotic pathogen was first described (Derrick 1939) but only sporadic 
efforts have been made since to quantify the interaction between them (Dane and 
Beech 1955; Munday 1972).  The availability of an optimised ELISA capable of 
testing serum from different marsupial species will enable further studies to better 
characterise the sylvatic and domestic cycles of C. burnetii in Australia.  
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5.4.2  Blocking non-specific binding of antibodies 
Results from testing the same set of unknown samples with and without the 
addition of skim milk powder to the secondary antibody diluents showed that the 
blocking  agent  had  greater  effect  on  the  „low‟  reactors  compared  to  the  „high‟ 
reactors.  This is interesting because it indicates that the absorbance produced by 
high reacting samples is more specific and thus more likely to be indicative of a 
truly  positive  test  result.    Enhancement  of  signal-to-noise  ratio  by  casein,  a 
component  of  skim  milk  powder,  is  a  well  established  phenomenon  utilised  in 
many immunological assays (Kaur, Dikshit et al. 2002; Sentandreu, Aubry et al. 
2007).  It is in part due to the small size of the casein proteins enabling formation 
of a tightly packed barrier to subsequently added antibodies  (Pratt and Roser).  
Microtitre plates with high-binding chemical properties, such as the plates used for 
the  assay  described  here,  have  been  shown  to  produce  high  background 
absorbance in some situations (Rebeski, Winger et al. 1999) and therefore require 
blocking agents to produce consistent results.  However, without verified control 
sera, preferably from animals infected under controlled conditions, it may be more 
important to consider the possibility that high absorbance values could in part be 
due to cross-reactivity with other infectious organisms. 
5.4.3  Cross-reactivity 
Dane and Beech (1955) noted that detection of anti-C. burnetii antibodies in 
kangaroos  can  be  difficult  due  to  the  presence  of  non-specific  Wassermann 
reactivity  related  to  generic  antibody-lipopolysaccharide  interactions.    Cross-
reactivity  has  also  been  observed  between  C.  burnetii  and  rickettsiae  (Field, 
Mitchell et al. 2000), bartonellaceae (La Scola and Raoult 1996; Numazaki, Ueno 
et al. 2000) and chlamydiae (Lukacova, Melnicakova et al. 1999).  Significantly, in 
1999 a new species of Bartonella was cultured from the blood of five eastern grey  
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kangaroos  (Macropus  giganteus)  but  the  pathogenicity  and  prevalence  of  this 
organism are as yet unknown (Fournier, Taylor et al. 2007).  Therefore, it would be 
beneficial to conduct cross-reactivity studies of the kangaroo sera collected as part 
of this study with antigens from the organisms noted previously. 
5.4.4  Selection of a cut-off point for positivity 
The  fully  optimised  assay  described  here  was  able  to  provide  distinction 
between those samples that produced strong reactivity to the antigen and those 
with a weak association with the antigen.  However, selecting a cut-off value that 
best separates these two populations and therefore provides optimum sensitivity 
and specificity is difficult.  If a bank of known-negative samples is available then a 
cut-off can be calculated using the mean negative sample absorbance plus two or 
three standard deviations of the mean, depending on the sensitivity and specificity 
desired (Greiner, Kumar et al. 1997).  While the true infection status of animals in 
this study was unknown, the animals sampled in Capel exhibited significantly lower 
reactivity  for  the  antigen  than  the  other  sampling  locations.    However,  of  the 
samples taken from Capel, variation in regards to the month in which the samples 
were collected was observed.  It is reasonable to define the samples collected in 
March and May as a negative population of animals based on the more extensive 
analysis  of  the  factors  that  are  related  to  the  reactivity of the kangaroo serum 
samples (Chapter 6).   
Using  this  putatively  negative  population  to  determine  a  cut-off  value  may 
have been confounded by the poor reproducibility of the test.  If a set OD value is 
used  to  determine  the  exposure  status  of  an  individual  sample,  the  variability 
caused by the antigen may have a significant effect on the results of the test.  In 
the absence of a known negative population the positive controls used in the test  
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can  serve  as  a  benchmark  from  which  positivity  can  be  inferred  for  unknown 
samples.    Normalising  test  serum  absorbance  results  against  positive  control 
absorbance and then implementing a cut-off at a certain percentage of the positive 
control mean has been used in research and commercially (OIE 2000) and this 
approach appeared to separate the sample population absorbance values quite 
well.    However,  the  positive  controls  used  for  all  testing  consisted  of  a  pooled 
sample  of  previously  identified  high  reacting  sera  that  were  not  confirmed  as 
positive by any other means due to a lack of appropriate tests.  Similarly, using the 
pooled negative control absorbance mean as a standardising point for test sample 
results may not be applicable to the wider population of kangaroos in Australia. 
When the various cut-offs were compared with an analysis of variance it was 
found that they were not significantly different, with the exception of the test in 
which the cut-off value was 30% of the positive control absorbance.  This cut-off 
was shown to give more „positive‟ results than the other cut-off values tested.  The 
„40%PP‟ and „NEG1.4‟ cut-offs correlated well with each other and were found to 
divide  the  samples  into  „positive‟  and  „negative‟  populations  that  had  mean  PP 
values that were not different from each other.  In most respects these two cut-offs 
can  be  considered  to  be  equivalent  and  either  would  be  appropriate  for 
classification  of  exposure  status  for  kangaroo  serum  samples  until  confirmed 
control sera are available.  However, given that the use of a „40%PP‟ cut-off is 
supported in the literature (OIE 2000; Rebeski, Winger et al. 2001; Giammanco, 
Chiarini et al. 2003; Hoet, Chang et al. 2003; Nielsen, Toft et al. 2004) and in 
commercial kits such as the CHECKiT Q fever ELISA as being a valid method for 
discriminating positive and negative samples, it was chosen for application to the 
kangaroo test samples.  It may also be beneficial to define an equivocal range 
within which tested samples have absorbance values close to, but not exceeding, 
the  cut-off  for  positivity  (Giammanco,  Chiarini  et  al.  2003).    Such  samples  are  
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considered to be „suspect‟ and are subsequently re-tested.  A second „suspect‟ 
result leads to the sample being classified as „negative‟ and „negative‟ or „positive‟ 
results are considered to be definitive.  This approach may be especially useful for 
the test described here until further development of the antigen can be undertaken 
to improve reproducibility. 
5.4.5  Specific reactivity of sera to phase I or II antigen 
Significant effort has been made to identify factors associated with C. burnetii 
that  are  predictive  of  either  chronic  or  acute  Q  fever  in  humans.    Molecular 
methods have met with debatable success (Yu and Raoult 1994; Toman, Hussein 
et  al.  2003)  but  the  correlation  between  immunological  factors  and  disease 
syndrome is much more widely accepted.  In humans it has been demonstrated 
that antibodies to phase II antigen predominate in the early stages of infection, 
whereas anti-phase I antibodies appear somewhat later (Hunt, Field et al. 1983; 
Peacock, Philip et al. 1983; Peter, Dupuis et al. 1985) and a high proportion of 
anti-phase I antibodies has been shown to indicate a chronic infection (Wilson, 
Neilson et al. 1976; Hunt, Field et al. 1983; Peacock, Philip et al. 1983; Tissot-
Dupont, Thirion et al. 1994).  This pattern has also been demonstrated in guinea 
pigs (Moos and Hackstadt 1987) and it seems possible that the same temporal 
relationship between infection stage and phase-specific antibodies exists for other 
host species. 
While  significant  differences  were  observed  when  comparing  the  different 
collection locations it was not possible to draw any strong conclusions because of 
a lack of data for all locations over all months.  Perhaps the most significant trend 
revealed is that, of all samples, those collected in March had a significantly higher 
phase  I  to  phase  II  ratio  than  any  other  month.    If  the  immune  response  
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progression in kangaroos is similar to that observed for humans and guinea pigs 
these  results  could  indicate  that  chronic  infection  predominated  in  March  and 
earlier  while  there  was  a  high  rate  of  new  or  acute  infections  in  months  after 
March.  The implications of these observations are presented in the discussion in 
Chapter 6. 
5.4.6  Conclusions 
In summary, the ELISA discussed in this chapter is the first optimised species-
specific immunological assay described for the detection of C. burnetii exposure in 
kangaroos.  Furthermore, the test appears to be compatible with other marsupial 
species and therefore could be an important epidemiological tool for surveillance 
of C. burnetii in these native Australian species.  Development of the assay using a 
generic-specificity secondary antibody allows scope for adaptation of the test to 
other  species  which  could  be  important  for  the  dissemination  of  C.  burnetii  in 
Australia.  Of particular interest is the feral pig population which often occupies 
locations close to water catchments for human consumption (DAFWA 2008).  The 
ELISA is also capable of providing important information regarding the specificity 
of  the  hosts‟  antibody  response  to  phase  I  or  phase  II  antigen  and  thus,  by 
inference, whether the animal tested has acute or chronic infection.  Applying this 
approach to the kangaroo samples collected for this project seemed to reveal that 
the faecal-oral route may be important in transmission of the pathogen.  
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6.  A survey of Western Australian sheep, cattle and kangaroos to 
determine the prevalence of Coxiella burnetii 
6.1  Introduction 
The agent responsible for Q fever, Coxiella burnetii, has a strong association 
with  domestic  ruminants,  including  sheep,  goats and cattle,  (Raoult and Marrie 
1995)  as well as native Australian marsupials  (Derrick 1939; Pope, Scott et al. 
1960).  Interaction with domestic livestock has been implicated as a significant 
factor contributing to C. burnetii seroconversion in wildlife species (Enright, Franti 
et  al.  1971)  and  this  domestic  animal  to  wildlife  transfer  may  represent  a 
permanent  cycle  for  maintenance  of  C.  burnetii  in  the  environment  (Dane  and 
Beech 1955).  There have been no published surveys on the prevalence of Q fever 
in domestic or native animals in Western Australia. 
Serological detection of exposure to C. burnetii in ruminants is well established 
using  complement  fixation  (Field,  Mitchell  et  al.  2000;  Rousset,  Durand  et  al. 
2007), immunofluorescence (Setiyono, Ogawa et al. 2005; Rousset, Durand et al. 
2007) and enzyme linked immunosorbent assays (Masala, Porcu et al. 2004; Berri, 
Crochet  et  al.  2005).    Likewise,  polymerase  chain  reaction-based  assays  have 
been used for detecting C. burnetii DNA in faeces and other bodily excreta from 
livestock  (Berri,  Laroucau  et  al.  2000;  Arricau  Bouvery,  Souriau  et  al.  2003; 
Guatteo, Beaudeau et al. 2006).   
There are four main groups of kangaroos in Australia; the eastern and western 
grey kangaroo group, the red kangaroo, the antelope kangaroo and the wallaroo-
euro  group  (Dawson  2002).    In  Western  Australia the western grey (Macropus 
fuliginosus) and the red kangaroos (M. rufus) are most common and are harvested  
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commercially.  The western grey kangaroo has flourished with the introduction of 
European  farming  methods  and  often  grazes  the  same  pastures  as  domestic 
livestock  while  the  Red  kangaroo  prefers  more  arid  conditions  (Management 
2002).   
This study was designed to apply immunological and molecular methods to 
determine the prevalence of C. burnetii in cattle, sheep and kangaroos in Western 
Australia. 
6.2  Materials and methods 
6.2.1  Collection of serum and faeces or urine from sheep, cattle and kangaroos 
in Western Australia 
A map showing the approximate locations of sampling sites is presented in 
Figure 6.1.  The map was generated using the Magellan Discover AUS Streets and 
Tracks software (Magellan, San Dimas, California, USA).  
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Figure 6-1.  Map of the approximate locations of sampling sites for collection of 
serum and faeces from cattle, sheep and kangaroos in Western Australia 
(adapted from a map generated in the Magellan Discover AUS software) 
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6.2.1.1  Bovine samples 
Paired samples of blood and faeces were collected from 124 cattle held at a 
feedlot  in  Vasse,  Western  Australia  (WA)  in  2007.    The  herd  comprised 
approximately 80% Bos indicus steers (except for one heifer) from three properties 
in the North West of WA and 20% Angus steers (B. taurus) from the South West 
of WA.  All animals were between 18 and 24 months of age. 
Paired blood and urine samples were also collected from 157 B. taurus cattle 
from  a  farm  in  Pinjarra,  WA  that  had  experienced  an  outbreak  of  leptospiral 
abortions in 2005 (Wai'in 2007).  A further 48 paired faecal and blood samples 
were collected from mixed age B. taurus cattle housed on the Murdoch University 
farm in February 2007. 
6.2.1.2  Ovine samples 
Paired faecal and blood samples were collected in February 2007 from 50 
merino ewes (Ovis ovis) approximately 5 years of age.  These animals were used 
for breeding purposes on the Murdoch University farm.  Samples were collected 
when the animals were not pregnant and had not lambed recently. 
6.2.1.3  Kangaroo samples 
Paired blood and faecal samples were taken from  western grey kangaroos 
from  various  locations  in  the  South  West  Western  Australia  including:  Preston 
Beach,  Whiteman  Park,  Manjimup,  Capel,  Badgingarra  and  Eneabba  (see  Fig. 
6.1).  The approximate age of each animal sampled was recorded as either „1‟ 
(pouch  young),  „2‟  (juvenile),  „3‟  (sub-adult)  or,  „4‟  (adult).    Pouch  young 
represented those joeys too young to leave the pouch, whilst juveniles represented 
those  young  at  foot  who  could  return  to  the  pouch  at  will.  Sub-adults  were  
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considered to be those kangaroos who had not yet reached mature body weight, 
compared to adults, who were considered fully grown. 
6.2.2  Detection  of  antibodies  to  Coxiella  burnetii  using  the  complement 
fixation test 
Serum from all ruminants and a preliminary selection of kangaroos was tested 
using  the  CFT  by  the  Department  of  Agriculture  and  Food  Western  Australia 
(DAFWA)  according  to  their  in-house  procedures.  All  samples  that  reacted 
strongly  at  a  1  in  8  dilution  were  heat-inactivated  at  58°C  for  30  minutes  and 
subsequently re-tested. 
6.2.3  Detection  of  antibodies  to  Coxiella  burnetii  in  serum  from  ruminants 
from Western Australia using an ELISA 
Sera were tested using the CHEKiT Q Fever ELISA kit (IDEXX Laboratories 
Inc.,  Switzerland)  according  to  the  manufacturers‟  instructions.    A  sample  was 
considered positive if the optical density (OD) was ≥40% of the mean OD value of 
the positive control wells for that plate.  Samples with OD values less than 30% of 
the positive control values were considered negative and samples with OD values 
between 30 and 40% of the positive controls were considered suspect and were 
re-tested.  Samples that were re-tested were evaluated in the same way except 
that  if  the  OD  value  of  a  sample  was  in  the  “re-test”  range  the  sample  was 
classified as negative.  
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6.2.4  Detection  of  antibodies  to  Coxiella  burnetii  in  serum  from  kangaroos 
from Western Australia using an ELISA 
The antibody-ELISA described in Chapter 5 was used to detect antibodies to 
C. burnetii in kangaroo serum.  All samples were tested in duplicate and the OD 
values of the samples were normalised by dividing them by the mean OD value of 
the positive control from the same microtitre plate and converted to a percentage 
(PP).  All samples with PP values ≥40% were classified as positive. 
6.2.5  Purification of Coxiella  burnetii whole genomic DNA from faeces and 
urine 
Whole genomic  DNA  was extracted  from  all marsupial faecal samples and 
most  ruminant  samples  using  the  optimised  procedure  described  in Chapter 2.  
The DNA purified from bovine urine were kindly provided by Dr. Peter Wai‟in.  The 
method used was as follows.  Five millilitres of each sample was centrifuged for 30 
minutes at 3,000 × g and all but 0.5 ml of the supernatant was discarded.  The 
pellet was resuspended in the retained supernatant and centrifuged for 10 minutes 
at 7,500 × g and the whole supernatant was carefully removed.  Whole genomic 
DNA  was  then  extracted  according  to  one  of  two  methods.    For  clear  urine 
samples the pellet was resuspended in 50 µl of sterile water by vigorous pipetting, 
incubated  at  room  temperature  for  two  minutes  then  incubated  at  95°C  for  10 
minutes.  Tubes were centrifuged briefly to condense droplets in the cap prior to 
storage at -20°C.  This method was obtained from the Animal Research Institute, 
Queensland  Department  of  Primary  Industry  and  Fisheries,  Moorooka, 
Queensland.  For urine samples that were contaminated by faecal matter a Qiagen 
Tissue Minikit (Qiagen, Hilden, Germany) was used to extract and purify whole  
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genomic  DNA  according  to  the  manufacturers  instructions  with the final elution 
made in 50 µl of buffer AE. 
6.2.6  Quantitative  PCR  detection  of  Coxiella  burnetii  DNA  isolated  from 
faeces and urine 
Coxiella burnetii DNA was amplified using two qPCR assays as described in 
Chapter 2 with 5 µl of DNA template per reaction.  All samples were tested in 
duplicate and two „no template‟ controls (NTC) were included with every run.  Four 
C. burnetii DNA standards made from Q Vax™ vaccine (CSL, Parkville, Australia) 
as described previously were also included in each run to enable quantification of 
target DNA in unknown samples. 
6.2.7  Conventional PCR and sequencing 
Coxiella burnetii DNA was also amplified using a conventional PCR with the 
OMP1/OMP2 primer set performed as described previously (Zhang, Nguyen et al. 
1998).    Briefly, reaction mixes contained 200 mM dNTP‟s, 1.5 mM magnesium 
chloride, 2.5 µl of 10x reaction buffer, 5 Units of TAQ-1 DNA polymerase (Fisher 
Biotech,  Perth,  Western  Australia),  20  pmoles  of  each  primer  and  PCR-grade 
water to a total volume of 23 µl.  Two microliters of purified DNA template was 
added to each reaction mix.  Cycling conditions consisted of an initial denaturation 
step at 94
oC for 3 minutes followed by 40 cycles of 94
oC for 1 minute, 54
oC for 1 
minute and 72
oC for 1 minute.  Cycling was performed on an Applied Biosystems 
GeneAmp® PCR System 2700 (Applied Biosystems, Foster City, California, USA). 
The purified PCR products  were sequenced using the Big Dye version 3.1 
terminator kit (Applied Biosystems) using the dideoxynucleotide chain termination 
method (Sanger, Nicklen et al. 1977).  The sequence was determined using an  
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ABI  Prism  Applied  Biosystems  377  automatic  DNA  sequencer  (Applied 
Biosystems) at the State Agriculture and Biotechnology Centre (Perth, Western 
Australia).    Chromatogram  sequencing  files  were  edited  using  Chromas  Lite 
version  2.0  (Technelysium  P/L,  Helensvale,  Queensland,  Australia).  Sequence 
information obtained was compared to sequence information previously submitted 
to GenBank using BLAST software available from http://www.ncbi.nlm.nih.gov. 
Sequencing was performed on all samples that were positive when tested with 
the JB153-3 qPCR and a random selection of samples that were positive when 
tested with the IS1111a qPCR. Sequencing was attempted on amplicons from 13 
ruminant samples and 16 kangaroo samples. 
6.2.8  Assessment of the effect of PCR-inhibitors in faecal DNA extractions 
Samples of DNA from faeces that produced no detectable amplification were 
used  to  assess  the  amount  of  PCR  inhibition  caused  by  factors  that  were  co-
purified during the DNA extraction process.  Forty two bovine samples, 20 ovine 
samples and 38 marsupial samples were selected for this experiment.  Eighteen 
micro litre aliquots were taken from each sample and 2 µl of DNA extracted from 
Q-Vax vaccine  using the Qiagen Tissue Minikit  was added.  Two microliters of 
DNA extracted from Q-Vax vaccine was also added to 18 µl of high-pure water to 
serve as an uninhibited control.  Amplification of 5 µl of template per reaction, in 
duplicate, was conducted and data analysed as described previously. 
The statistical significance of any differences in the estimate concentration of 
genome equivalents present in control and test samples was determined using a 
one-way ANOVA and post-hoc (LSD) analysis at a 95% confidence limit.  
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6.2.9  Isolation of Coxiella burnetii from bovine and kangaroo faeces 
Isolation of viable C. burnetii cells was attempted with four ruminant and six 
kangaroo samples.  All in vitro culture work was conducted by Michelle Lockhart in 
the PC-3 biocontainment laboratory [AQIS approved] of the Australian Rickettsial 
Reference Laboratory (ARRL), in the Hunter Area Pathology Service, John Hunter 
Hospital,  Newcastle,  NSW.    In  the  procedure  developed  by  the  ARRL  faecal 
samples were resuspended in 10 ml of PBS and mixed until the suspension was 
homogenous.    Solid  matter  was  removed  by  centrifugation  at  100  ×  g  for  five 
minutes and the resulting supernatant was centrifuged at 5,000 × g for 15 minutes 
to pellet bacterial cells which were subsequently resuspended in 5 ml of PBS.  The 
suspensions were subjected to two further slow speed/high speed centrifugation 
steps (100 × g/5,000 × g) before passing the resuspended pellet through a 0.45 
µm filter.  Half of the filtrate was divided into two confluent cultures of vero cells 
and two microfuge tubes for DNA extraction according to the procedure described 
by Klee and company (2006).  The remaining filtrate was passed through a 0.22 
µm filter and the resulting liquid was again divided equally between two flasks of 
vero cells and two microfuge tubes for DNA extraction according to the procedure 
of Klee and company (2006).  Faecal samples had been frozen after collection and 
subjected to at least three freeze-thaw cycles prior to attempts at isolation. 
6.2.10  Data analysis 
All statistical analyses were performed with the Statistical Package for Social 
Sciences  (SPSS  version  15.0,  SPSS  Inc.,  Chicago,  USA)  unless  indicated 
otherwise. 
Analysis  of  raw  qPCR  data  was  performed  using  the  Rotorgene
®  3000 
software to automatically select optimal cycle threshold cut-offs based on the slope  
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of the standard curve and the R
2 value.  The user-defined DNA concentration of 
the standards was then used by the software to provide estimates of the DNA 
concentration of the unknown samples. 
The  level  of  agreement  between  the  immunological  tests  and  qPCR  was 
determined  by  calculation  of  the  kappa  statistic  (Petrie  1999).    A  two-tailed 
dependent  sample  Student‟s  T-test  was  also  used  to  determine  the  statistical 
significance of any difference in genome equivalents estimated using the IS1111a 
qPCR and JB153-3 qPCR with samples classified as either positive or negative 
using data from the ELISA results. 
Due  to  the  low  number  of  immunologically-positive  ruminant  samples  no 
statistical analyses were performed using these data.  The apparent prevalence 
and 95% binomial confidence intervals (Petrie and Watson, 1999) were calculated 
using  results  from  testing bovine and ovine serum and faeces with ELISA and 
qPCR respectively. 
A  one-way  ANOVA  with  post-hoc  analysis  (Tukey‟s  HSD)  and  two-tailed 
independent sample Student‟s T-test with 95% confidence limits were used where 
appropriate to determine the statistical significance of observed differences in the 
mean genome equivalent copy number estimated using results from the qPCR and 
ELISA for ruminant and kangaroo samples and other factors including: collection 
location and month, age and sex.  
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6.3  Results  
6.3.1  Results from testing ruminant and kangaroo serum for the presence of 
anti-Coxiella burnetii antibodies 
6.3.1.1  Results of testing sera for the presence of anti-Coxiella burnetii 
antibodies using the complement fixation test 
All bovine and ovine serum samples were negative when tested with the CFT.  
None  of  the  sera  reacted  strongly  at  a  dilution  greater  than  1  in  8.  No  strong 
reactions were seen in any of the samples that were heat inactivated. 
A random selection of 20 serum samples from kangaroos was tested using 
the CFT to determine if the test was applicable to this species.  Strong non-specific 
reactions that could not be reduced through heat inactivation were observed in all 
samples and this made interpretation of results impossible. 
6.3.1.2  Detection of antibodies to Coxiella burnetii in serum from using an 
ELISA 
Two  of  the  329  bovine  sera  (0.6%;  0-1.4%  CI‟s)  and  no  ovine  sera  were 
positive  using  the  CHEKiT  Q  fever  ELISA  based  on  the  cut-off  specifications 
recommended  by  the  manufacturer.    Four  bovine  sera  were  classified  in  the 
„suspect‟ range (between 30% and 39% of the absorbance value for the positive 
control wells) when initially tested.  All of these samples were re-tested and none 
met the criteria for positivity and thus were classified as negative.  One of the two 
positive  samples  was  collected  from  an  animal  in  Pinjarra  while  the  other  was 
taken from an animal at the Vasse experimental feedlot, which had originally been 
purchased from a farm in the Gascoigne region of WA.  
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6.3.1.3  Detection of antibodies to Coxiella burnetii in serum from kangaroos 
using an ELISA 
A  total  of 115 of 343 (33.5%; 28.5-38.5% CI‟s)  sera from  kangaroos were 
positive when tested using the modified ELISA.  The number of ELISA-positive 
samples from animals from each location, the number of ELISA-positive samples 
for  each  sex  and  age  group  of  kangaroo  and  the  number  of  ELISA-positive 
samples for each collection month are shown in Tables 6.1-6.3 respectively.  
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Table 6-1.  The number of ELISA-positive serum samples from kangaroos 
from different locations in Western Australia (95% confidence intervals in 
parentheses) 
Location  Number positive  Number sampled  Percent positive (95% CI’s) 
Capel  10  123  8.13 (3.3, 13.0) 
Manjimup  43  113  38.05 (29.10, 47.01 
Bagingarra  12  30  40.00 (22.47, 57.53) 
Preston Beach  23  28  82.14 (67.96, 96.33) 
Eneabba  10  17  58.82 (35.43, 82.22) 
Whiteman Pk   17  32  53.13 (35.83, 70.42) 
TOTAL  115  343  33.53 (28.53, 38.52) 
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Table 6-2.  The number and proportion of ELISA-positive kangaroo serum 
samples for each sex and age group (95% CI‟s in parentheses) 
      Number positive  Number sampled  Percent positive (95% CI’s) 
Sex  Male  64  177  36.2 (29.1, 43.2) 
Female  51  166  30.7 (23.7, 37.7) 
Age  1  0  3  0.0 
2  2  4  50.0 (1.0, 99.0) 
3  12  40  30.0 (15.8, 44.2) 
4  101  296  34.1 (28.7, 39.5) 
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Table 6-3.  The number and proportion of ELISA-positive kangaroo serum 
samples for each collection month (95% CI‟s in parentheses) 
Month  Number positive  Number sampled  Percent positive (95% CI’s) 
March  0  36  0.0 
April  0  20  0.0 
May  22  65  33.9 (22.3, 45.4) 
June  61  138  44.2 (35.9, 52.5) 
July  32  84  38.1 (27.7, 48.5) 
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Serum  from  three  pairs  of  females  and  their  pouch  young  (young  number 
1433  with  mother  1434,  young  1594  with  mother  1604  and  young  1595  with 
mother 1600) were tested with the modified ELISA (using combined phase I and 
phase II antigen) and with phase I and phase II antigen individually as described in 
Chapter 5.  For the first pair no antibodies were detected in either mother or young 
using the combined C. burnetii antigens and the ratios of pI/pII for mother and 
young were 1.18 and 0.66 respectively.  For the second and third mother/young 
pairs the mothers were ELISA-positive but the pouch young were negative.  All 
serum  samples  from  pouch  young  had  OD  values  below  the  negative  control 
values when tested with the ELISA. 
The mean PP values of samples collected in June were significantly higher 
than the PP means of samples collected in March, April and May (p<0.05).  The 
mean PP values of samples collected in July were significantly higher than the PP 
values of samples collected in March and April (p<0.005). 
There was no significant difference in the mean PP values of male and female 
kangaroos and there was no significant association between the calculated PP 
values and the age group of the kangaroos. 
The mean PP for samples collected in Capel was significantly lower than the 
PP for samples collected in all other locations with the exception of Badgingarra 
(p<0.001).    The  mean  PP  values  of  samples  collected  from  Manjimup  and 
Badgingarra were significantly lower than the PP values of samples collected at 
Preston Beach (p<0.05). 
The mean PP values for samples collected from Capel in March and May were 
found to be significantly lower than the mean PP values for samples collected in  
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July (p<0.05).  No statistically significant association was found between the mean 
PP values and the sex of the animals sampled in Capel. 
The  mean  PP  values  of  samples  collected  from  Manjimup  in  April  were 
significantly  lower  than  the  mean  PP  of  samples  collected  in  other  months 
(p<0.001).  No statistically significant association was found between the mean PP 
values and the sex of the animals sampled in Manjimup. 
6.3.2  Results from testing ruminant faecal and urine samples for the presence 
of Coxiella burnetii DNA using a quantitative polymerase chain reaction 
The number of positive bovine and ovine samples in each collection location 
according to the IS1111a qPCR tests are shown in Table 6.5.  As there were only 
three ruminant samples that were positive when tested with the JB153-3 qPCR 
these results have been excluded from the table.  Table 6.6 shows the number of 
IS1111a  qPCR-positive  samples  that  were  detected  in  each  collection  location, 
table 6.7 shows the number of IS1111a qPCR-positive samples that were detected 
for  each  sex  and  age  group  of  kangaroo  and  table  6.4  shows  the  number  of 
IS1111a qPCR-positive samples that were detected for each collection month.  As 
there  were  only  six  kangaroo  samples  that  were  positive  when  tested  with  the 
JB153-3 qPCR these results have been excluded from the following tables.  
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Table 6-4.  Results from testing faeces and urine collected from cattle and 
sheep from different collection locations with the IS1111a qPCR 
   
Species 
      Bovine  Ovine 
Pinjarra  No. Tested  113  NA 
No. Pos  14  NA 
%  12.4  NA 
Northern  No. Tested  124  NA 
No. Pos  11  NA 
%  8.9  NA 
Murdoch  No. Tested  48  50 
No. Pos  1  6 
%  2.1  12 
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Table 6-5.  Results from testing faeces from kangaroos from different locations 
with the IS1111a qPCR (95% CI‟s in parentheses) 
   Number positive  Number sampled  Percent positive (95% CI’s) 
Capel  10  123  8.1 (3.3, 13.0) 
Manjimup  17  113  15.0 (8.5, 21.6) 
Bagingarra  3  30  10.0 (-0.7, 20.7) 
Preston Bch  1  28  3.6 (-3.3, 10.5) 
Eneabba  2  17  11.8 (-3.6, 27.1) 
Whiteman Pk   8  32  25.0 (10.0, 40.0) 
TOTAL  41  343  123.0 (8.5, 15.4) 
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Table 6-6.  Results from testing faeces from kangaroos for each sex and age 
group with the IS1111a qPCR (95% CI‟s in parentheses) 
      Number positive  Number sampled  Percent positive (95% CI’s) 
Sex 
Male  26  177  14.7 (9.5, 19.9) 
Female  15  166  9.0 (4.7, 13.4) 
Age 
1  0  3  0.0 
2  0  4  0.0 
3  6  40  15.0 (3.9, 26.1) 
4  35  296  11.8 (8.2, 15.5) 
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Table 6-7.  Results from testing faeces from kangaroos for each collection 
month with the IS1111a qPCR (95% CI‟s in parentheses) 
   Number positive  Number sampled  Percent positive (95% CI’s) 
March  8  36  22.2 (8.6, 35.8) 
April  5  20  25.0 (6.0, 44.0) 
May  8  65  12.3 (4.3, 20.3) 
June  11  138  8.0 (3.5, 12.5) 
July  9  84  10.7 (4.1, 17.3) 
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6.3.2.1  Inhibition of PCR by factors co-purified during the DNA isolation 
procedure 
Five  of  the  42  bovine  samples  of  faeces  tested  contained  factors  that 
significantly reduced the estimated DNA concentration (p<0.05) in a qPCR system.  
None of the 20 ovine extracts tested displayed inhibition of amplification that was 
significant  at  the  95%  confidence  level,  while  five  of  the  32  kangaroo  faecal 
extracts  had  significantly  lower  estimates  of  C.  burnetii  DNA  concentration 
(p<0.05) than the mean DNA concentration of all samples. 
6.3.2.2  Results from testing ruminant faecal and urine samples for the 
presence of Coxiella burnetii DNA using a quantitative polymerase chain 
reaction 
All no template controls were negative in all runs of the PCR.  No significant 
differences were found when comparing sample result classification and collection 
location or ruminant species. 
6.3.2.3  Results from testing kangaroo faecal samples for the presence of 
Coxiella burnetii DNA using a quantitative polymerase chain reaction 
No template controls were negative in all runs of the PCR.  There were no 
significant associations observed in the proportion of all samples positive using the 
JB153-3 and IS1111a qPCR tests and the origin, age and sex of the kangaroos 
and  month  of  sample  collection.    There  were  significantly  more  qPCR-positive 
samples detected from animals sampled in March in Capel compared to May and 
July (p<0.05).  
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6.3.2.4  Sequencing results 
Sequencing of the com1 amplicon was successful in all but one instance with 
all matches showing greater than 99% identity with C. burnetii Dugway strain.  A 
summary of the sequence results is shown in Appendix B. 
6.3.3  Isolation of Coxiella burnetii from faeces 
Attempts  to  isolate  C.  burnetii  from  four  ruminant  and  six  kangaroo  faecal 
samples  were  unsuccessful.  Samples  were  re-tested  with  the  JB153-3  qPCR 
which confirmed the presence of C. burnetii DNA. 
6.4  Discussion  
6.4.1  Testing bovine and ovine serum samples for the presence of anti-Coxiella 
burnetii antibodies using the complement fixation test and ELISA 
There are many published reports that confirm that C. burnetii is endemic in 
the world-wide ruminant population with greater than 19% of animals showing an 
immunological  response  indicative  of  exposure  (Arricau-Bouvery  and  Rodolakis 
2005).    There  is  also  evidence  suggesting  that  prevalence  of  exposure  to  C. 
burnetii  is  increasing  in  some  countries  (Hellenbrand,  Breuer  et  al.  2001; 
Hatchette, Campbell et al. 2002).  Despite this there is little data on the prevalence 
of C. burnetii infection in domestic livestock in Australia.  Indeed, one of the few 
studies in Australia suggested that ruminant livestock in South Australia were not a 
significant reservoir of C. burnetii infection (Dane and Beech 1955).  This finding 
was  supported  by  a  serological  survey  of  abattoir  workers  in  Queensland  that 
found  that  only  1%  of  individuals  had  detectable  antibodies  against  C.  burnetii 
(McKelvie 1980).  These studies were conducted over 28 years ago and so the 
data provided and the methods used are not current.  However, the results of this  
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study indicate that the conclusions of Dane and Beech (1955) and McKelvie (1980) 
may still be relevant. 
Results from testing 379 ruminant samples with the CFT and CHEKiT Q fever 
ELISA  showed  low  to  negligible  sero-prevalence.  It  is  possible  that  the  low 
apparent prevalence of C. burnetii infection may be due to the poor sensitivity of 
the tests used.  It has been found that the sensitivity of CFT (73%) is inferior to 
that obtained in an ELISA (99%) but the CFT has superior specificity (90%) in 
comparison to ELISA (88%) (Field, Mitchell et al. 2000).  However, it is unlikely 
that the population of ruminants sampled had a true seroprevalence any higher 
than 2%.  It is also possible that using antigen made with the Nine Mile strain of C. 
burnetii may not be appropriate for use in Australian studies and may lead to an 
underestimation of the serological prevalence of this pathogen (Rodolakis, Bouzid 
et al. 2007).  However, the animals in this study had diverse points of origin prior to 
being  sampled  and  thus  the  results  presented  here  may  represent  a  more 
widespread trend in the state of Western Australia. 
6.4.2  Testing ruminant faecal and urine samples for the presence of Coxiella 
burnetii DNA and the agreement of these results with immunological findings 
Sequencing of the OMP1/OMP2 PCR products gave results that were most 
similar  to  the  Dugway  C.  burnetii  strain.    Previous  studies  have  placed  an 
Australian human isolate of C. burnetii in genetic Group II while the Dugway strain 
has been placed in Group VI according to RFLP analysis (Hendrix, Samuel et al. 
1991).  However, a more recently published study found that, on the basis of 16S 
rRNA  and  IS1111a  DNA  sequence  comparisons,  a  series  of  wombat  isolates 
showed greatest similarity to the Dugway strain (Vilcins, Old et al. 2009).  Further 
genetic characterisation of C. burnetii DNA in positive kangaroo faecal samples  
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may  provide  valuable  insights  into  the  relatedness  of  Australian  isolates  of  C. 
burnetii. 
There  was  poor  agreement  between  the  ELISA  results  and  the  qPCR 
targeting  the  IS1111a  repetitive  element,  which  detected  a  significantly  higher 
proportion of test- positive samples.  This may be because in the early stages of C. 
burnetii  infection  the  host  may  not  have  generated  an  immune  response  to 
Coxiella but may still be shedding organisms in bodily secretions and faeces (Berri, 
Souriau et al. 2002).  The sensitivity of the Idexx CHEKiT ELISA has also been 
questioned (Rodolakis, Berri et al. 2007) and this must be taken into account when 
interpreting these data.  However, the issue of contamination of the qPCR samples 
should also be considered.  Contamination could have occurred before or after 
DNA extraction with either PCR product or with C. burnetii cells themselves (Kwok 
and Higuchi 1989).  The likelihood of contamination of new reaction mixtures with 
PCR product was reduced through the use of Invitrogen Platinum qPCR master 
mix (refer  to Chapter 2 for  details) and confirmatory testing with qPCR assays 
targeting other C. burnetii genes.  Results that show a positive classification of 
samples in only one assay supports the theory that contamination was not caused 
by  carryover  of  PCR  amplicon.    Therefore,  if  contamination  was  causing  false 
positive PCR and sequencing results it was most likely due to whole phase II C. 
burnetii cells (only the phase II form was cultured at Murdoch University) and the 
distinction between a true and false result would not be possible with the gene 
targets  used  to  detect  the  organism.    Thus,  the  quantitative  PCR  that  was 
developed  to  amplify  phase  I  C.  burnetii  only,  JB153-3,  may  provide  a  more 
accurate  representation  of  the  samples  that  were  truly  positive.    However,  the 
JB153-3  gene  lies  in  a  redundant  genomic  region  that  is  not  under  the  same 
selection pressure as genes which are transcriptionally active.  It is possible that 
wild-type strains may not have retained this genetic element although the JB153-3  
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element was present in the genomes of all four phase I strains tested and absent 
from the four phase II strains of C. burnetii that have been analysed (Hoover, Culp 
et al. 2002).  If the JB153-3 qPCR results are used to identify the positives then 
the  confidence  in  a  positive  result  increases  and  the  confidence  in  a  negative 
result decreases.  These results also highlight the extreme contamination risk that 
C.  burnetii  poses  in  laboratories  where  in  vitro  culture  and  ultra-sensitive 
diagnostic qPCR are performed side-by-side. 
6.4.3  Ruminants and Q fever in Australia 
The finding that the prevalence of antibodies to, and shedding of, C. burnetii 
by  the  ruminants  sampled  is  at  odds  with  epidemiological  studies  from  other 
countries.  However, it is almost certain that cattle, sheep, and to a lesser extent, 
goats  are  involved  in  transmission  of  C.  burnetii  to  humans  in  Australia.  Many 
human cases are reported  every year  in red meat industry workers and it is a 
recognized  occupational  hazard  in  this  group  (Garner,  Longbottom  et  al. 1997; 
Worksafe 2001; Chong, La Brooy et al. 2003).  A retrospective cohort study in 
Australia showed that of 2555 abattoir workers who were vaccinated with Q-Vax, 
two cases of Q fever were reported and both of these were within a few days of 
vaccination (Ackland, Worswick et al. 1994).  Conversely, Ackland et al. (1994) 
noted that there were 55 cases among the 1365 unvaccinated employees.  The 
results of the study by Ackland et al. (1994) indicated that vaccination appeared to 
be protective for at least five years (the period of the study) although repeated 
natural exposure may have contributed to protection.  Therefore, the mandatory 
vaccination program in the red meat and kangaroo abattoirs in some Australian 
States appears to be justified, but the interaction between domestic and wildlife 
cycles of C. burnetii in Australia remains unknown.  
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6.4.4  Detection  of  antibodies  to  Coxiella  burnetii  in  serum  from  kangaroos 
from Western Australia using an ELISA 
Results from testing serum from kangaroos from WA suggest that Australian 
marsupials may play a more significant role in the maintenance of C. burnetii in the 
environment than was previously thought.  The ELISA results suggest an exposure 
rate  of  nearly  34%  in  all  collection  locations  spanning  approximately  500 
kilometres from the most northerly location to the location furthest south.  In some 
areas the prevalence of anti-C. burnetii antibodies was as high as 92.8%, although 
there  was  a  strong  relationship  between  sero-positivity  and  the  month  that  the 
samples were collected which probably skewed the results for locations that were 
only sampled once or twice.  Samples collected in Capel did not yield test results 
that were significantly influenced by month whereas those collected in Manjimup 
did,  indicating  that  seropositivity of kangaroos may also be linked to the home 
range  of  a  particular  population.    The  results  support  earlier  work  in  Australia 
(Pope,  Scott  et  al.  1960)  that  found  that  68  of  296  kangaroos  sampled  were 
antibody  positive  for  C.  burnetii  according  to  the  CFT  and  44  of  296  were 
agglutinin positive.  Pope et al. (1960) observed that red kangaroos had a higher 
incidence of complement fixing antibodies than did grey kangaroos and in some 
locations the percentage of complement fixing antibodies in red kangaroos was as 
high as 54%.  Pope et al. (Pope, Scott et al. 1960) successfully isolated C. burnetii 
from  the  blood  of  one  grey  kangaroo  and  13  of  nearly  3,000  kangaroo  ticks 
(Amblyomma triguttatum) collected in the study.  Interestingly, four of the 13 ticks 
from which C. burnetii was isolated were found on goats and sheep.  Amblyomma 
triguttatum requires three different hosts to develop to maturity and thus Pope et al 
(1960) proposed that the tick may be responsible for the transfer of C. burnetii 
between host species.  The authors also concluded from these data that a natural 
kangaroo-tick cycle existed.  
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In other animals it has been shown that for several days to months following 
parturition C. burnetii is shed in milk, urine and faeces and thus it is during this 
period that naïve animals are most at risk of being infected (Berri, Souriau et al. 
2001;  Arricau  Bouvery,  Souriau  et  al.  2003).    Parturition  in  Western  grey 
kangaroos  occurs  approximately  in  February  (Dawson  2002)  but  spread  of 
infection from kangaroo birth products is unlikely because products of parturition 
are minimal in quantity.  However, animals may have suppressed immune systems 
around this time which may increase their susceptibility to infection via the faecal-
oral  route.    This  mode  of  infection  may  be  facilitated  by  increased  rainfall  in 
April/May,  which  leads  to  a  proliferation  of  new  green  feed.    This  is  because 
sudden change in the composition of feed being ingested by kangaroos may result 
in  decreased  faecal  consistency  and  disruption  of  the  natural  gut  flora  of  the 
kangaroos which may reduce their intrinsic resistance to enteric pathogens.  This 
theory is supported by preliminary data on the prevalence of  Salmonella in the 
faeces of the same kangaroos included in this study (Bestall 2008) and by a time-
series  analysis  of  Q  fever  in  French  Guiana  which  found  a  strong  correlation 
between rainfall and disease incidence with a lag period of one to three months 
(Gardon, Heraud et al. 2001).  Alternatively, the explosion in arthropod populations 
that occurs after heavy rainfall (Mushi, Binta et al. 2003) may facilitate vector-born 
transfer of coxiellae. 
On the three occasions that dams and their pouch young were sampled and 
tested serologically there was no evidence that the young had been exposed to C. 
burnetii.  This might indicate that kangaroos do not shed coxiellae in milk but given 
the small samples size it is not possible to draw any conclusions with confidence.  
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6.4.5  Testing  kangaroo  faecal  samples  for  the  presence  of  Coxiella  burnetii 
DNA using a quantitative polymerase chain reaction 
It was surprising that the level of agreement between the results from testing 
samples from kangaroos with the ELISA and JB153-3 qPCR was much lower than 
the  results  obtained  from  ruminant  samples.    Fundamental  differences  in  host 
biology may help to explain the differences observed.  However, it is not possible 
to  confirm  them  without  undertaking  a  histopathological  study  of  tissues  from 
kangaroos that are confirmed to be infected with C. burnetii.  Sanchez et al. (2006) 
found that C. burnetii was detectable by PCR in mammary gland and lung, but not 
in liver or spleen eight days after abortion in a group of experimentally infected 
goats.  These animals continued to shed C. burnetii in vaginal secretions and milk 
26 and 30 days post abortion respectively (Sanchez, Souriau et al. 2006).  These 
results may indicate that during pregnancy coxiellae proliferate and invade several 
tissue types but following parturition the pathogen may retreat to tissues that are 
conducive to its dissemination.  Conducting similar experiments in kangaroos, in 
combination with histopathology, would allow the natural transmission cycle to be 
defined,  which  will  help  determine  the  role  of  marsupials  as  reservoirs  of  C. 
burnetii. 
6.4.6  Conclusions 
In other livestock species there is considerable variation in data linking season 
with outbreaks of disease (Enright, Franti et al. 1971; Yanase, Muramatsu et al. 
1997; Raoult, Tissot-Dupont et al. 2000; Hellenbrand, Breuer et al. 2001).  There 
has been no defined link between season and outbreaks of Q fever in humans in 
Australia (McKelvie 1980; Garner, Longbottom et al. 1997).  The lack of agreement 
between studies related to the seasonal variation of Q fever between and within  
12/06/2009  School of Veterinary and Biomedical Sciences   
6-235 
countries indicates that not all contributing factors have been identified.  In Cyprus, 
a  geographic  information  system-based  approach  was  used  to  examine  the 
relationship between human and ruminant seropositivity to C. burnetii.  However, 
the analysis revealed that the prevalence in the human population  was greater 
than  that  found  in  local  ruminants  suggesting  that  there  could  be  another 
significant  reservoir  of  Q  fever  in  Cyprus  (Psaroulaki,  Hadjichristodoulou  et  al. 
2006).  The importance of a wild reservoir to the dissemination of C. burnetii was 
also highlighted in a study of Q fever in French Guiana where wind and livestock 
movements were found to be insufficient to account for the exposure distribution 
observed  (Gardon,  Heraud  et  al.  2001).  Because  different  ELISA  assays, 
incorporating different antigens, were used for ruminants and kangaroos it is not 
possible to make direct comparisons between the two data sets.  However, current 
serological  findings of the seroprevalence of  C. burnetii in Australian ruminants 
cannot account for all cases of transmission of Q fever.  Further work is required to 
elucidate the role that a putative wildlife reservoir plays in transmission to both 
domestic  animals  and  humans. 
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7.  General Discussion 
Coxiella burnetii is a significant pathogen of humans but, perhaps due to its 
ubiquity in all geographic locations, there has been no effort to develop integrated 
detection  and control measures in the livestock production industry.  The main 
goal of this study was to develop a highly sensitive, robust and specific quantitative 
polymerase  chain  reaction  assay  which  was  compatible  with  environmental 
samples  associated  with  domestic  ruminants  and  native  Australian  marsupials.  
The resulting qPCR assay system, including a DNA purification method, targeting 
the repetitive IS1111a element was shown to be extremely sensitive, specific and 
reproducible under laboratory conditions for the detection of C burnetii. 
This is the first time an ELISA has been successfully used to detect anti-C. 
burnetii antibodies in kangaroos.  The ELISA also appears to be compatible with 
bandicoot  serum  and  thus  will  be  an  important  tool  for  future  surveillance  of 
Coxiella  infections  in  Australian  marsupials.    The  results of this research also 
suggest that domestic ruminants may not be the most significant reservoir of C. 
burnetii in Western Australia and that kangaroos may pose a significant threat for 
zoonotic  transfer  of  this  pathogen,  particularly  for  people  associated  with  the 
kangaroo meat industry.  Further research is required to adequately define the 
significance of this threat in WA and the Eastern states of Australia and to help 
understand the epidemiology of Coxiella infections in marsupials. 
A  cell  culture/qPCR-based  assay  system  to  determine  the  efficacy  of 
disinfectants against C. burnetii was optimised and validated.  This assay system 
provided quantitative results with a wide dynamic range and was compatible with 
both physical and chemical agents.  The results showed that sodium hypochlorite 
had high efficacy against  C. burnetii, a finding which is at odds with published  
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data.    These  findings  need  to  be  confirmed  using  phase  I  cells  and  animal 
inoculation before they can be accepted as valid but it appears likely that treatment 
of liquid waste with sodium hypochlorite is a viable method of reducing the load of 
C. burnetii in such matrices. 
An  RNA  extraction  and  quantitative  reverse  transcription  PCR  system  for 
detection  of  gene  expression  by  C.  burnetii  in  soil  samples  was  developed  to 
provide a method for the assessment of viability.  This method was able to detect 
transcriptional  activity  in  C.  burnetii  cells  added  to  soil  for  at  least  35  days.  
However, the correlation between detection of the presence of RNA and the actual 
viability of a cell is not always perfect and thus results yielded by this type of test 
should be interpreted with caution.  This is particularly true with an organism such 
as C. burnetii that can be metabolically dormant and remain viable and infectious 
in the environment for long periods of time.  Furthermore, the results from this 
study need to be validated against the gold standard viability assay for C. burnetii, 
animal  inoculation,  and  be  reassessed  with  the  virulent  phase  I  form  of  the 
organism. 
Results from  testing faecal or  urine samples from  livestock and kangaroos 
showed  that  interpretation  of  the  PCR  results  may  be  confounded  by 
contamination with extraneous DNA.  The source of the contamination was most 
likely the phase II C. burnetii that was cultured for other experiments.  A qPCR 
targeting a redundant  gene,  JB153-3, which is deleted in phase II strains, was 
developed to clarify the classification of test results for all samples.  However, the 
JB153-3  qPCR  is  potentially  less  sensitive  compared  to  the  IS1111a  qPCR 
because it is less abundant in the C. burnetii genome.  This may explain why the 
proportion of faecal samples from ruminants and kangaroos was approximately 
75% lower when the JB153-3 PCR compared to the IS1111a qPCR.  
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The  lack  of  agreement  observed  between  qPCR  and  serological  results 
appeared to be a function of the cryptic nature of shedding that occurs during C. 
burnetii infection and serves to highlight that neither test can provide categorical 
infection status data when used in isolation.  A strong association was observed 
between  seropositivity  of kangaroos and the months of June and July, a trend 
which  may  be  related  to  the  first  significant  rainfall  of  the  year.    However,  a 
corresponding  increase in qPCR-positive samples in May was not observed as 
would be expected given that it may take as long as 30 days for a detectable IgG 
response to develop after initial infection.   
Overall, this project  has developed tools to improve the surveillance for  C. 
burnetii in livestock-associated industries while also providing a means to assess 
the efficacy of disinfectants in the liquid waste these industries produce.  Used as 
an integrated suite of technologies, these tools can provide the livestock industry 
with  the  means  to  assess  the  risk  of  infection  posed  by  C.  burnetii  and  to 
implement  control  strategies  which  have  quantifiable  efficacies.    Informed  risk-
management can thus be undertaken that can aid in-house occupational health 
and safety programs and be used as evidence for Government regulators.  During 
the development of these tools it was revealed that a commonly used industrial 
disinfectant may be efficacious against C. burnetii and also that native Australian 
marsupials may be a significant wild reservoir of coxiellae.  Both of these findings 
have implications for individuals who come into contact with domestic ruminants 
and  native  marsupials  and  will  hopefully  lead  to  new  research  into  the 
epidemiology  of  Q  fever  in  Australia. 
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8.  Appendices 
Appendix A  OD  values  and  percentage  reduction  in  OD  value 
following addition of blocking agents for kangaroo serum samples 
tested with an ELISA 
  Absorbance   
Sample 
ID 
No secondary Ab 
blocking 
With secondary Ab 
blocking 
% reduction in 
Abs 
1265  1.6  1.2  20.8 
1266  0.6  0.4  32.9 
1268  0.7  0.6  21.2 
1269  1.3  1.1  20.1 
1270  1.3  1.1  19.4 
1271  1.4  1.2  16.3 
1272  1.5  1.1  23.0 
1273  1.4  1.2  18.6 
1274  0.8  0.6  32.7  
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1275  1.5  1.3  16.2 
1276  1.5  1.1  25.4 
1277  1.0  0.7  27.5 
1278  2.0  1.5  25.7 
1279  1.8  1.3  29.8 
1280  0.8  0.5  39.2 
1281  1.6  1.0  37.9 
1282  0.8  0.4  47.5 
1283  0.9  0.5  41.6 
1284  1.3  0.9  33.4 
1285  1.2  0.9  25.3 
1287  0.7  0.4  34.6 
1407  0.8  0.6  24.4 
1408  0.9  0.5  50.9 
1409  0.6  0.3  45.8  
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1410  0.9  0.5  41.7 
1411  0.9  0.5  41.9 
1412  1.9  1.5  18.6 
1413  0.8  0.6  34.7 
1414  1.4  1.0  25.8 
1415  0.8  0.6  31.2 
1416  0.9  0.5  45.8 
1417  1.9  1.5  20.9 
1418  0.8  0.5  42.5 
1419  1.0  0.5  44.1 
1420  1.0  0.5  44.6 
1421  0.7  0.5  33.5 
1422  0.8  0.5  38.6 
1423  1.0  0.8  23.6 
1424  1.0  0.5  44.5  
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1425  1.0  0.8  15.8 
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Appendix B Summary of com1 gene sequencing results from both 
ruminant and kangaroo samples 
Sample  Species  BP  Match  Accession  Max. ID  % Cov.* 
90  bovine  442  C.b Dugway  CP000733.1  100  100 
159  bovine  444  C.b Dugway  CP000733.1  100  100 
175  bovine  447  C.b Dugway  CP000733.1  100  99 
189  bovine  456  C.b Dugway  CP000733.1  100  100 
190  bovine  449  C.b Dugway  CP000733.1  100  99 
193  bovine  376  C.b Dugway  CP000733.1  99  99 
200  bovine  448  C.b Dugway  CP000733.1  100  100 
203  bovine  332  C.b Dugway  CP000733.1  100  99 
249  bovine  440  C.b Dugway  CP000733.1  100  100 
348  ovine  361  C.b Dugway  CP000733.1  99  99 
366  ovine  369  C.b Dugway  CP000733.1  99  100 
367  ovine  450  C.b Dugway  CP000733.1  100  100  
12/06/2009  School of Veterinary and Biomedical Sciences   
8-244 
379  ovine  460  C.b Dugway  CP000733.1  100  100 
1202  kangaroo  389  C.b Dugway  CP000733.1  100  100 
1263  kangaroo  -  unsuccessful       
1275  kangaroo  460  C.b Dugway  CP000733.1  100  100 
1348  kangaroo  389  C.b Dugway  CP000733.1  100  100 
1356  kangaroo  444  C.b Dugway  CP000733.1  100  99 
1363  kangaroo  460  C.b Dugway  CP000733.1  100  99 
1374  kangaroo  399  C.b Dugway  CP000733.1  100  100 
1412  kangaroo  376  C.b Dugway  CP000733.1  99  99 
1427  kangaroo  411  C.b Dugway  CP000733.1  100  100 
1437  kangaroo  458  C.b Dugway  CP000733.1  100  100 
1458  kangaroo  401  C.b Dugway  CP000733.1  100  100 
1467  kangaroo  368  C.b Dugway  CP000733.1  99  100 
1503  kangaroo  442  C.b Dugway  CP000733.1  100  100 
1585  kangaroo  377  C.b Dugway  CP000733.1  99  99  
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1607  kangaroo  396  C.b Dugway  CP000733.1  99  99 
1608  kangaroo  418  C.b Dugway  CP000733.1  100  100 
 
*”% Cov” refers to Percent Coverage, or the percentage of nucleotides in the reference 
sequence that are covered by the query sequence. 
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